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Background: Heart failure (HF) is a prevalent disease with a complex symptom 
experience. Black women with Heart Failure preserved Ejection Fraction (HFpEF) are 
especially burdened by symptoms, and their symptom experience is poorly understood. 
Clustering HF symptoms to understand which symptoms are experienced together is a 
potential option for helping patients recognize impending exacerbations. 
Methods: The dissertation's first manuscript is an integrative review to examine the 
current state of HF symptom cluster literature. The second manuscript explores the 
feasibility and acceptability of a mixed methods HF symptom cluster study of Black 
women with HFpEF (N=44) and presents preliminary symptom cluster results. The third 
manuscript presents symptom experience themes from qualitative interviews (N=15) and 
integrates those findings with quantitative questionnaire data.   
Findings: An integrative review of HF symptom cluster literature revealed a need for 
exploring the symptom experience of Black women with HFpEF using mixed methods. A 
convergent-parallel mixed methods study protocol met feasibility benchmarks and was 
deemed acceptable by Black women with HFpEF. Preliminary symptom clusters were 
identified using quantitative symptom data from symptom questionnaires. Qualitative 
themes emerged relating to the symptom experience and person, and mixed methods 
integration provided additional key findings of concordance, discordance, and expansion.   
Conclusion: This dissertation describes the symptom experience of Black women with 
HFpEF, provides valuable information on the recruitment of an understudied population 
and their acceptability of a study protocol, and builds the foundation for conducting a 




Background and Gaps in Knowledge 
 
Heart failure (HF) is a severe cardiovascular disease in which up to 30% of 
patients die within one year after diagnosis (1, 2). HF is the most common cause of 
hospitalization in the U.S. for those over the age of 65, and almost 25% of patients with 
HF will be readmitted within 6 months after discharge (3). Persons with HF experience a 
complex and multifactorial array of symptoms that make symptom self-monitoring and 
self-management difficult (1, 4-6). 
HF symptoms are especially burdensome for Black patients and women. Black 
Americans are 1.5 times more likely to develop HF compared to White Americans (7). 
Black Americans also have a 2.5 times greater risk of dying from HF than White 
Americans (7). Females with HF report more depression, worse quality of life and 
symptom severity, and more frequent and longer hospitalization than males (2, 4, 8-10). 
Females also are more likely to be diagnosed with Heart Failure preserved Ejection 
Fraction (HFpEF) a type of HF caused by diastolic dysfunction in which relaxation of the 
left ventricle is impaired from increased stiffness (2, 11, 12). This type of HF is poorly 
understood, and more research is needed to characterize the symptom experience of 
patients with HFpEF (2, 12). 
Females with HF are diagnosed or referred to cardiologists later than males and 
disproportionately receive fewer recommended therapies or less self-management 
education (2, 13, 14). Black Americans with HF have been noted to have difficulty 
recognizing and interpreting HF symptoms (7). An inadequate understanding of the 
 2 
symptom experience for Black females with HF may lead to delays in treatment and 
ultimately result in avoidable hospitalizations from HF exacerbations (7).  
So far, Black females have been underrepresented in heart failure symptom 
cluster research. There is a critical need to examine the symptom experience of Black 
women with HFpEF and how symptoms cluster in this population. This study aims to 
examine how the intersection of such factors can impact symptom clusters and the 
symptom experience of Black women with HFpEF using mixed methods.  
 
Heart Failure Symptom Clusters 
A symptom cluster is two or more symptoms that occur simultaneously in disease 
(5). Knowledge about how symptoms cluster can help patients to recognize impending 
exacerbations more easily, be used for developing more targeted and effective 
interventions, and assist in determining risk for adverse health outcomes (5, 8, 15-30). A 
small body of literature exists for HF symptom clusters that validates these potential uses 
(5, 8, 15-30).  
However, research that has been conducted in this area minimally examines sex 
differences, does not include qualitative methodologies, and lacks racial and ethnic 
diversity (5, 8, 15-30). Yet, sex/gender and race/ethnicity have a complex interaction that 
influences health and should be considered when studying symptoms (31). Sex and 
gender differences in symptom perception and impact are also prevalent in other chronic 
diseases. Females with Chronic Obstructive Pulmonary Disorder (COPD) report higher 
levels of anxiety and depression, worse quality of life, worse perceived control of 
symptoms, and greater functional impairment (32-35). Women are noted to have 
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increased pain sensitivity and risk, and women with Chronic Venous Disease (CVD) 
were found to have worse neuropathic pain (burning, throbbing, and night cramps) 
compared to males (36). Woman's sex/gender in asthma is associated with more severe 
symptom intensity, frequency, and limitations from symptoms, and women with asthma 
report poorer quality of life (37). This evidence supports the need for sex/gender-specific 
exploration of symptom clusters and the symptom experience. 
Since few Black females have been included in HF symptom cluster research, it is 
first necessary to determine if it is feasible to recruit this population, explore if and what 
barriers and facilitators to adequate recruitment exist, and determine participants' 
willingness to participate in research studies (38). Qualitative methods are needed to 
explore the intersection of gender, sex, and race and their impact on the symptom 
experience, as quantitative instruments alone have limited ability in encompassing such 
factors. Studying the symptom experience and symptom clusters concerning gender, sex, 
race, and type of HF is warranted considering the increased burden of HF symptoms, 
greater risk, and worst outcomes in females, Black Americans, and patients with HFpEF 
(2, 4, 7, 8, 10).  
 
Theoretical Framework 
Many factors contribute to the health disparities and worse outcomes that are 
evident for multiple conditions, such as societal and cultural stressors (7). The Symptom 
Management Model (SMM), shown in Figure 1, highlights the multi-faceted nature and 
complex interactions of symptom components (39). The six components that comprise 
the SMM are symptom experience, components of symptom management strategies, 
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outcomes and symptom status, person, environment, and health and illness (39). For this 
study, symptom experience and person influenced the semi-structured interview guide, as 
these components are well suited for individual interviews, best answer the overall 
research question, and allow for exploration of demographic, psychological, and 
sociological factors that can influence the symptom experience of a Black woman with 
HFpEF (39). These components also guided content analysis of interview data and the 
triangulation of questionnaire and interview results (39). The Minnesota Living with 
Heart Failure Questionnaire (MLHFQ) is a quality-of-life questionnaire that was used to 
collect quantitative data on physical symptoms, emotional symptoms, and quality of life 
(40). These three domains of the MLHFQ also influenced interview guide questions, 
which set the stage for merging of quantitative and qualitative results (40, 41). 
Figure 1: Conceptual model of mixed methods feasibility study components within the 




Current HF practice paradigms diagnose and treat males and females using the 
same guidelines, despite growing evidence of sex differences in symptom expression, 
disease burden, and quality of life (1, 2, 4-6). This study is innovative in that it sought to 
shift this paradigm by emphasizing sex and race, which was consistently lacking in a 
review of the literature (30). This was done by initially exploring the symptom 
experience and symptom clusters for Black females with HFpEF using a mixed methods 
research design.  
The convergent mixed methods design is a novel approach to HF symptom cluster 
research that, to our knowledge, has not been conducted before. Utilizing mixed methods 
allowed for a more comprehensive exploration of the HF symptom experience and 
symptom clusters for Black women. Symptom clusters are created based on data from 
questionnaires, which have a limited ability in assessing personal factors and symptom 
perceptions, evaluations, and responses. Individual, semi-structured interviews guided by 
qualitative description allowed for a straight description of the symptom experience as 
described by participants (42-45).  
Examining study feasibility was needed for understanding the nuances of 
recruitment and data collection within a population of Black females with HFpEF (38). 
Also, the Symptom Status Questionnaire Heart Failure (SSQ-HF) had not been validated 
in this population (38, 46). The SSQ-HF was used to assess the presence, frequency, 
severity, and distress of physical HF symptoms (46). A review of HF symptom cluster 
literature revealed that out of eight studies conducted in the U.S., five had >70% white 
participants, and SSQ-HF has not been well validated in a Black population (24-26, 28-
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31, 36, 46). This study's findings can increase the population's inclusion in future 
research, thus expanding the generalizability of HF symptom cluster research long-term.  
The National Institute of Nursing Research (NINR) has highlighted symptom 
cluster research as a critical component to advancing symptom science (21). This study 
provides valuable insights for recruiting a high-risk and understudied population and 
determining barriers to success for a mixed methods HF symptom cluster study. This 
study can also improve research efforts for the health of women by considering sex and 
gender influences, a specific goal of the 2019-2023 Trans-NIH Strategic Plan for 
Women's Health Research (47). 
 
Specific Aims and Brief Description of Manuscripts 
           There are three manuscripts included in this dissertation: (1) an integrative review 
of heart failure symptom cluster studies; (2) an analysis of the feasibility and 
acceptability of a mixed methods approach to ascertain symptom clusters in Black 
women with HFpEF, with reporting of preliminary symptom cluster analysis findings; 
and (3) a qualitative study examining the symptom experience of Black women with 
HFpEF and integration of qualitative themes with quantitative symptom data. The aims 
and a brief description of each manuscript are listed below. 
 
Aim 1: To synthesize the current state of literature related to symptom clusters in heart 
failure (HF) utilizing the Symptom Management Model (SMM) by Dodd et al., 2001 
The first dissertation manuscript is a comprehensive review of HF symptom 
cluster literature with the following stated purpose: to determine the current state of 
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literature related to symptom clusters in HF using the SMM in order to discover themes 
within each component of the model (39). The HF symptom experience is complex and 
should be examined within multiple components to ensure a more comprehensive and 
holistic understanding. The integrative review revealed that symptom clusters can be 
useful in clinical practice for monitoring patients remotely; educating patients on self-
management and symptom surveillance; determining the risk of cardiac events, 
hospitalization, morbidity, and mortality; and incorporating psychological symptoms (5, 
8, 15-30).  
The review also highlights how future research should further examine the effect 
that social and physical environments have on HF symptoms, as the environment 
component of the SMM was the least studied. Research on cultural and sex differences 
related to symptom responses or impact should be conducted rather than only examining 
if clusters are similar. The included study designs lacked any qualitative component. A 
mixed methods or qualitative approach to symptom cluster research will result in a richer 
description of the symptom experience and how each component impacts this experience. 
 
Aim 2: To (1) explore the feasibility and acceptability of a convergent mixed methods 
symptom cluster study with a population of Black females with HFpEF and (2) explore 
preliminary HF symptom clusters of physical and psychological/emotional symptoms by 
cluster analysis of data collected symptom questionnaire data  
           The second manuscript reports the feasibility and acceptability of the convergent 
parallel mixed methods dissertation study that examined the symptom experience and 
how symptoms cluster in Black females with HFpEF. The qualitative and quantitative 
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data were collected in the same time frame with equal priority. This manuscript also 
presents preliminary findings from a symptom cluster analysis for this population to 
describe the symptom clustering technique and identify findings that could later be 
explored with a larger sample size.  
The PI obtained IRB approval (Pro00101261) and recruited participants (N=44) 
from social media to complete screening and demographics questionnaires, the Single 
Item Literacy Screener, the Minnesota Living with HF Questionnaire, Symptom Status 
Questionnaire – HF, and Personal Health Questionnaire – 8 (40, 46, 48, 49). Participants 
who were interested and consented (N=15) were interviewed about their symptom 
experience using a semi-structured interview guide. Feasibility outcomes were tracked 
and measured throughout the study and were analyzed using descriptive statistics (38). 
An exploratory hierarchical cluster analysis of questionnaire data was conducted in SPSS 
version 25 (SPSS Inc, Chicago, Illinois) to form preliminary clusters.  
All feasibility benchmarks of consent rate, recruitment rate, interview interest 
rate, survey completion rate, and feasibility and acceptability question scores were met 
for the study, and participants positively rated acceptability of the study protocol. Three 
symptom clusters were formed, which included a highly symptomatic cluster (which 
reported a high proportion of physical and psychological symptoms), a mildly 
symptomatic cluster (which reported a lower proportion of symptoms, especially less 
psychological symptoms), and a psychologically symptomatic cluster (which reported 




Aim 3: To (1) describe the symptom experience of Black women with HFpEF using 
qualitative descriptive methods and (2) to integrate qualitative themes and quantitative 
symptom data to examine confirmation, expansion, and discordance of results  
           The third manuscript presents qualitative results and integrates quantitative 
findings with identified qualitative themes from the convergent parallel mixed methods 
study. Qualitative data were collected using individual, semi-structured interviews 
(N=15) and were analyzed using NVivo 20.3 software (QSR International, Pty, 
Doncaster, Australia). Analysis was guided by qualitative descriptive methods, and a 
directed approach to content analysis was used with SMM components and MLHFQ 
domains as broad code types to guide the development of sub-codes (39, 40, 42-45). 
Interviews were transcribed and analyzed as they were collected using a constant 
comparative method (42-45). For mixed methods analysis, quantitative and qualitative 
data were each analyzed separately, and results were integrated into a joint display and 
compared and contrasted to highlight confirmation, expansion, and discordance (41-45). 
Qualitative themes emerged relating to the person and symptom experience. Black 
women with HFpEF discussed interactions of physical and emotional symptoms, and 
positive correlations between symptom scales supported this theme. Women reported 
shortness of breath and chest pain causing worry and fears of death. Participants reported 
feeling like a burden to others and hid or downplayed their symptoms. Reduced physical 






(1) Bozkurt B, Khalaf S. Heart Failure in Women. Methodist Debakey Cardiovasc J 2017 
Oct-Dec;13(4):216-223.                                                                                                                                     
(2) Westerman S, Wenger NK. Women and heart disease, the underrecognized burden: 
sex differences, biases, and unmet clinical and research challenges. Clin Sci 2016 
Apr;130(8):551-563. 
(3) Lesyuk W, Kriza C, Kolominsky-Rabas P. Cost-of-illness studies in heart failure: a 
systematic review 2004–2016. BMC Cardiovasc Disord 2018 -5-2;18. 
(4) Riegel B, Dickson VV, Lee CS, Daus M, Hill J, Irani E, et al. A mixed methods study 
of symptom perception in patients with chronic heart failure. Heart Lung 2018 Mar - 
Apr;47(2):107-114. 
(5) Moser DK, Lee KS, Wu J-, Mudd-Martin G, Jaarsma T, Huang T-, et al. 
Identification of symptom clusters among patients with heart failure: an international 
observational study. Int J Nurs Stud 2014;51(10):1366-1372. 
(6) Hopper I, Kotecha D, Chin KL, Mentz RJ, von Lueder TG. Comorbidities in Heart 
Failure: Are There Gender Differences? Curr Heart Fail Rep 2016 Feb;13(1):1-12.    
(7) Dickson VV, Knafl GJ, Wald J, Riegel B. Racial Differences in Clinical Treatment 
and Self‐Care Behaviors of Adults With Chronic Heart Failure. Journal of the American 
Heart Association 2015 Apr 13,;4(4). 
(8) Park J, Johantgen ME. A Cross-Cultural Comparison of Symptom Reporting and 
Symptom Clusters in Heart Failure. J Transcult Nurs 2017;28(4):372-380. 
 11 
(9) Dreyer RP, Dharmarajan K, Hsieh AF, Welsh J, Qin L, Krumholz HM. Sex 
Differences in Trajectories of Risk After Rehospitalization for Heart Failure, Acute 
Myocardial Infarction, or Pneumonia. Circ Cardiovasc Qual Outcomes 2017 05;10(5). 
(10) Parissis JT, Mantziari L, Kaldoglou N, Ikonomidis I, Nikolaou M, Mebazaa A, et al. 
Gender-related differences in patients with acute heart failure: management and 
predictors of in-hospital mortality. Int J Cardiol 2013 Sep 20,;168(1):185-189. 
(11) Redfield M. Heart Failure with Preserved Ejection Fraction. The New England 
Journal of Medicine 2016 Nov 10,;19(375):1868-1877. 
(12) Lewis EF, Claggett B, Shah AM, Liu J, Shah SJ, Anand I, et al. Racial Differences 
in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection 
Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial. Circ Heart 
Fail 2018 03;11(3):e004457. 
(13) Evangelista LS, Kagawa-Singer M, Dracup K. Gender differences in health 
perceptions and meaning in persons living with heart failure. Heart Lung 2001 May-
Jun;30(3):167-176. 
(14) Pedrotty DM, Jessup M. "Frailty, thy name is woman": syndrome of women with 
heart failure with preserved ejection fraction. Circ Cardiovasc Qual Outcomes 2015 
Mar;8(2 Suppl 1):48. 
(15) Smith ORF, Gidron Y, Kupper N, Winter JB, Denollet J. Vital exhaustion in chronic 
heart failure: symptom profiles and clinical outcome. J Psychosom Res 2009 
Mar;66(3):195-201. 
 12 
(16) Schiffer AA, Pelle AJ, Smith ORF, Widdershoven JW, Hendriks EH, Pedersen SS. 
Somatic versus cognitive symptoms of depression as predictors of all-cause mortality and 
health status in chronic heart failure. J Clin Psychiatry 2009 Dec;70(12):1667-1673. 
(17) Jurgens CY, Moser DK, Armola R, Carlson B, Sethares K, Riegel B. Symptom 
clusters of heart failure. Res Nurs Health 2009;32(5):551-560. 
(18) Hertzog MA, Pozehl B, Duncan K. Cluster analysis of symptom occurrence to 
identify subgroups of heart failure patients: A pilot study. J Cardiovasc Nurs 
2010;25(4):273-283. 
(19) Lee KS, Song EK, Lennie TA, Frazier SK, Chung ML, Heo S, et al. Symptom 
clusters in men and women with heart failure and their impact on cardiac event-free 
survival. J Cardiovasc Nurs 2010;25(4):263-272. 
(20) Song EK, Moser DK, Rayens MK, Lennie TA. Symptom clusters predict event-free 
survival in patients with heart failure. J Cardiovasc Nurs 2010;25(4):284-291. 
(21) Park J, Moser DK, Griffith K, Harring JR, Johantgen M. Exploring Symptom 
Clusters in People With Heart Failure. Clin Nurs Res 2019;28(2):165-181. 
(22) Lee CS, Hiatt SO, Denfeld QE, Mudd JO, Chien C, Gelow JM. Symptom-
hemodynamic mismatch and heart failure event risk. J Cardiovasc Nurs 2015;30(5):394-
402. 
(23) Hawkins MAW, Dolansky MA, Schaefer JT, Fulcher MJ, Gunstad J, Redle JD, et al. 
Cognitive function in heart failure is associated with nonsomatic symptoms of depression 
but not somatic symptoms. J Cardiovasc Nurs 2015;30(5):E9-E17. 
 13 
(24) Herr JK, Salyer J, Flattery M, Goodloe L, Lyon DE, Kabban CS, et al. Heart failure 
symptom clusters and functional status - a cross-sectional study. J Adv Nurs 
2015;71(6):1274-1287. 
(25) Zhang J, Hobkirk J, Carroll S, Pellicori P, Clark AL, Cleland JGF. Exploring quality 
of life in patients with and without heart failure. Int J Cardiol 2016;202:676-684. 
(26) Yu DSF, Chan HYL, Leung DYP, Hui E, Sit JWH. Symptom clusters and quality of 
life among patients with advanced heart failure. J Geriatr Cardiol 2016;13(5):408-414. 
(27) Huang T-, Moser DK, Hwang S-. Identification, Associated Factors, and Prognosis 
of Symptom Clusters in Taiwanese Patients with Heart Failure. J Nurs Res 
2018;26(1):60-67. 
(28) Son Y-, Won MH. Symptom clusters and their impacts on hospital readmission in 
patients with heart failure: A cross- sectional study. Res Theory Nurs Pract 
2018;32(3):311-327. 
(29) Salyer J, Flattery M, Lyon DE. Heart failure symptom clusters and quality of life. 
Heart Lung 2019;48(5):366-372. 
(30) Ruppe A. Miller S. Magwood G. Heart Failure Symptom Clusters: An Integrative 
Review [unpublished manuscript]. Medical University of South Carolina. 2020. 
(31) Plank-Bazinet JL, Kornstein SG, Clayton JA, McCaskill-Stevens W, Wood L, Cook 
N, et al. A Report of the Women's Health Congress Workshop on The Health of Women 
of Color: A Critical Intersection at the Corner of Sex/Gender and Race/Ethnicity. J 
Womens Health (Larchmt) 2016 -1-01;25(1):4-10.  
(32) Raghavan D, Varkey A, Bartter T. Chronic obstructive pulmonary disease: the 
impact of gender. Current Opinion in Pulmonary Medicine 2017 Mar;23(2):117-123. 
 14 
(33) Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, et al. 
Anxiety and depression in COPD patients: The roles of gender and disease severity. 
Respiratory Medicine 2006;100(10):1767-1774. 
(34) Kanervisto M, Saarelainen S, Vasankari T, Jousilahti P, Heistaro S, Heliövaara M, et 
al. COPD, chronic bronchitis and capacity for day-to-day activities: Negative impact of 
illness on the health-related quality of life. Chronic Respiratory Disease 2010 
Nov;7(4):207-215. 
(35) Laurin C, Lavoie KL, Bacon SL, Dupuis G, Lacoste G, Cartier A, et al. Sex 
Differences in the Prevalence of Psychiatric Disorders and Psychological Distress in 
Patients With COPD. Chest 2007 Jul;132(1):148-155. 
(36) Kelechi TJ, Mueller M, Dooley M. Sex differences in symptom severity and clusters 
in patients with stage C4 and stage C5 chronic venous disease. European Journal of 
Cardiovascular Nursing 2017 Jan;16(1):28-36. 
(37) Pignataro FS, Bonini M, Forgione A, Melandri S, Usmani OS. Asthma and gender: 
The female lung. Pharmacological Research 2017 May;119:384-390. 
(38) Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot 
studies: the what, why and how. BMC medical research methodology 2010 Jan 
6,;10(1):1. 
(39) Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J, et al. 
Advancing the science of symptom management. J Adv Nurs 2001 Mar;33(5):668-676. 
(40) Rector T. FDA Medical Device Development Tool (MDDT) Qualification Package 
for the Minnesota Living with Heart Failure Questionnaire (MLHFQ). 2017 November. 
 15 
(41) Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. 
Third edition, international student edition ed. Los Angeles [und fünf weitere]: Sage; 
2018. 
(42) Creswell JW, Poth CN. Qualitative Inquiry and Research Design. 4th ed. Thousand 
Oaks, Calif.: Sage; 2018. 
(43) Sandelowski M. Whatever happened to qualitative description? Res Nurs Health 
2000 Aug;23(4):334-340. 
(44) Sandelowski M. What's in a name? Qualitative description revisited. Res Nurs 
Health 2010 Feb;33(1):77-84. 
(45) Hsieh H, Shannon SE. Three approaches to qualitative content analysis. Qual Health 
Res 2005 Nov;15(9):1277-1288. 
(46) Heo S, Moser D, Pressler S, Dunbar S, Mudd-Martin G, Lennie T. Psychometric 
Properties of the Symptom Status Questionnaire–Heart Failure. The Journal of 
Cardiovascular Nursing 2015 Mar;30(2):136-144. 
(47) National Institutes of Health. Advancing Science for the Health of Women: The 
Trans-NIH Strategic Plan for Women's Health Research. 2019 February 21. 
(48) Hammash MH, Hall LA, Lennie TA, Heo S, Chung ML, Lee KS, et al. 
Psychometrics of the PHQ-9 as a measure of depressive symptoms in patients with heart 
failure. European Journal of Cardiovascular Nursing 2013 Oct;12(5):446-453. 
(49) Brice JH, Foster MB, Principe S, Moss C, Shofer FS, Falk RJ, et al. Single-item or 
two-item literacy screener to predict the S-TOFHLA among adult hemodialysis patients. 




Manuscript 1: Integrative Review 
 
Title: Heart Failure Symptom Clusters: An Integrative Review  
 
Authors: Alexandra Ruppe, RN, BSN, BSPH; Sarah Miller, PhD, RN; Gayenell 
Magwood, PhD, RN, FAHA, FAAN 
 
Affiliations: Medical University of South Carolina College of Nursing 
 
Acknowledgements: Julie Barroso, PhD, RN, FAAN, Ayaba Logan, MLIS, MPH 
 
Conflicts of Interest: The authors declare no conflicts of interest related to this study 
 
Keywords: Chronic disease, Cognitive symptoms, Disease management, Emotional 
symptoms, Heart failure, Physical symptoms, Review, Signs and symptoms, Symptom 









Heart Failure Symptom Clusters: An Integrative Review 
Abstract 
Background: Patients with heart failure have difficulty recognizing and understanding 
their symptoms, contributing to 4 out of 5 people with heart failure requiring 
hospitalization each year in the U.S. Clustering symptoms have been proposed to help 
patients and clinicians identify and manage heart failure symptoms.  
Objectives: The purpose of this integrative review was to determine the current state of 
literature related to symptom clusters in patients with heart failure using the Symptom 
Management Model to discover themes within each component of the framework. 
Methods: We systematically searched Scopus, ProQuest, and PubMed databases to 
identify peer-reviewed, original research published in English between 2009 - August 
2020. Search terms included "heart failure" AND "symptom cluster" OR "symptom 
relationships." The Whittemore and Knafl (2005) methodological framework was used to 
guide this integrative review.  
Results: Twenty-nine manuscripts underwent full-text review, and 18 were deemed 
eligible. Physical and emotional/psychological symptoms clustered together and 
separately. Younger age, lower education level, and female sex corresponded with more 
distress from symptom clusters. Clinicians can use symptom clusters for risk 
assessment.   
Conclusions: Symptom cluster data lacked racial diversity and minimally examined sex 
differences. No studies were identified that used qualitative methods. Current evidence 
supports the use of heart failure symptom clusters for patient education, self-
management, symptom surveillance, and risk assessment. Clinicians should especially 
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consider emotional/psychological heart failure symptoms, which can be distressing and 
associated with worse outcomes.  
  
Tweetable abstract: Clinicians can use heart failure symptom clusters for risk 
assessment, especially psychological symptoms associated with worse outcomes. 
  
What is already known about the topic? 
• Heart failure is associated with a substantial symptom burden, affecting patients' 
quality of life, functional status, and disease outcomes. 
• Patient misinterpretation or lack of knowledge related to symptoms contribute to 
frequent hospitalizations from heart failure. 
• Clinicians typically assess for disease-specific individual symptoms rather than 
clusters of symptoms. 
What this paper adds 
• Heart failure symptom clusters exist, and physical and emotional/psychological 
symptoms clustered together and separately. 
• Current evidence supports the use of heart failure symptom clusters for patient 
education, self-management, symptom surveillance, and risk assessment, and 
clinicians should especially consider emotional/psychological symptoms, which 
can be distressing and associated with worse outcomes. 
• Symptom cluster studies lacked racial diversity, minimally examined sex 




Heart Failure (HF) is a prevalent issue in the United States (U.S.), with an estimated 
6.2 million Americans living with this disease (Benjamin et al., 2019). HF is a complex 
disease in which ventricular filling or ejection of blood is impaired due to structural 
changes or decreased cardiac functioning (Yancy 2013). HF is the most common cause of 
hospitalization for those over the age of 65, and 4 out of 5 people with HF require 
hospitalization each year (Pedrotty & Jessup, 2015; Riegel et al., 2018). Frequent HF 
hospitalizations are attributed to patient misinterpretation of, or lack of knowledge related 
to, symptoms, due to the complexity of symptom interactions and inadequate patient 
education tools, resulting in delays in seeking care and inadequate self-management 
(Pedrotty & Jessup, 2015; Riegel et al., 2018). 
HF is associated with a substantial symptom burden, affecting patients' quality of life, 
functional status, and disease outcomes (Dodd, Miaskowski, & Lee, 2004; Moser et al., 
2014; Pedrotty & Jessup, 2015). Clinicians typically assess for disease-specific individual 
symptoms; however, they could examine symptoms in clusters (Dodd et al., 2004; Moser 
et al., 2014). A symptom cluster is when two or more symptoms co-occur in a disease 
process (Denfeld, 2020). Symptoms can be a derivative of procedures, medications, or 
the disease process itself (Dodd et al., 2004). Effectively utilizing symptom clusters in 
clinical practice could result in targeted patient education, enhanced surveillance of 
exacerbations, and improved health outcomes (Dodd et al., 2004; Moser et al., 2014). 
The existence of symptom clusters has been explored in other chronic diseases such 
as cancer, yet the concept is still relatively new and unrefined (Aktas, 2013). Based upon 
preliminary database searching, it does not appear there is a large body of evidence for 
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symptom clusters in HF. Therefore, the purpose of this integrative review is to determine 
the current state of literature related to symptom clusters in HF using the Symptom 
Management Model (SMM) to discover themes within each component of the model 
(Dodd et al., 2001). 
 
Theoretical Framework 
Existing evidence about symptom clusters in people with HF will be synthesized 
using the SMM, depicted in Figure 1 (Dodd et al., 2001). The SMM considers the 
complex and multi-faceted nature of symptoms and can help identify which areas of 
symptom management have been well described within the literature and which areas 
need further exploration (Dodd et al., 2001). The SMM focuses on the three components 
of symptom experience, management strategies, and outcomes. The three components of 
the symptom experience include perception, evaluation, and response to symptoms. 
Management strategies incorporate aspects of treatment decisions, such as when to begin 
treatment and dosing. Outcomes incorporate various components of symptom status, such 
as quality of life, morbidity, and mortality. Together, these three components encompass 
the symptom experience and management as a whole (Dodd et al., 2001).  
The SMM was revised in 2001 to include three nursing science domains: person, 
health and illness, and environment (Dodd et al., 2001). The person domain allows for 
examining demographic, psychosocial, sociological, physiological, and developmental 
factors. The health and illness domain includes risk factors, health status, and disease and 
injury. The environment domain considers the impact of physical, social, and cultural 
environments, which affect symptom interpretation and treatment decisions.  
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Figure 1 
Modified SMM (Dodd et al., 2001) 
 
Methods 
The Whittemore and Knafl (2005) methodological framework was used to guide 
this integrative review. A well-defined literature search was undertaken within Scopus, 
ProQuest, and PubMed with the assistance of a medical reference librarian using the 
search terms "heart failure" AND "symptom cluster" OR "symptom relationships." Peer-
reviewed, original research articles published in English between 2009 and August 2020 
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were reviewed to exclude very outdated references while including the essential early HF 
symptom cluster studies. The search yielded 88 results, as shown in the Prisma flow 
diagram in figure 2 (Moher et al., 2009). Twenty-three manuscripts remained after 
duplicates were removed, and titles and abstracts were screened to exclude manuscripts 
that were not about HF symptom clusters or did not meet the inclusion criteria specified 
previously. An additional six studies were identified through a review of references for a 
total of 29 manuscripts. Ten of the 29 manuscripts were excluded for examining 
symptom patterns or relationships rather than clustering, and one manuscript was 
excluded for not being specific to people with HF. After exclusions, 18 manuscripts 
remained for data analysis. 
For data evaluation, study quality was assessed using the quantitative non-
randomized category of the Mixed Methods Appraisal Tool (MMAT) (Hong et al., 2018). 
The quality criteria consisted of 7 items, and a "yes," "no," or "can't tell" was assigned to 
each criterion and displayed in Table 1 (Hong et al., 2018). Manuscripts were analyzed 
chronologically by year published, beginning with the oldest. Chronologically analyzing 
the manuscripts allowed for an illustration of research progression over the previous ten 
years and built a chain of evidence (Whittemore & Knafl, 2005). Data were extracted by 
hand from manuscripts and organized in a literature table under the SMM components 
(supplementary material table 1), allowing for systematic comparison. Similar findings 






Figure 2                                                                                                    
Prisma Flow Diagram (Moher et al., 2009)  
 
Results 
      Of the 18 included studies, nine were conducted in the U.S., two in the Netherlands, 
two in Korea, one in Hong Kong, one in the United Kingdom, and one in Taiwan. Two 
studies were conducted cross-culturally in the U.S. and Asia, and one of those studies 
included European centers in the Netherlands and Sweden (Moser et al., 2014; Park & 
Johantgen, 2017). There was a relatively even split of study designs with five cross-
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sectional studies, five prospective cohort studies, seven secondary data analyses, and one 
cluster analysis pilot study, as shown in Table 1. Components of symptom management 
and outcomes and symptom status were present in all the included studies, and two 
studies addressed every component of the SMM (Huang et al., 2018; Son & Won, 2018). 
Prominent results were categorized according to SMM components, beginning with 
outcomes and symptom status to familiarize the reader with identified symptom clusters, 
and then person, health and illness, symptom experience, and components of symptom 
management strategies. 
 
Table 1: Included studies, study info, Symptom Management Model components present 
in each study, and Mixed Methods Appraisal Tool Methodological Quality Scoring 
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*Mixed Methods Appraisal Tool (MMAT) Methodological Quality Criteria (Quantitative nonrandomized) 
(Hong et al., 2018) S1. Are there clear research questions? S2. Do the collected data allow you to address 
the research questions? 3.1. Are the participants representative of the target population? 3.2. Are 
measurements appropriate regarding both the outcome and intervention (or exposure)? 3.3. Are there 
complete outcome data? 3.4. Are the confounders accounted for in the design and analysis? 3.5. During the 
study period, is the intervention administered (or exposure occurred) as intended? 
 
Outcomes and Symptom Status  
Outcomes and symptom status include functional status, emotions, costs, self-care 
activities, quality of life, morbidity, co-morbidities, and mortality (Dodd et al., 2001). 
Emotional, depressive, or psychological symptoms formed a cluster in 7 studies, 
consisting of symptoms such as depression, worrying, anxiety, difficulty concentrating, 
and poor self-esteem (Jurgens et al., 2009; Lee, 2010; Hawkins et al., 2015; Moser et al., 
2014; Schiffer et al., 2009; Smith et al., 2009; Zhang, Hobkirk, Carroll, Pellicori, Clark, 
& Cleland, 2016). Three studies created somatic/affective and cognitive/affective 
depression symptom clusters (Hawkins et al., 2015; Schiffer et al., 2009; Smith et al., 
2009). Psychological clusters were associated with memory and cognitive problems 
(Hawkins et al., 2015; Jurgens et al., 2009; Lee, 2010). Psychological symptoms also 
clustered with physical symptoms, including shortness of breath, daytime sleepiness, and 
fatigue (Salyer et al., 2019; Yu, Chan, Leung, Hui, & Sit, 2016). A sickness behavior 
cluster was found to significantly influence quality of life (b = - 0.603, p = 0.0001) and 
accounted for 40% of its variance (F = 75.12, R2 = 0.404, p = 0.0001) (Salyer et al., 
2019). 
For physical symptom clusters, shortness of breath clustered with fatigue with low 
energy and increased need to rest, trouble sleeping, and difficulty walking or climbing in 
three studies (Jurgens et al., 2009; Lee, 2010; Moser et al., 2014). Four studies found 
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lower extremity edema or swelling did not fall within a symptom cluster (Lee, 2010; 
Moser et al., 2014; Song, Moser, Rayens, & Lennie, 2010; Yu et al., 2016). A 
gastrointestinal stress cluster was unique to three studies and included loss of appetite, 
nausea, and decreased hunger (Herr et al., 2015; Salyer et al., 2019; Son & Won, 2018). 
Six studies clustered participants by the symptom frequency, severity, and distress 
they reported (Denfeld et al., 2020; Hertzog, Pozehl, & Duncan, 2010; Huang et al., 
2018; Lee, 2015; Park & Johantgen, 2017; Park et al., 2019). Creating clusters of 
participants based on how they experienced symptoms rather than the symptoms 
themselves allowed the authors to examine how symptoms may impact participants on an 
individual level. For instance, Hertzog et al. (2010) found that clusters of participants 
who reported fewer symptoms or less symptom impact were associated with fewer 
physical and social limitations and better quality of life (all p < 0.001). Denfeld et al. 




The person domain consists of demographics, psychosocial, sociological, 
physiological, and developmental factors (Dodd et al., 2001). The studies in this review 
predominately explored age, education level, and sex. Younger age was associated with 
more psychological or emotional distress than older age, regardless of physical symptom 
severity (Lee, 2010, Park et al., 2019). Park et al. (2019) found that for every 5-year age 
increase, a patient with HF was 4.85 times less likely to be in the psychological distress 
cluster (95% CI = [4.76, 4.95]) and 4.89 times less likely to be in the high physical and 
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psychological distress cluster (95% CI= [4.82, 4.96]) (Park et al., 2019). Older 
participants were also more likely to rate symptom severity that matched their 
hemodynamic profile than younger participants (p= 0.003) (Lee et al., 2015). 
Higher educational attainment was associated with inclusion in less severe 
symptom clusters (Hertzog et al., 2010; Park et al., 2019; Smith et al., 2009; Son & Won, 
2018). Participants with less than a high school degree were more likely to be in a 
physical distress cluster (OR = 0.27; 95% CI = [0.16, 0.48]) and a high distress cluster 
(OR = 0.16; 95% CI = [0.08, 0.33]) than those with at least some college (Park et al., 
2019). One study designed to study sex differences found that men and women had the 
same symptom clusters, but women had significantly higher distress from their fatigue 
symptoms and the increased need to rest, sleep disturbances, and feeling depressed than 
men (Lee et al., 2010). Women also had significantly higher symptom distress scores for 
a circulatory and GI symptom cluster (p< 0.001) and physical symptom cluster (p< 0.05) 
than males in two other studies (Lee, 2010; Son & Won, 2018). 
 
Health & Illness  
The health and illness component addresses risk factors, health status, disease, 
and illness (Dodd et al., 2001). Co-morbid conditions were the most prominent theme 
found within the health and illness component. Jurgens et al. (2009) found diabetes to be 
a predictor of inclusion in an emotional symptom cluster (Jurgens et al., 2009). Park et al. 
(2019) found that participants with diabetes were also 1.91 times more likely to be in a 
physical distress class (95% CI = [1.32, 2.75]) and 1.66 times more likely to be in a high 
distress class (95% CI = [1.12, 2.46]) (Park et al., 2019). Participants with atrial 
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fibrillation were 2.71 times more likely to be in a high distress class (95% CI = [1.85, 
3.96]) and had significantly higher symptom scores for bodily pain and energy 
insufficiency clusters (p=0.015) (Park et al., 2019; Son & Won, 2018). Participants with 
hypertension were twice as likely to be in a high distress cluster than in a low distress 
cluster (OR = 2.04; 95% CI = [1.38, 3.02]) (Park et al., 2019). 
Multiple studies assessed the relationship between symptom distress and risk. 
Findings from Jurgens et al. (2009) suggested distress from HF symptoms had little 
association with degree or type of cardiac dysfunction (Jurgens et al., 2009. However, 
Schiffer et al. (2009) found that distress from a cognitive/affective depressive symptom 
cluster was a significant predictor of disease-specific health status (HR=2.3, 95% CI = 
1.21-4.44, p=0.01) (Schiffer et al., 2009). Lee et al. (2015) discovered that total symptom 
distress scores from an emotional/cognitive symptom cluster were an independent 
predictor of cardiac event-free survival (HR=1.18; 95% CI, 1.03-1.37) (Lee et al., 2015). 
Participants with severe symptom profiles were 3.3 times more likely to have a clinical 
HF event, and those with high-severity dyspnea and fatigue had a significantly higher risk 
for a cardiac event (p=0.016) (Huang et al., 2018; Lee, 2010). Inclusion in a 
somatic/affective depressive symptom cluster predicted risk of mortality (HR=1.8, 95% 
CI, 1.03-3.07, p=0.04). 
 
Symptom Experience  
Symptom experience incorporates how a person perceives, evaluates, and 
responds to their symptoms. Manuscripts included in this review focused on symptom 
distress, impact, and perceptions (Dodd et al., 2001). 
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For symptom impact, an acute volume overload cluster high in shortness of breath 
severity accounted for 45.7% of the variance in impact of symptoms on living as desired 
(Jurgens et al., 2009). This finding coincides with results from a respiratory distress 
cluster that accounted for 21.3% of the variance (21.3%) of symptom impact (Son & 
Won, 2018). For symptom distress, lack of energy was the most distressful physical 
symptom in one study, and orthopnea the least (Song et al., 2010). Although edema is a 
common HF symptom, it was not particularly distressing to participants or sometimes 
even noticed unless severe (Lee, 2010; Moser et al., 2014). Those with higher distress 
from symptoms had a more significant co-morbidity burden (Lee et al., 2010). Distress 
symptom clusters and functional limitation secondary to breathlessness were independent 
predictors of quality of life (Yu et al., 2016; Zhang et al., 2016). 
  
Components of symptom management strategies  
Creating a symptom management plan includes encompassing the other SMM 
components and considering them when making symptom management 
recommendations (Dodd et al., 2001). Authors of the included studies suggested using 
symptom clusters for patient monitoring, intervention development, patient education on 
when to seek care, prognosis, proper medication management, and a better understanding 
of the interplay between physical and psychological symptoms. Multiple studies 
recommend using symptom clusters for monitoring patients with HF for exacerbations 
(Huang et al., 2018; Jurgens et al., 2009; Moser et al., 2015; Park & Johantgen, 2017). It 
has been noted that examining symptoms in clusters could improve surveillance of 
symptoms and promote early detection of worsening symptoms, which is especially 
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important considering the increasing utilization of telehealth monitoring without physical 
assessment (Huang et al., 2018; Jurgens et al., 2009).  
Clinicians and researchers can also use symptom clusters to develop interventions 
that manage an entire cluster of symptoms (Herr et al., 2015; Lee, 2010; Park et al., 2019, 
Yu et al., 2016). Yu et al. (2016) discussed how these targeted interventions could be 
more beneficial than addressing symptoms individually due to the synergistic effect 
clustered symptoms have of causing more distress when they are co-occurring (Yu et al., 
2016). 
Symptom clusters can also be used as an educational tool to empower people with 
HF to understand when to seek care and promote awareness of symptoms (Herr et al., 
2015; Jurgens et al., 2009; Lee et al., 2010; Moser et al., 2014; Son & Won, 2018; Song 
et al., 2010). Only 9% of hospitalized patients with HF reported regular monitoring of 
symptoms before hospitalization, and patients were less efficient at recognizing 
symptoms when they gradually worsened over time (Song et al., 2010). Clinicians can 
use symptom clusters to educate patients on alleviating symptoms and discussing 
symptom management at discharge to reduce hospital re-admissions and decreased 
functional status (Herr et al., 2015; Moser et al., 2014; Son & Won, 2018). 
 
Discussion 
The SMM highlights how symptoms have multi-faceted and complex interactions 
with various components (Dodd et al., 2001). The results of the included symptom cluster 
studies coincide with this theory. For instance, lower extremity edema was not clustered 
with other symptoms in 4 studies and was often not noticed or distressing unless severe 
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(Lee et al., 2010; Moser et al., 2014; Song & Won, 2010; Yu et al., 2016). Suppose 
patients are not feeling impacted by symptoms, such as lower extremity edema. In that 
case, they may delay seeking treatment, as evidence suggests patients with HF are prone 
to ignore or adapt to symptoms they do not consider significant (Jurgens et al., 2009). 
Therefore, clinicians need to educate patients on the most concerning symptom clusters 
that indicate worsening HF disease status. 
An example is shortness of breath, a symptom linked to anxiety and depression in 
a distress symptom cluster, which accounted for 21.3% of the variance in symptom 
impact when included in a respiratory distress cluster (Son & Won, 2018; Yu et al., 
2016). Clinicians can educate patients on the most effective ways to monitor for shortness 
of breath and the symptoms that cluster alongside it. This education could help patients 
better recognize signs of impending HF exacerbation rather than attributing shortness of 
breath to aging or other co-morbidities and not seeking help. Future research should 
evaluate whether an educational tool for monitoring symptom clusters would be feasible 
and beneficial (Song et al., 2010). 
It is also important to note that none of the studies included in the review 
contained a qualitative component, showing a significant gap in HF symptom cluster 
research that future research should address. A qualitative component is needed to begin 
a more in-depth, robust understanding of how people with HF perceive, interpret, and 
respond to symptom clusters. Qualitative interviewing is especially warranted for 
exploring psychological, emotional, and cognitive symptom clusters. The need for 
clinicians to recognize such symptom clusters and expand assessments beyond physical 
symptoms was the most prominent theme found within symptom management strategies. 
 36 
People with higher distress from emotional/cognitive symptoms may be at the highest 
risk for adverse outcomes, especially younger people who report more distress (Herr et 
al., 2015; Lee et al., 2010). At this time, the American College of Cardiology 
Foundation/American Heart Association (ACCF/AHA) guidelines for the management of 
HF do not propose strategies for addressing psychological symptoms (Lee et al., 2010; 
Park et al., 2019; Yancy et al., 2013). The ACCF/AHA HF guidelines recognize 
depression as a common co-morbidity in people with HF that can lead to poor self-care 
behaviors, worse quality of life and disease outcomes, and the need for more frequent 
medical services (Yancy et al., 2013). However, the guidelines state that an effective 
intervention strategy for depressive symptoms is unknown (Yancy et al., 2013; Yancy et 
al., 2017; Hollenberg et al., 2019). Clustering symptoms may help connect physical and 
psychological symptoms for improved understanding and management of the disease 
(Lee et al., 2015). Providers need to listen to how patients feel to assess the risk of 
adverse events, as clinical data may not accurately reflect their risk alone (Lee et al., 
2015). 
Of the 18 included studies, 14 had over 30% females in their sample. However, 
sex differences were not addressed in depth. One study examined sex differences in 
symptom clusters and found identical clusters, but women reported significantly higher 
symptom distress from a physical symptom cluster (p< 0.05) than males (Lee et al., 
2015). This finding indicates that there can be variation in symptom response and the 
impact the cluster has on quality of life. To further examine sex differences and enhance 
data's robustness, future research should use qualitative methods to explore the higher 
levels of symptom distress women experience. 
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The environment domain was the most understudied. Three manuscripts 
addressed culture, and none addressed social and physical environment. Son and Won 
(2018) suggest using the ecological approach to explore differences in symptom clusters 
across cultures, races, and locations. Park and Johantgen (2017) state that a mixed-
methods study design could provide a more holistic depiction of cultural differences in 
HF symptom clusters. 
The MMAT was used to evaluate the included studies' methodological quality 
(Hong et al., 2018). All of the studies met at least four of the seven criteria, and two 
studies met all seven (Hawkins, 2015; Park, 2017). A lack of racial diversity for U.S. 
studies was noted, with 6 out of 9 studies conducted within the U.S. having over 70% 
White participants (Denfeld et al., 2020; Hawkins et al., 2015; Hertzog et al., 2010; Lee 
et al., 2010; Lee et al., 2015; Park et al., 2019). Considering that Black Americans are 1.5 
times more likely to develop HF than White Americans, diversity and inclusion in HF 
symptom cluster research is imperative for generalizability to the U.S. population 
(Parashar et al., 2009). Also, the studies used questionnaires such as the MLHFQ, 
limiting the number of symptoms that participants can report to only symptoms that 
appear on the questionnaire. Researchers can explore more symptoms with a qualitative 
approach, which current HF symptom cluster studies currently lack.  
This integrative review has some limitations. Only Scopus, ProQuest, and 
PubMed were searched, and after exclusions, all included manuscripts were from Scopus. 





The HF symptom experience is complex and should be examined within 
multiple components to ensure a more comprehensive and holistic understanding. This 
integrative review synthesized the most prominent themes from current HF symptom 
cluster research. HF symptom clusters can be useful in clinical practice for determining 
the risk of cardiac events, hospitalization, morbidity, and mortality. HF symptom 
clusters that incorporate psychological symptoms are instrumental, as psychological 
symptoms were often associated with increased risk. Clinicians should examine factors 
related to the person alongside symptom clusters, especially regarding younger age. 
Future research should further investigate the effect that social and physical 
environments have on HF symptoms, as the environment was the least studied SMM 
component. Future research should explore cultural and sex differences related to 
symptom responses or impact. The included study designs lacked any qualitative 
component. A mixed methods or qualitative approach to symptom cluster research will 
result in a richer description of the symptom experience and how each component 
impacts this experience. 
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Supplementary Material Table 1: Integrative Review Literature Table with Data Organized within Each Symptom 







































- >75 reported less 
symptom impact for 
all 3 clusters  
-Patients not feeling 
impacted by 
symptom cluster 
may delay seeking 
treatment  
-guide patients to 
monitor for specific 
symptoms in clusters  
-understanding clusters = 
tool for when to seek 
care  
-remote monitoring 
means need for symptom 
self-identification  
3 clusters  
-acute volume 
overload cluster: shortness of 
breath, tired/fatigue/low 
energy, trouble sleeping at 
night  
-emotional cluster: depressed, 
worried, difficulty 
concentrating/ remembering  
-chronic volume overload: 
lower extremity edema, need 
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symptom impact for 
all 3 clusters  
-guide patients to 
monitor for specific 
symptoms in clusters  
3 clusters  
-acute volume overload 























-Patients not feeling 
impacted by 
symptom cluster 
may delay seeking 
treatment  
-understanding clusters = 
tool for when to seek 
care  
-remote monitoring 
means need for symptom 
self-identification  
tired/fatigue/low energy, 
trouble sleeping at night  
-emotional cluster: depressed, 
worried, difficulty 
concentrating/ remembering  
-chronic volume overload: 
lower extremity edema, need 




NONE NONE -somatic/ affective 
depressive cluster 
predictor of all-






health status  
NONE -depressive clusters can 
predict mortality and 
health status; depression 




















more likely to 





likely to be in 
cluster 3 
NONE -cluster 1 less 
likely to be 
NYHA class III or 
IV, have diabetes, 
or use diuretic  
-cluster 3 NYHA 
class III or IV, 





cluster 2 (P=.01) 
and 3 (P=.001) 
-re-hospitalization 
more likely in 
cluster 3 than 1  
-vital exhaustion 
consists of fatigue, 
cognitive/ affective 
depressive 
symptoms, lack of 
concentration, sleep 
difficulties  
-clinicians should not 
focus on depressive 
symptoms in isolation 
3 clusters  
Cluster 1: no VE group 
(24.1%) 
Cluster 2: VE symptoms 
(increased fatigue, decreased 
concentration) but no 
cognitive/ affective depression 
symptoms and sleep 
difficulties (47.2%) 
Cluster 3: VE symptoms 
WITH cognitive/ affective 
depression symptoms and 




-cluster 1 most 
educated (p 
<.05) 
NONE -cluster 1 mostly 
NYHA class I or 
II, cluster 2 
-symptoms in 
cluster 2 more 
bothersome than 3, 
-ACE inhibitors 
prescribed significantly 
less in cluster 2 than 1 
3 clusters  
-cluster 1: few symptoms 











than 1 (P = 
.03) 
mostly NYHA 
class II or III, 
cluster 3 mostly 
NYHA class III or 
IV (p=.03 for all)  
-Cluster 2 had 
greater 
impairment than 1 
(P < .001) 
regardless of 
frequency 




(44.4% compared to 
74.7%; P = .01)  
-cluster 2: very symptomatic 
(n=18) 
cluster 3: very symptomatic 
























ratio, 1.18; 95% 
confidence 
-higher distress from 
physical cluster for 
women and NYHA 
class III/IV (p < .05) 
-higher distress from 
emotional/ cognitive 
cluster for young 
patients (p <.05) 
 
- emotional/ cognitive 
clusters may be highest 
risk for adverse 
outcomes 
-Current guidelines do 
not include depressive 
interventions 
-need education on 
clusters to increase 
symptom self-awareness 
2 clusters 
-Physical symptom cluster: 
dyspnea, increased need to 
rest, low energy, and sleep 
disturbances (low energy most 
distressful, lower extremity 
edema least) 
-Emotional/cognitive 
symptom cluster: worrying, 
feeling depressed, and 















burden in high 
distress group 
than all others  
and healthcare-seeking 
behaviors 
most distressful, feeling 
depressed least) 























-weary symptom cluster 
to assess re-
hospitalization risk  
-better self-monitoring 
needed (9% reported 
monitoring, and difficult 
when symptoms progress 
slowly) 
2 clusters 
-dyspneic symptom cluster 
(shortness of breath, difficulty 
breathing when lying flat, and 
waking up breathless at night) 
-weary symptom cluster (lack 
of energy, lack of appetite, and 
difficulty sleeping) 
-Lower extremity edema not 



















 -Lower extremity 
edema often not 
distressing or 
noticed by patients 
unless severe in all 3 
regions 
-use clusters to assess 
risk of poor outcomes 
-similar clusters across 
cultural groups 
-better monitoring could 
improve help seeking 
and decrease 
hospitalizations 
3 clusters  
-physical capacity cluster: 
dyspnea, walking or climbing 
difficulty, increased need to 
rest, low energy in all 3 
regions (also sleep difficulties 
in Asia) 
-emotional/cognitive cluster: 
worrying, feeling depressed, 
and cognitive problems in all 3 












NONE -clinicians should aim to 
treat both depressive 
symptom clusters due to 
increased likelihood of 
cognitive impairment 
2 clusters 
-somatic depressive cluster: 
sleep disturbance, fatigue, 
appetite changes 
-non-somatic cluster: 







(r =0.30)  problems, psychomotor 












NONE NONE NONE -cluster specific 
interventions 
-sickness behavior and 
discomforts of illness 
clusters impact 
functional limitation and 
mobility (80%  
reported limitations with 
activities of daily living) 
3 symptom clusters  
-sickness behavior cluster: 
anxiety, depression, daytime 
sleepiness, cognitive 
dysfunction, fatigue 
-discomforts of illness cluster: 
shortness of breath, lower 
extremity edema, pain 
-gastrointestinal stress cluster: 












NONE -severe symptom 
profile patients 
3.3 times more 
likely to have 
clinical HF event 
-most adults with 
HF do not have 
concordant 
symptoms and 
hemodynamics   
-clustering may connect 
biological with non-
biological symptoms for 
improved understanding 
of symptoms and 
management  
3 symptom profiles  
-concordant symptoms: 
moderate physical and 
psychological symptoms, good 











, p=.008)  
-poor 
hemodynamics 









-poor hemodynamics: worst 
hemodynamics, lowest 






NONE NONE NONE -63.25% of 
variance in 
symptom experience 
explained by 3 
clusters, predict 
quality of life 
-anxiety and 
depression linked to 
shortness of breath 
in distress cluster  
-managing entire cluster 
rather than individual 
symptoms optimal 
-need for palliative care 
interventions for 
symptom distress related 
to advanced HF 
3 symptom clusters  
-distress cluster (shortness of 
breath, anxiety, depression)  
-decondition cluster (fatigue, 
drowsiness, nausea, reduced 
appetite)  
-discomfort cluster (pain, 
generalized discomfort) 
-Lower extremity edema and 
poor sleep quality were not 











NONE NONE -symptom cluster 
patterns similar 
between those 
with and without 
HF  
 
-Quality of life 
unlikely to be stable 
over time  
-functional 
limitation secondary 
to breathlessness is 
key determinant of 
quality of life 
-clinicians may be able 
to ask one question 
regarding quality of life 
to assess rather than 




7 clusters  
-breathlessness  





-respiratory system  
-chest pain  
-clusters accounted for 65% of 



















lower than U.S. (all 
p < .05) 
 
-clinicians may need to 
consider culture when 
assessing symptom 
burden and providing 




U.S.- 4 clusters 
-class 1: all mild (25%) 
-class 2: moderate physical 
(33%) 
-class 3: moderate 
psychological (7%) 
-class 4: all severe (36%) 
Eastern Asia- 3 clusters 









Asia did not 
-class 2: all moderate (31%) 


























event rates for 
typical cluster (p 
= .016) and 
-higher perceived 
anxiety = more 
likely to be in 
typical cluster (OR 
= 1.23,  
p < .05) 
-higher perceived 
control = less likely 
to be in typical 
cluster 
(OR = 0.93,  
p < .05) 
-determine how 
demographics affect 
clusters for early 
detection and diagnosis 
-pay attention to atypical 
physical symptoms since 
found to increase risk of 
1-year cardiac events 
(HR 2.11, 95% CI [1.15, 
3.88], p=.016) 
3 symptom clusters  
-non-severe cluster (all low 
severity, n=191) 
-typical severity cluster (high 
severity dyspnea/ fatigue, low 
for lower extremity edema, 
moderate others, n=28)  
-atypical severity cluster (low 
severity dyspnea and fatigue 
(1.6 and 1.1), high for lower 
extremity edema, moderate 










































-bodily pain and 
energy 
insufficiency 




(OR = 6.59, 95% 
CI [1.29, 32.79]) 
-those with atrial 
fibrillation 
significantly 
higher scores for 




higher scores for 
-respiratory distress 
cluster accounted 
for 21.3% variance 
of symptom impact 
-bodily pain cluster 
explained 18.86% 
variance in distress  
-circulatory/GI 
cluster explained 
17.84% variance  in 
distress 
-respiratory distress 
cluster could be an early 
sign of worsening HF; 
clinicians should educate 
on how to alleviate 
symptoms at home  
-highest readmission 
from bodily pain cluster, 
patients may think these 
symptoms don’t warrant 
asking for help and need 
education  
3 symptom clusters identified 
-respiratory distress cluster: 
difficulty breathing while 
lying flat, shortness of breath 
at rest, waking up breathless at 
night 
-bodily pain and energy 
insufficiency: bodily pain, 
fatigue, sleep disturbance 
-circulatory and 
gastrointestinal distress: feet 

























low distress  
NONE - atrial fibrillation 
2.81 X likely to 
be in physical 
distress class, 2.61 
X likely to be in 
psych distress 
class, and 2.71 X 
likely to be in 
high distress 
-Patients with 
diabetes 1.91 X 
likely to be in 
physical distress 
class and 1.66 X 
likely to be in 
high distress class 
-younger patients 
with HF show 
greater distress from 
psychological 
symptom cluster 
than older patients 
(despite how severe 
or not severe 
physical symptoms 
are) 
-tailor interventions to 
groups of patients and 
symptoms  
-focus on psychological 
health of younger 
patients with HF 
-psychological 
symptoms not addressed 
in current guidelines for 
managing HF 
4 classes of HF patient 
symptom clusters 
-class 1: low distress (mild 
physical and psychological 
symptoms) 
-class 2: physical distress 
(severe physical, moderate 
psych) 
-class 3: psychological distress 
(severe psych, moderate 
physical) 
-class 4: high distress (severe 







-Hypertension 2 X 







NONE NONE NONE NONE -manage symptoms of 
sickness behavior cluster 
to improve quality of life 
-hallmark HF symptoms 
did not negatively affect 
quality of life (expand 
assessments to include 
other symptoms) 
3 symptom clusters 
-sickness behavior cluster: 
anxiety, depression, daytime 
sleepiness, cognitive 
impairment, and fatigue 
(explains 40% of variance in 
quality of life) 
-Discomforts of illness: 
dyspnea, lower extremity 
edema, and pain 






NONE NONE -incongruent 
group 98% more 
likely to have a 
180-day event (p 
= 0.014) than 




4 symptom clusters 
-Severe physical (26.3% 
-Mild physical (73.7%) 
-Severe affective (21.2%) 









group not more 
likely to have an 
event within 180 










-Those in severe physical 
cluster more likely to be in 
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Background: Clustering symptoms and developing patient profiles could result in more 
targeted and effective heart failure (HF) interventions down the line. However, Black 
females remain significantly underrepresented in current HF symptom cluster research, 
which also minimally examines sex differences and does not include qualitative 
methodologies.  
Objective: This manuscript evaluates the feasibility and acceptability of a study protocol 
and procedures for a mixed methods approach to ascertain symptom clusters in Black 
women with HF preserved ejection fraction (HFpEF). It then presents preliminary 
symptom cluster analysis findings.  
Methods: Participants recruited from social media completed screening and 
demographics questionnaires, the Minnesota Living with HF Questionnaire, Symptom 
Status Questionnaire – HF, and Personal Health Questionnaire – 8. Feasibility outcomes 
were measured and analyzed, and a portion of participants were interviewed about their 
symptoms. 
Results: Forty-four Black women were enrolled in the study, with one of the 44 
identifying as multiracial. The majority of the participants were married (45.5%) with a 
mean age of 51.8 years. A hierarchical cluster analysis formed three clusters of 
participants with statistically significant differences in the proportion of symptoms 
experienced and co-morbidities. Cluster 1 was highly symptomatic with most participants 
reporting most symptoms, cluster 2 reported fewer symptoms than cluster 1, especially 







Conclusions: The results of this study support the feasibility and acceptability of a mixed 
methods protocol for studying symptom clusters in Black women with HFpEF. Symptom 
clusters should be further explored with a larger sample.  
 
Feasibility of a Mixed Methods Approach to Identifying Symptom Clusters in Black 
Women with Heart Failure Preserved Ejection Fraction 
 
Introduction 
Heart Failure (HF) is a severe chronic disease that results in 30% of patients dying 
within one year of diagnosis, and patients often suffering from prominent symptoms that 
can impact physical functioning and health-related quality of life1-3-7. Heart Failure 
preserved Ejection Fraction (HFpEF) is a specific type of HF caused by diastolic 
dysfunction in which increased myocardial stiffness impairs relaxation of the left 
ventricle8-9.  A symptom cluster consists of two or more symptoms occurring 
simultaneously in a disease10.  Current evidence supports the existence and use of HF 
symptom clusters and patient profiles to characterize which symptoms co-occur and 
assess risk for adverse health outcomes4, 10-26.  
Existing literature indicates that HF symptoms are especially burdensome to 
females, who report more depression, worse symptom severity and quality of life, and 
longer and more frequent hospitalization than males3-7. HF with preserved ejection 
fraction (HFpEF) is more prevalent in females, by a factor of 2 in some studies2. Black 
Americans are 1.5 times more likely to develop HF and have a 2.5 times greater risk of 






affected by HFpEF, as they tend to be younger, have earlier onset, report worse QoL, and 
have a greater risk of hospitalization than White Americans with HFpEF9.  
Black women remain significantly underrepresented in current HF symptom 
cluster research4, 10-26. Considering the increased burden of HF symptoms and overall 
outcomes in women and Black Americans, studying the symptom experience and 
symptom clusters concerning gender, sex, race, and type of HF is warranted3-7.  
Furthermore, there are limited studies examining sex differences. To our knowledge, 
there are no current HF symptom cluster studies that include qualitative methodologies4, 
10-26. Mixed methods and qualitative approaches to symptom cluster research are needed 
to provide a richer description of the symptom cluster experience and the impact of sex 
and race/ethnicity on this experience. To achieve this, Black women with HFpEF should 
be recruited to share their symptom experience through surveys and interviews. However, 
it is first necessary to determine the feasibility of recruiting Black women with HFpEF, 
identify potential barriers and facilitators to adequate recruitment, and examine 
acceptance of a study protocol28. Therefore, this manuscript reports the feasibility and 
acceptability of a study protocol and procedures for a mixed methods approach to 
ascertain symptom clusters in Black women with HFpEF. We also present preliminary 
findings from symptom cluster analysis for this population to describe the symptom 
clustering technique and preliminary findings that can later be explored with a larger 










         After institutional review board approval, participants were recruited through 
social media using Facebook ads, posts within Facebook groups, and snowball sampling. 
Respondents completed a screening survey to determine eligibility online in REDCap or 
via phone. Participants were eligible if they were 35- to 74 years old, identified as a 
Black female and woman, and had a self-reported diagnosis of HFpEF (with an ejection 
fraction greater than or equal to 50%). Exclusion criteria consisted of self-reported cancer 
or end-stage disease diagnosis (end-stage heart failure, renal disease, respiratory/lung 
disorder, liver disease, or cancer), stroke or myocardial infarction in the last six months, 
or a recent hospitalization within the previous four weeks. A sample size of 50 was 
targeted for this study based on a pragmatic approach to determining the feasibility 
sample size29. 
  Eligible participants gained access to the fully study survey in REDCap or could 
call the PI to assist in completing the survey if needed. Instructions for completing the 
survey were presented before the questionnaires, and participants consented to 
participating in the research study by completing the survey. The symptom cluster survey 
included a demographics questionnaire with a single item literacy screener (SILS)30, the 
Minnesota Living with Heart Failure Questionnaire (MLHFQ)31, Symptom Status 
Questionnaire - Heart Failure (SSQ-HF)32, Personal Health Questionnaire - 8 (PHQ-8)33, 
and feasibility and acceptability questions.  
 
Measures 
Demographic data were collected using a combination of the screening 






MLHFQ31, SSQ-HF32, and PHQ-833. The first questionnaire, the MLHFQ, is a 21-item 
quality-of-life questionnaire designed for patients with HF, that includes questions related 
to the impact of physical symptoms, emotional/ psychological symptoms, and HF-related 
activities on daily life31. Participants rate how much an item affected their life in the past 
month, using a Likert scale of 0-5 ranging from 0 indicating none to 5 very much31. The 
MLHFQ has excellent internal consistency with a Cronbach’s α usually ranging from 
0.89-0.96 and has been used successfully in forming symptom clusters in multiple other 
HF symptom cluster studies4, 10, 11-13, 15, 23, 25, 31. The MLHFQ is short, easy to administer, 
validated for its psychometric properties, and has been used to assess quality of life in 
Black Americans in HF clinical trials4,10, 11-13, 15, 23, 25, 31,34.  
The second questionnaire, the SSQ-HF, measures the presence, frequency, 
severity, and distress of 7 physical symptoms most commonly reported in HF (shortness 
of breath during daytime, shortness of breath lying down, fatigue or lack of energy, chest 
pain, leg or ankle swelling, difficulty sleeping, and dizziness or loss of balance) in the last 
four weeks32. If a symptom is present, the respondent rates frequency, severity, and 
distress using a Likert scale of 1-4, with 1 being the least and 4 being the most32. 
Cronbach's α for the SSQ-HF is 0.80 and the instrument asks about symptoms in the last 
four weeks, the same time frame as the MLHFQ31, 32.  
The third questionnaire, the PHQ-8, asks respondents to rate the severity of eight 
depressive symptoms from 0 (not at all) to 3 (nearly every day) over the past two 
weeks33. This depressive symptom scale is widely used and has a Cronbach’s α of 0.8333.  
Finally, the SILS was included to assess health literacy in the study population30. 






participant, with a score of >1 indicating a “positive” result for low health literacy30.  
Participants were also asked eleven questions about feasibility and acceptability at the 
end of the survey related to instructions, study processes, time, compensation, the 
purpose of the study, and recommendation of the study to others. Feasibility and 
acceptability questions were adapted from Orsmond & Cohn’s guiding questions for 
feasibility studies35. Scores ranged from 1 (completely disagree) to 5 (completely agree) 
with 5 being the optimal score. 
 
Feasibility Outcomes  
The feasibility of study processes, resources, and human and data management 
were analyzed as the primary aim of this study28. Study process feasibility outcomes were 
assessed by examining consent rate, recruitment rate, interview interest rate, survey 
completion rate, and feasibility and acceptability question scores. The consent rate was 
determined by calculating the percentage of eligible participants who consented by 
completing the next survey after the eligibility survey, with a 90% consent rate as the 
benchmark. The recruitment rate was assessed by calculating the percentage of 
participant recruitment goal met for both the survey and interviews. A benchmark goal 
was >85% of recruitment, with a recruitment goal of 50 survey participants and 15 
interview participants. The interview interest rate was determined by calculating the 
percentage of participants who indicated they were interested in being interviewed at the 
end of the survey, with the goal interview interest rate of 30%. The percentage of 
completed surveys without missing data was calculated by dividing the number of fully 






benchmark goal of >85%. Feasibility and acceptability question scores were averaged, 
with a goal average score of 4 or higher.  
Resource feasibility outcomes were assessed by examining interview data 
collection time and recruitment burden. The interview data collection time was assessed 
by calculating the average interview duration and the range of interview times. The goal 
interview duration was <60 minutes. For recruitment burden, we tracked time spent 
recruiting for the survey and interviews and calculated an average time per week for 
each. Recruitment time for the survey included writing and sharing posts in social media 
groups, responding to potential participants and social media group admins via messages 
or comments, and management of Facebook ads. Recruitment time for the interviews 
included emailing and calling participants who indicated interest in being interviewed at 
the end of the survey. This recruitment time also included time spent scheduling 
interviews. The recruitment burden benchmark was an average of < 20 hours per week. 
The feasibility of management outcomes was examined based on transcription 
time, software reliability, and adverse patient events. Phone interviews were transcribed 
using automated software for clear audio and dialects and a transcription service was 
used when this was not the case. Transcripts were reviewed and edited word-for-word for 
correctness. The time spent editing transcripts was tracked, with the goal of < 2 hours 
spent per transcript. Major events related to issues with software and data management 
platforms or adverse events during data collection were tracked, with a goal of no major 
events.  
 






A hierarchical cluster analysis was performed in SPSS version 25 (SPSS Inc, 
Chicago, Illinois) to explore preliminary symptom clusters of physical and 
emotional/psychological symptoms included in the MLHFQ, SSQ-HF, and PHQ-831-
33,36,37. The hierarchical cluster method is used to cluster variables (symptoms) or cases 
(study participants) and allows the researcher to determine the optimal number of clusters 
after conducting the analysis rather than a priori36,37. Hierarchical clustering creates 
compact and homogeneous clusters and maximizes differences in clusters36,37. The three 
main steps to hierarchical clustering are calculating distances between variables, linking 
clusters, and determining the number of clusters based on dendrogram and agglomeration 
schedule results37. Branches of the dendrogram are based on semi-partial r-squared 
scores, and smaller branches signify more similar clusters37.  
To standardize scoring for symptoms across the three different questionnaires, 
variables were dichotomized to either yes, the symptom was present for any symptom 
score other than 0, or no, the symptom was not present. First, a hierarchical cluster 
analysis was attempted to cluster by symptoms utilizing Euclidean distance and Ward’s 
method of clustering. Ward’s method is best for maximizing significant differences 
between clusters by using the F value and forms more homogenous clusters close to 
equal in size37. However, due to the small sample size and the dichotomized variables, 
this method was not optimal for forming meaningful clusters. Therefore, we employed an 
alternative strategy to clustering by participant rather than cluster, described by Hertzog 
et al14. We used between-groups linkage method and simple-matching to calculate 
distance, both of which better suit the small sample size14. After conducting the cluster 






began significantly decreasing. This drop occurred at stage 41 in the agglomeration 
schedule. The number of stages, 41, was then subtracted from the total number of cases, 
44, suggesting that a 3-cluster solution was optimal.   
The clusters were then compared by demographic variables and symptom 
presence. Comparisons were completed using one-way ANOVA for continuous data, 
Kruskal-Wallis Test for interval level data, and Fisher’s exact test for nominal data, with 
a significance level of .05 for all tests. Pair-wise comparisons were also completed for 
Kruskal-Wallis tests using Dunn’s (1964) test with a Bonferroni correction within SPSS 
(SPSS Inc, Chicago, Illinois). 
Results 
A total of 70 participants were deemed eligible from the screening questionnaire, 
and of these, 67 participants completed the consent process and the survey. After a 
review of data to remove participants who did not meet inclusion criteria based on 
responses to the demographic questionnaire, 44 participants remained for analysis. All 44 
participants (Table 1) identified as Black race, with one of the respondents also 
identifying as White. The average participant age was 51.8 years old, with an age range 
of 37 to 74. The majority of the participants were married (45.5%) or single (27.3%), 
with an average of 2 children. Thirty-nine percent of women had a high school diploma 
or GED, 18.2% reported no high school degree, and 43% of participants had an associate 
degree or higher. The majority (77.3%) of participants reported “never” or “rarely” 
needing someone to help them read written materials from their doctor or pharmacist in 
response to the single item literacy screener30. The majority of participants were 






the last five to eight years and no participants reporting a diagnosis for nine years or 
longer. All participants had some type of insurance, with Medicare and Medicaid being 
the most common (54.6%). Twenty-six of the 44 participants reported having one or 
more co-morbidity, with hypertension (34.1%), respiratory diseases (31.8%), and atrial 
fibrillation (27.3%) being the most commonly reported. Body Mass Index (BMI) was 
calculated based on self-reported height and weight. The majority of the participants 
(56.8%) were classified as having a “healthy” BMI within the range of 18.5-24.9, while 6 
(13.6%) had an “overweight” BMI of 25-29.9, 11 (25%) were classified as “obese” with 
a BMI greater than or equal to 30, and 2 were classified as “underweight” with a BMI 




 Analysis of study processes, resources, and management was conducted to 
determine this study protocol’s feasibility28, as shown in table 2. Study process feasibility 
results were as follows. The consent rate was 95.7% for the study. A total of 70 
participants were recruited using social media over 5 weeks; 67 out of 70 consented to 
participate in the study.  Out of the 67 participants who completed the survey, 38 (56.7%) 
were interested in being interviewed about their symptom experience. Of those 38, 15 
were successfully interviewed, which satisfied 100% of the interview recruitment goal of 
15 participants. The other participants who were not interviewed either did not respond to 
the initial email invitation to be interviewed (N=14), stopped responding during interview 
scheduling (N=6), or did not answer calls during their scheduled interview time (N=3). 






reviewed to assess eligibility. Twenty-three participants out of 67 were excluded for ages 
outside criteria (N=19) or not identifying as Black (N=4). Forty-four eligible participants 
remained for analysis, resulting in 88% of the survey recruitment goal, which was above 
the 85% benchmark. Out of the 44 included survey respondents, 43 (97.7%) surveys were 
fully completed without missing data. The average rating across all feasibility and 
acceptability questions was 4.87 out of 5, and no participants rated feasibility or 
acceptability lower than a 3 (neither agree nor disagree).  
 Feasibility outcomes of resources were also examined to identify resources 
needed to conduct the study on a larger scale. Data collection time for phone interviews 
ranged from 18 to 55 minutes, with an average interview duration of 35 minutes. This 
time frame only includes the interview, not quantitative survey completion that was 
completed on REDCap. An average time of 14.4 hours was spent recruiting participants 
over five weeks for the survey recruitment burden. Recruiting and scheduling participants 
for interviews took, on average, 5.8 hours per week for 13 weeks. For management 
feasibility outcomes, interview transcripts took less than two hours to edit for accuracy 
with the assistance of transcription software. No significant events were reported with 
software reliability or adverse patient events. 
 
Cluster Analysis 
A preliminary symptom cluster analysis was conducted with the feasibility study 
sample to observe the hierarchical clustering technique and identify preliminary findings 
that could later be explored with a larger sample. Clusters were formed by clustering 






schedule was reviewed to determine the three-cluster solution. We then compared 
clusters by presence of symptoms (figure 1 and table 3) and demographic variables by 
cluster (table 4) to validate cluster differences.  
 
Highly Symptomatic Cluster 
           Cluster 1, the highly symptomatic cluster, reported the most symptoms of the 
clusters and contained the largest number of participants (26). Over 75% of participants 
reported experiencing all symptoms except chest pain (65.4%) and dizziness (61.5%). All 
participants (100%) reported feeling depressed and fatigued (need to rest), and 25 of 26 
participants reported shortness of breath, lack of energy, leg swelling, and feeling bad 
about themselves. The mean age in Cluster 1 was 50.3 years (SD=10.9), and the average 
BMI was 25 (SD=5.8). Most of the participants in the highly symptomatic cluster 
reported not having any comorbidities (57.7%). Of the comorbidities that were present, 
hypertension (23.1%), atrial fibrillation (19.2%), and diabetes (15.4%) were the most 
commonly reported. 
 
Mildly Symptomatic Cluster 
           Cluster 2 was mildly symptomatic, as this cluster reported fewer symptoms than 
cluster 1, especially regarding depressive symptoms. All participants reported a lack of 
energy, and almost all (93.3%) reported shortness of breath, leg swelling, and fatigue or 
need to rest. Otherwise, 33.3% of participants or less reported experiencing the rest of the 
symptoms. Every participant in the study reported experiencing fatigue or need to rest 






participants, who were, on average, 54.1 years old (SD=12.5) with an average BMI of 
29.6 (SD=20.9). The most commonly reported comorbidities in cluster 2 were atrial 
fibrillation (46.7%), hypertension (40%), coronary artery disease (33.3%), and Chronic 
Obstructive Respiratory Disease (33.3%), while 20% of participants reported not having 
any comorbidities.  
 
Psychologically Symptomatic Cluster 
           Cluster 3 reported few physical symptoms, considering the only physical symptom 
these participants reported was fatigue (need to rest) (3/3, 100%), but this cluster reported 
more psychological symptoms included in the PHQ-8, such as poor appetite (2/3, 66.6%), 
feeling bad about themselves (2/3, 66.6%), trouble concentrating (1/3, 33.3%), feeling 
depressed (1/3, 33.3%), and anhedonia, or inability to feel pleasure (1/3, 33.3%). This 
psychologically symptomatic cluster was the smallest cluster, with only three 
participants. The three participants had a mean age of 52.7 years (SD=2.5) and a BMI of 
36.6 (SD=11.3). All 3 participants in this cluster reported comorbidities, with 2 (66.7%) 
reporting diabetes, 2 (66.7%) reporting hyperlipidemia, and all (100%) reporting 
hypertension.  
 
Comparison of clusters 
           Clusters were compared according to demographics, comorbidities, and symptoms 
experienced. No statistically significant differences were observed between clusters for 
age (F (2, 41) = 0.574, p = .568)) or BMI (F (2, 41) = 1.332, p = .275)). For differences in 






reported coronary artery disease (p=.049) and those who reported having no 
comorbidities (p =.02) between the highly symptomatic and mildly symptomatic clusters. 
The highly symptomatic cluster reported a statistically significant higher proportion of 
psychological symptoms than the mildly symptomatic cluster (p <.001). Though not 
found statistically significant, the highly symptomatic cluster was the most highly 
educated group, with over 50% of participants having their bachelor's degree or higher.  
 
Discussion 
           Results from this feasibility study are relevant for a variety of reasons. First, 
almost all feasibility and acceptability benchmarks were met. Reaching these benchmarks 
shows that Black females with HFpEF can be successfully recruited via social media for 
an HF symptom cluster study and, just as importantly, they were satisfied with the study 
protocol according to their positive responses to acceptability questions. Recruiting via 
Facebook advertisements and snowball sampling is a viable method, as dynamic 
Facebook ads can learn overtime who engages with the advertisement the most and 
shows the ad to users like those individuals, thereby increasing potential reach. Access to 
the survey link also allows participants to share the study with family members or friends 
who may also be eligible for the study, further increasing the reach for participant 
recruitment.  
           One barrier to reaching 50 participants for the study was having several 
respondents who were not actually eligible once we analyzed their responses, especially 
pertaining to age and race/ethnicity. This may have been due to errors while completing 






entering their age incorrectly. In the future, these factors should be analyzed in real-time 
to allow for discussion with the participant to provide clarity and confirm eligibility. A 
Facebook ad's benefit is that it enables the recruitment of a large number of participants 
with minimal time and resources. The largest cost associated with recruiting individuals 
was compensating them with a $25 Amazon gift card for completing the survey and 
participating in an interview.  
           Though a hierarchical cluster analysis requires more than 44 participants for 
statistically meaningful results, we conducted the cluster analysis to test the process and 
develop preliminary clusters. The clusters formed in this study were similar to clusters 
formed in the symptom cluster analysis completed by Hertzog, et al. in 2010, which used 
similar methods. Comparison between clusters showed statistically significant differences 
when compared to one another for the presence of almost all symptoms, which validates 
the number of clusters chosen based on the agglomeration schedule. Interestingly, every 
participant in the study reported experiencing fatigue (need to rest), except one 
participant. Though the psychologically symptomatic cluster was small with only three 
participants, the cluster showed prominent differences in symptoms experienced and 
comorbidities, especially considering that almost all the symptoms experienced for this 
cluster were psychological. Though no formal comparison was carried out due to the 
small cluster size, the observed mean BMI for the psychologically symptomatic cluster 
was 36.6 (SD=11.3) compared to 29.6 (SD=20.9) for the mildly symptomatic cluster and 
25.0 (SD=5.8) for the highly symptomatic cluster. These characteristics should be 






The highly symptomatic cluster had over half of participants reporting every 
symptom. This group also had the youngest mean age, though not a statistically 
significant difference. As the youngest and most symptomatic cluster, cluster participants 
were also statistically significantly more educated than participants in the mildly 
symptomatic cluster. HF symptom cluster literature has shown a relationship between 
younger age and more distress from symptoms15, 17. This phenomenon should be more 
closely explored in future larger samples. Qualitative data from interviews will also be 
integrated with this symptom cluster data in a future manuscript to expand upon these 
findings and further explain the symptom experience of Black women with HFpEF.  
           Though this study has a small sample size, the sample was adequate for assessing 
feasibility and acceptability of the study protocol and allowed for the formation of 
preliminary clusters of participants as a first step towards developing meaningful 
symptom clusters for this population. Utilizing social media is a valuable resource for 
reaching a large number of potential participants39. However, participants must be 
properly screened to ensure accurate eligibility39. It is possible that respondents try to 
gain access to the survey when they are not actually eligible because they did not 
understand eligibility criteria, wanted to be included in the research, or for monetary 
gain39. Extra measures were added to the survey to deter this from happening, such as 
adding captchas, a test meant to distinguish humans from bots, screening for surveys 
completed back-to-back with the same or very similar email addresses and requiring 








Summary and Implications 
The results of this study support the feasibility and acceptability of a mixed 
methods study protocol for studying symptom clusters in Black women with HFpEF. 
Preliminary clusters showed statistically significant differences in the proportion of 
symptoms experienced and comorbidities. Cluster development and differences in 
clusters should further be explored in a larger sample of participants adequate for 
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Table 1: Study Sample Demographics 
N=44 Frequency (Valid %) Mean (SD) 




Black  44 (100%)  
Single item literacy screener   
Never 26 (59.1%)  
Rarely 8 (18.2%)  
Sometimes 5 (11.4%)  
Often 5 (11.4%)  
Always 0 (0%)  
Education   
No High School Diploma 8 (18.2%)  
Diploma or GED 17 (38.6%)  
Associate degree 3 (6.8%)  
Bachelor’s Degree 7 (15.9)  
Master’s Degree 7 (15.9%)  
Doctoral Degree 2 (4.5%)  
Current marital status    
Single 12 (27.3%)  






Separated 3 (6.8%)  
Divorced 4 (9.1%)  
Widowed 5 (11.4%)  
Length of HF Diagnosis   
0 – 12 months 11 (25%)  
>1 year – 2 years 15 (34.1%)  
3 years – 4 years 13 (29.5%)  
5 years – 8 years 5 (11.4%)  
Primary Insurance Status   
None 0 (0%)  
Medicare / Medicaid 24 (54.6%)  
Public (marketplace) 7 (15.9%)  
Private (employer) 10 (22.7%)  
Other 3 (6.8%)  
BMI Categories   
Underweight (< 18.5) 2 (4.5%)  
Healthy (18.5 – 24.9) 25 (56.8%)  
Overweight (25 – 29.9) 6 (13.6%)  
Obese (> 30) 11 (25%)  
Age (years)  51.75 (11.1) 
# of children   2 (range 0-8) 








Table 2: Feasibility Outcomes  









Process    










% of participant 
recruitment goal 
>85% of recruitment 
goal (goal N=50 for 
survey, goal N=15 for 
interview) 
88% of survey 
recruitment goal met 
(N=67 recruited for 
survey, 44 eligible for 
analysis) 
 
100% of interview 
recruitment goal met 
































Average score of 4 or 
higher 
4.87 average across 











< 60 minutes Average interview 
duration = 35 minutes 
Interview duration 




Time spent with 
recruitment / 
week 
< 20 hours Questionnaire 
recruitment: 14.4 
hours/week average 











Management    
Transcription 
editing time 





< 2 hours / interview 100% of interviews 
transcribed in <2 





software / data 
management 
platforms 
No major events None reported 
Adverse 




No major events None reported 
 

































76.9 (20) 33.3 (5) 0 .008 
LACK OF ENERGY 96.2 (25) 100 (15) 0 .634 
CHEST PAIN 65.4 (17) 33.3 (5) 0 .048 
LEG SWELLING 96.2 (25) 93.3 (14) 0 .604 
DIFFICULTY 
SLEEPING 
88.5 (23) 13.3 (2) 0 <.001 
DIZZINESS 61.5 (16) 33.3 (5) 0 .078 
FATIGUE NEED TO 
REST 
100 (26) 93.3 (14) 100 (3) .366 
ANHEDONIA 88.5 (23) 13.3 (2) 33.3 (1) <.001 
FEELING 
DEPRESSED 
100 (26) 0 33.3 <.001 
POOR APPETITE 88.5 (23) 33.3 (5) 66.6 (2) <.001 
FEELING BAD 
ABOUT SELF 
96.2 (25) 0 66.6 <.001 
TROUBLE 
CONCENTRATING 
80.8 (21) 13.3 (2) 33.3 <.001 
SLOW OR RESTLESS 76.9 (20) 0 0 <.001 
*p-value obtained from Fischer’s exact test (only clusters 1 and 2 were compared due to small 








Table 4: Demographic variables by cluster  






















HYPERTENSION 23.1 40 100 .21 
HYPERLIPIDEMIA 11.5 26.7 66.7 .21 
DIABETES 15.4 6.7 66.7 .39 
ATRIAL 
FIBRILLATION 
19.2 46.7 0 .07 
CORONARY 
ARTERY DISEASE 
7.7 33.3 0 .049 





11.5 33.3 0 .10 
OBSTRUCTIVE 
SLEEP APNEA 
3.8 3.0 0 .30 
NONE 57.7 20 0 .02 




54.1 (12.5) 52.7 (2.5) .57 







*p-value obtained from Fischer’s exact test (only clusters 1 and 2 were compared due to small 
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Background: Black women with Heart Failure preserved Ejection Fraction (HFpEF) 
have an increased burden of symptoms and worse health outcomes than White patients 
with HF.  
Objective:  The purpose of this study was to characterize the symptom experience of 
Black women with HFpEF and to integrate qualitative themes and quantitative symptom 
data to examine confirmation, expansion, and discordance of results.  
Methods: Using a convergent-parallel mixed methods design, a purposive sample of 44 
Black women who were 35 – 74 years old with HFpEF were recruited using social media. 
Quantitative data including demographics, Single Item Literacy Screener (SILS), 
Minnesota Living with HF Questionnaire (MLHFQ), Symptom Status Questionnaire – 
HF (SSQ-HF), and Personal Health Questionnaire – 8 (PHQ-8) were collected through 
online surveys (N=44). Qualitative interviews were conducted to explore the background 
and symptom experience of 15 participants. We used a directed approach to content 
analysis and qualitative descriptive methods to analyze interview data, and descriptive 
statistics and Pearson correlation to analyze quantitative data. The Symptom 
Management Model (SMM) guided content analysis of interview data and integration of 
data, in which findings from both qualitative and quantitative analyses were merged, 
compared and contrasted.  
Results: Ten themes emerged relating to the person and symptom experience. 
Participants had an average MLHFQ quality of life score of 64.1 out of 105 and 45.5% of 






Conclusions: Black women with HFpEF discussed interactions of physical and 
emotional symptoms. Positive correlations between symptom scales supported this 
theme. Women reported shortness of breath and chest pain causing worry and fears of 
death. Participants reported feeling like a burden to others and hid or downplayed their 
symptoms. Reduced physical functioning impacted family life, household chores, and the 
ability to work.  
 
Qualitative and Integrated Results from A Mixed Methods Approach to Symptom 
Clusters in Black Women with Heart Failure Preserved Ejection Fraction 
 
Background 
Patients with heart failure (HF) have a complex and multi-factorial symptom 
experience that makes symptom self-monitoring and self-management challenging1-5. 
Four out of five patients with HF are hospitalized each year with exacerbations that could 
be avoided with early detection1. Females experience worse quality of life (QoL) and 
functional impairment, and have higher rates of edema, depression, exercise intolerance, 
and dyspnea on exertion compared to males3,4. Little is known about the symptom 
experience in patients with HF preserved ejection fraction (HFpEF), a type of HF caused 
by diastolic dysfunction in which relaxation of the left ventricle is impaired from 
increased stiffness6,7. Black patients with HFpEF tend to be younger, report worse QoL, 
and have a greater risk of hospitalization than White patients7. A better understanding of 
symptoms and symptom experiences in this population may inform approaches to care to 






 Qualitative studies are needed to explore how gender, sex, and race interact and 
impact the symptom experience, as quantitative instruments alone have limited ability in 
encompassing such factors. Considering the increased burden of HF symptoms, greater 
risk, and worse outcomes in females, Black Americans, and patients with HFpEF1,6-8, this 
study seeks to illuminate the experiences of those who are underdiagnosed, undertreated 
and have a greater symptom burden3,4. A convergent mixed methods approach allows for 
a more comprehensive examination of the HF symptom experience by integrating 
qualitative interview data with quantitative symptom data to examine results for 
confirmation, expansion, and discordance. Thus, the objective of this study was to 
characterize the symptom experience of Black women with HFpEF and how symptoms 
affect their life by presenting qualitative themes within the framework of the Symptom 
Management Model. The integration of qualitative themes with corresponding 
quantitative symptom scale data will be presented in a joint display and results will be 
compared and contrasted to examine for convergence, discordance, and expansion. 
 
Methods 
 A convergent-parallel mixed methods feasibility design was used to collect  
qualitative and quantitative data in the same time frame with equal priority. Qualitative 
data were collected using individual, semi-structured interviews with 15 participants. 
Quantitative data were collected through online surveys using questionnaires and well-
validated symptom scales. The study survey consisted of a demographics questionnaire 
with a single item literacy screener9, the Minnesota Living with Heart Failure 






Personal Health Questionnaire - 8 (PHQ-8)12, and feasibility and acceptability questions. 
Each type of data was analyzed separately, results were integrated in a joint display, and 
common concepts were compared and contrasted. Details of the feasibility study and 
quantitative symptom cluster results are reported in a previous manuscript8.  
 
Sample and setting 
Following institutional review board approval (Pro00101261), a purposive sample 
of participants was recruited using Facebook ads and posts within Facebook groups, and 
snowball sampling by allowing participants to share the link with others who may qualify 
for the study. Participants responded to a screening survey to determine if they fit the 
eligibility criteria of a 35- to 74-year-old Black female who identified as a woman and 
had a self-reported diagnosis of HFpEF (with an ejection fraction greater than or equal to 
50%). Participants were not eligible if they reported having cancer or an end-stage 
disease diagnosis (end-stage heart failure, renal disease, respiratory/lung disorder, liver 
disease, or cancer), stroke or myocardial infarction in the last six months, or a recent 
hospitalization within the previous four weeks. At the end of the quantitative survey, 
participants were asked if they were interested in being interviewed about their symptom 
experience and their preferred contact method. All participants who were interested in 
being interviewed (n=38) were contacted via email or phone to schedule individual, semi-
structured interviews. We conducted interviews with all participants who responded and 








The Symptom Management Model (SMM) highlights the multi-faceted nature 
and complex interactions of symptom components13. Six components comprise the 
SMM,13 symptom experience, components of symptom management strategies, outcomes 
and symptom status, person, environment, and health and illness. For this study, 
symptom experience and person influenced the semi-structured interview guide, as these 
components are well suited for individual interviews, best answered the overall research 
question, and allowed for exploration of demographic, psychological, and sociological 
factors that can influence the symptom experience of a Black woman with HFpEF13. 
These components guided content analysis of interview data and the integration of 
questionnaire and interview results13,14. The three domains of the MLHFQ (physical 
symptoms, emotional symptoms, and QoL)10 also influenced interview guide questions, 
which set the stage for the merging of quantitative and qualitative results14, 15. Table 1 
shows the merging of qualitative and quantitative data collection instruments within the 
SMM framework.   
 
Qualitative data collection 
A semi-structured interview guide was developed to facilitate consistency in data 
collection while allowing for unanticipated responses and was reviewed by industry 
experts for completeness and clarity. Our team created open-ended questions about the 
SMM13 components of symptom experience (perception, evaluation, and response) and 
person, and the domains of the MLHFQ10 (physical symptoms, emotional symptoms, and 
quality of life) about each participant and their symptom experience. Participants were 






videoconference. One participant requested a videoconference, and all other participants 
requested to conduct interviews via telephone, either due to technological capabilities or 
personal preference.  
Participants were asked to discuss their background and to describe their 
symptoms in the last 4 weeks to correspond with the MLHFQ and SSQ-HF symptom 
recall time frame10. Probes, both questioning and silent, were used to facilitate thoughtful 
responses from participants16. Mirroring was utilized to ensure the PI was capturing the 
true perspective of each participant by repeating phrases and ideas back to the participant 
for confirmation of what they meant by their statements16. Each interview lasted on 
average 35 minutes, with times ranging from 18 minutes to 55 minutes.  
 
Qualitative data analysis 
Interviews were audio recorded, transcribed verbatim using a professional 
transcription service, and all transcripts were checked for accuracy. Transcripts were 
coded with NVivo 13 software (QSR International, Pty, Doncaster, Australia) and 
qualitative description was used to guide analysis of semi-structured interview data37-39. 
This methodology is data near, meaning it aims to capture the true experience of 
individuals by keeping analysis close to the given data rather than significantly 
transforming data17-19. Interviews were transcribed and analyzed as they were collected 
using a constant comparative method16. A directed approach to content analysis was used 
with SMM13 components and MLHFQ10 domains as broad code types developed a priori, 






The PI initially performed level 1 coding before coding data within a priori 
codes19. This first step was meant to increase trustworthiness by not allowing broad code 
structures to result in missing important findings that did not fit within the selected 
frameworks19. Two to three transcripts were analyzed at a time. Codes and emerging 
themes were then reviewed with the research team qualitative expert and the HF content 
expert, and codes were revised as needed16. Themes emerged from within and across 
coding categories.  
The research team qualitative expert oversaw coding of all interview transcripts 
and debriefing occurred at each stage of the data analysis process to increase 
transparency of coding and allow for triangulation of findings to increase credibility16. A 
detailed audit trail was maintained throughout data collection and analysis to support 
dependability16. All codes were developed by the 9th interview, and saturation occurred 
after the 13th interview was analyzed, in which responses coincided with already 
developed themes without adding new or differing information20.  
 
Quantitative Data Collection and Analysis 
We collected data on demographics, quality of life, physical symptoms, and 
emotional / psychological symptoms using well-validated instruments, described in detail 
in another manuscript8. Quantitative data were analyzed for standard descriptive 
statistics, including medians, ranges, means and standard deviations. We examined the 
relationship between questionnaire scores using a Pearson correlation analysis after 







Mixed Methods Integration Analysis 
Qualitative and quantitative data were integrated through methods, interpretation, 
and reporting. In the methods stage, we merged qualitative and quantitative data 
collection instruments within the SMM13 to better facilitate integration, as shown in 
Table 1. Qualitative and quantitative data collection were conducted concurrently, and 
each type of data was analyzed separately in parallel.  
Once data analysis was complete and themes were identified from qualitative 
data, we interpreted and reported both types of data using a joint display to integrate 
results (Table 3). The first column of the joint display shows themes that were identified 
from qualitative data analysis. The themes are organized within the SMM13 framework, 
arranged by the headings of perception, evaluation, response, and person. The 2nd column 
of the joint display contains quotes from interviews that relate to each theme for 
participant contextualization, and the 3rd column shows quantitative data that corresponds 
to each qualitative theme. We then integrated these data through the narrative below by 




           We reached out to all participants who indicated they were willing to participate in 
an interview (N=38), and those who were not interviewed (23/38) either did not respond 
to initial calls and emails for scheduling or did not answer during their scheduled 
interview times. If participants did not answer during their scheduled time, the PI 






from the participant. The demographics for interview participants (n=15) are presented in 
Table 2. The average age of interviewees was 46.9 years (range 37-60). All participants 
reported having children, with an average of 3 children, and the average number of 
household members was four. Most (12/15) of the participants were married or living 
with a partner, and 3 were single. Five participants did not have a high school degree, 5 
had a high school degree or GED, 1 had some college, and 4 had a bachelor's degree. 
Four of the participants currently worked as a teacher, baker, hairdresser, and 
receptionist, with 11 reporting not having a job or not working right now. 
Ten themes emerged from qualitative interviews related to symptom perception, 
evaluation, response, and person. Themes were organized according to the SMM13 
framework, as shown in Table 3, and are described below. 
Emotional symptoms co-occurring with physical symptoms 
Participants often described that their physical and emotional symptoms either co-
occurred or interacted with each other. One participant reported that their emotional 
symptoms impacted their physical symptoms by stating, "Sometimes when… sometimes 
I become depressed. And the moment I become depressed and start thinking about my 
condition too much, I find that I start experiencing (physical) symptoms". Feeling worry, 
sadness, and fear along with physical symptoms was discussed in interviews.  
 
Shortness of breath, fatigue, dizziness, and chest pain occurring together and leg or 






Participants reported that shortness of breath, fatigue, dizziness, and chest pain 
co-occurred or caused one another. Participants described this by stating, "The shortness 
of breath and fatigue and tiredness, that all happens at once", and "Dizziness comes from 
the shortness of breath". This was especially the case for shortness of breath and fatigue. 
Participants also discussed how leg or ankle swelling happened alone or separate 
from other symptoms. Though a common symptom mentioned in interviews, participants 
rarely associated feeling swelling with other symptoms.  
 
Shortness of breath and chest pain causing fear, worry, and fears of death 
When participants were asked how experiencing their symptoms made them feel, 
they reported feelings of fear, worry, and fear of death when experiencing shortness of 
breath and chest pain. One participant described why these two symptoms make her feel 
this way by stating, "At times with the dizziness, with shortness of breath, fear can kick 
in because you never know when the day is going to be your day. And by that, I mean 
that you say goodbye to this Earth or that you may check in to the hospital."  
 
Feeling like a burden to others  
Women also reported feeling like a burden to others when they were experiencing 
symptoms, such as in the quote, "Sometimes that it also makes... it can make me feel like 
a burden because you're supposed to take care of your children, not your children take 
care of you." Eight participants explicitly discussed feeling like a burden for needing help 






paired with another feeling that others were pitying or judging them when they were 
suffering from symptoms.  
 
Daily life affected by physical functioning 
For symptom evaluation, we identified the theme that daily life was affected by 
activity level and physical functioning. In interviews, all participants discussed their daily 
life being affected by decreased physical functioning. They often discussed difficulty 
leaving the house and completing tasks around the house. One participant stated, "Even 
with my walker, I'm not going to get there. I mean, I can tell myself. And then, to myself, 
I'm saying, I'm going to go. And I wouldn't get to the driveway. So, I've got to go back to 
the house." 
 
Feelings of missing out  
The feelings of missing out, either from not being able to do things with friends or 
family or not being able to eat the types of food they used to enjoy, was a common theme 
in interviews, in which 11 participants discussed these feelings. One participant described 
this as "That I'm not experiencing the world at its fullest, you know? And when I do go 
out, and I get out there, I'm like a kid in a candy store. I want to see everything, but I just 
can't." Some participants also discussed how it was difficult being around others while 
they were eating the food they used to be able to enjoy but no longer can. 
 






The most prominent symptom response was reduction of activity level, which all 
interview participants reported. Participants reported that they would "rest," "lay down," 
or "just relax" if they were experiencing symptoms. Nine participants described how 
overexerting or overworking themselves caused their symptoms to occur or become more 
severe. 
 
Not sharing feelings or downplaying symptoms 
The theme emerged that participants often downplayed their symptoms or did not 
share what they were experiencing with others. Ten interview participants discussed 
hiding or downplaying their symptoms, mostly around their children, extended family, 
friends, and co-workers. One participant stated, "But that can be real frightening, 
especially if it happens and if the children sitting around and they're like, 'What's wrong?' 
And you try to play it off to them like you're okay. But you know you're not, but you still 
got to try to look okay, at least for them, so you're not instilling fear into them." All 
participants reported not hiding their symptoms from nurses or doctors. One participant 
described hiding things from their healthcare team as "self-defeating." 
 
Inability to work or difficulty working due to symptoms 
For the person component, we identified the theme that symptoms made working 
difficult. Most interview participants (11) reported not currently working or having a job. 
Out of those 11, 1 was retired, 4 were stay-at-home moms or homemakers, and 6 reported 
not working because of their heart condition. One participant stated, "And I've worked 






participants with a job reported missing work or not being able to do as much at work due 
to symptoms, and one even mentioned how she had been thinking of quitting her job due 
to her symptoms. 
 
Support 
We also identified the theme of support. Most participants reported having 
support from their significant other, family, or religion. Twelve out of fifteen interview 
participants (80%) were married or living with a partner, with 10 of those participants 
saying they found support in that person. Seven interview participants said their support 
system came from their children or other family members. The two participants who 
discussed not having a support system in family or friends said they leaned on their 
religion or God for support. Some discussed how difficult it is to share how they feel with 
their support person. One participant described this as "Yes. And then I have them, but 
sometimes we build up these walls. So, I would say they can support me for as long as I 
allow them to support me. Because as soon as I quit expressing how I'm feeling, then 
they're under the assumption that I'm okay." 
 
Quantitative Results 
Quantitative survey respondents (N=44) had mean total quality of life score from 
the MLHFQ of 64.1 (9.4), and values ranged from 21 to 95, with 105 being the highest 
possible score, as shown in Table 4. A higher score indicates more of an impact from HF. 
The average total SSQ-HF score was 39.2 (16.0), and scores ranged from 0 to 68. A score 






symptoms. The mean PHQ-8 score was 9.0 (6.2) and ranged from 0 to 24, where 24 is the 
highest possible score indicating more depressive symptoms. Any score greater than 10 is 
considered major depression, and any score greater than 20 is considered severe 
depression. In the sample, 45.5% of participants had a score of 10 or higher, and 2 
participants had a score of 20 or higher. 
The Shapiro-Wilk's test showed scores were normally distributed for MLHFQ and 
PHQ-8 scores (p > .05), but not for SSQ-HF scores (p < .05). Therefore, Spearman 
correlation was used to assess the relationship between symptom scales. A strong positive 
correlation was found between MLHFQ scores and SSQ-HF scores (r=.61, p < .01), and 
moderate positive correlations were found between the PHQ-8 and MLHFQ (r=.48, p < 
.01) and the PHQ-8 and SSQ-HF (r=.42, p < .01), indicating that as scores for one 
questionnaire increase, so do scores for the others.  
Integrated results 
           We integrated qualitative themes with quantitative data to gain additional insights 
on the symptom experience and examine how results converged or diverged. There was 
concordance between quantitative data and the theme of emotional/psychological and 
physical symptoms co-occurring. All survey participants, except one, reported 
experiencing worry and physical symptoms and rated worry as very impactful with an 
average score of 4 and a median score of 5. Moderate to strong correlations were found 
between the three scales, which measured different types of symptoms. Forty-six percent 






           The theme that shortness of breath, fatigue, dizziness, and chest pain co-occurred 
aligned with quantitative symptom data. Thirty-nine out of 44 survey participants 
reported shortness of breath, and 38 of those participants (97%) also reported fatigue. 
Twenty-two out of 44 participants reported chest pain, with 15 of those participants 
(68%) also reporting dizziness. Out of the entire study sample, participants (30%) 
reported experiencing all symptoms of shortness of breath, fatigue, dizziness, and chest 
pain. Leg and ankle swelling was a common symptom reported by 14 out of 15 interview 
participants and 89% of survey participants. Interview participants discussed that 
swelling occurred separately from other symptoms. This phenomenon could not be 
confirmed with quantitative data, as participants were stating whether they experienced a 
symptom in a certain time frame, not which symptoms actually showed up together. 
Participants reported that swelling frequently occurred, with most participants (67%) 
experiencing it 3 times a week or more. However, most participants did not find swelling 
to be severe or more than somewhat distressful. 
           In interviews, shortness of breath and chest pain were described as distressful to 
participants and were often accompanied by fears of death. However, there was 
discordance between these feelings and quantitative scores. Average distress scores from 
chest pain (1.91) were very similar to distress scores from swelling (1.95), where 4 is the 
highest on the scale. Shortness of breath was slightly more distressful, with an average 
score of 2.44. Participants reported in both interviews and surveys that overall, symptoms 
made them feel like a burden to their family and friends. The median score for the 
MLHFQ item of feeling like a burden was 3.5, with 50% of participants rating feeling 






           MLHFQ item scores confirmed the qualitative theme of daily life being affected 
by physical functioning. Every survey participant reported experiencing difficulty 
working around the house or yard, with a mean impact score of 3.2 (1.5). All survey 
participants except one reported experiencing difficulty going places away from home, 
with a mean impact score of 3.25 (1.5). These scores coincide with interview findings, 
where all participants discussed their daily life being affected by them having to keep 
their activity levels low or decreased physical functioning. They often discussed 
hardships related to leaving the house and difficulty completing tasks around the house. 
MLHFQ responses also confirmed the theme of feelings of missing out on doing things 
with friends and family, which all survey participants experienced. 
           The MLHFQ scores for lying down or resting during the day confirmed interview 
findings that rest was the most common response to experiencing symptoms, as every 
interview participant discussed. The MLHFQ item showed how much this impacts 
participants, considering the average score of 3.5 and median score of 4. Survey 
participants indicated that their HF made it difficult to work or earn a living according to 
the MLHFQ item, a prominent interview theme. The majority of survey respondents 
(52%) rated the MLHFQ item of making your working to earn a living difficult as a 5, 
very much, making the median score a 5 and the average a 3.5. These high scores 
coincide with interview findings, as even those who were able to work reported some 
difficulty with their current jobs. 
Discussion 
           Examining symptom data with a convergent mixed methods design allowed us to 






emotional symptoms interact. Symptom clusters, created using symptom scales, show 
when participants are experiencing symptoms together or at the same time. With the 
qualitative interview, we know that some participants believe that their physical 
symptoms actually trigger their emotional symptoms, or vice versa. This concept should 
be explored further in future studies, as this could add valuable information about how 
symptoms cluster. Moderate to strong correlations were found between symptom scale 
total scores, though the sample was small. 
           During interviews, participants seemed to create their own symptom clusters of 
how they believed their symptoms occurred together or interacted. Participants 
commonly associated shortness of breath, fatigue, dizziness, and chest pain together. 
Shortness of breath clustering with fatigue has been shown in other HF symptom cluster 
studies2,21,22, which is consistent with our findings of 97% of participants reporting 
shortness of breath along with fatigue. These were two of the most commonly reported 
symptoms in this study. In the future, the interactions of these symptoms with one 
another should be more robustly explored. 
The participants also noted that leg and ankle swelling often happened alone. This 
was also information that we exclusively gained from interviews, as the quantitative data 
simply showed that 89% of participants experienced leg or ankle swelling along with 
their other reported symptoms. Four other HF symptom cluster studies have found that 
lower extremity edema did not cluster with other symptoms2,22-24. It is possible that 
patients put swelling in its own category as they considered the symptom more 
manageable or less distressful. However, distress scores from ankle and leg swelling were 






participants described these symptoms in interviews, in which fear, worry, and fears of 
death often coincided with feeling shortness of breath or chest pain, but not swelling. One 
participant stated, "The feet swelling isn't going to kill you, but when you can't catch the 
air, that can take you out. And when you get the chest pain, that's stress to your heart. So 
that again can take you out." Therefore, the perceived threat of a symptom may impact 
the feelings of fear or worry for participants, which may explain the divergence in 
results.   
Reduced physical functioning was a common theme throughout interviews, as 
participants stated that low physical functioning impacted their family life, household 
chores, and ability to work. These interview findings were supported by high MLHFQ 
scores, especially for making an earning difficult, in which the majority (53%) of 
participants rated this item as a 5. Most participants discussed not being able to work due 
to their symptoms or condition, and the four participants who did have jobs discussed the 
challenge of managing their symptoms while working. Working to provide financial 
income and a sense of accomplishment in a career both hold meaning, and the impact of 
not having those should be explored in future interviews. 
Participants also reported that experiencing HF symptoms made them feel like a 
burden to others or that others would judge or pity them if they knew what they were 
experiencing. These feelings tie into the symptom response of participants hiding or 
downplaying their symptoms from others. Mothers especially downplayed their 
symptoms while around their children and working women around their co-workers. 
Women reported finding support mostly with their significant other or family members, 






 Our study had several limitations. Firstly, participants self-reported their 
diagnosis of HFpEF based on their ejection fraction being greater than or equal to 50% or 
the participant reporting their doctor diagnosed them with HFpEF or diastolic heart 
failure. HFpEF is a complex disease process and asking participants to self-report their 
diagnosis is inferior to a confirmed diagnosis from a medical chart. Also, data from 
qualitative interviews of 15 individuals were integrated with quantitative data of 44 
individuals as a whole rather than examining quantitative data specific to each 
interviewed participant. Future studies should aim to link these types of data for further 
exploration of convergence, divergence, and expansion.  
 
Conclusion 
With a mixed-methods design, we were able to examine the symptom experience 
of Black females with HFpEF. The majority of interview participants discussed that their 
physical and emotional symptoms interacted with one another beyond simply co-
occurrence, and positive correlations between symptom scales supported this theme. 
Clinicians should include emotional/psychological symptoms and how they interact with 
physical symptoms in their assessment. Women experienced shortness of breath with 
fatigue, chest pain, and dizziness, while ankle and leg swelling often occurred alone. 
Participants may place swelling in its own category as a common symptom that is 
frequently present but not very distressful, as shown in survey data. Women reported that 
shortness of breath and chest pain often caused them fear, worry, and fear of death. 
Though symptom distress scores were not as high as expected for these symptoms, it may 






close attention to how shortness of breath and chest pain impact their patients. The 
participants reported their symptoms made them feel like a burden to others, or that 
others judged or pitied them and often hid or downplayed their symptoms. The prominent 
qualitative theme confirmed by quantitative data was that reduced physical functioning 
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What’s New and Important?  
• Considering the increased burden of HF symptoms, greater risk, and worse 
outcomes in females, Black Americans, and patients with HFpEF1,6-8, this study 
seeks to illuminate the experiences of those who are underdiagnosed, undertreated 
and have a greater symptom burden3,4. 
• Black women with HFpEF discussed interactions of physical and emotional 
symptoms and positive correlations between symptom scales supported this 
theme.  
• Participants reported feeling like a burden to others and hid or downplayed their 
symptoms and reduced physical functioning impacted family life, household 



















Table 1: Merging of SMM components with QUAL and QUANT data collection 
instruments 
 




Perception   
 
Physical symptoms 
What physical / emotional 
symptoms did you 




Emotional symptoms What physical / emotional 
symptoms did you 




How your symptoms make you 
feel 
How did experiencing those 
symptoms make you feel? 
 
Significance- what feeling 
symptoms means to you 
When you experience those 
symptoms, what does that 
mean to you? 
 
Evaluation   
Distress  SSQ-HF 







Severity How severe? SSQ-HF 
Impact on daily life How much do they impact 
your daily life? 
MLHFQ 
Symptom causes What do you think causes 
your symptoms? 
 
Response   
Management and treatment  
 
How do you think your 
symptoms can be managed 
or treated? 
 
How you respond to 
experiencing symptoms, or what 
you do when they become more 
frequent, severe, impact your life 
more? 
What do you usually do 
when you are experiencing 
symptoms?  
Have you ever 
hid/downplayed? 
 
Person   

















Sociologic  Do you have a support 
system to help? 
 
 
Table 2: Study Sample Demographics 
Frequency (Valid %) OR Mean (SD) 








Black  44 (100%) 15 (100%) 
Education   
No High School Diploma 8 (18.2%) 5 (33.3%) 
Diploma or GED 17 (38.6%) 5 (33.3%) 
Associate degree 3 (6.8%) 1 (6.7%) 
Bachelor’s Degree 7 (15.9) 4 (26.7%) 
Master’s Degree 7 (15.9%) 0 
Doctoral Degree 2 (4.5%) 0 
Current marital status    
Single 12 (27.3%) 3 (20%) 
Married/ living with partner 20 (45.5%) 12 (80%) 
Separated 3 (6.8%) 0 






Widowed 5 (11.4%) 0 
Age (years) 51.75 (11.1) 46.9 
# of children  2  3 
# people in household 3 4 
Length of HF Diagnosis   
0 – 12 months 11 (25%)  
>1 year – 2 years 15 (34.1%)  
3 years – 4 years 13 (29.5%)  
5 years – 8 years 5 (11.4%)  
Primary Insurance Status   
None 0 (0%)  
Medicare / Medicaid 24 (54.6%)  
Public (marketplace) 7 (15.9%)  
Private (employer) 10 (22.7%)  
Other 3 (6.8%)  
BMI Categories   
Underweight (< 18.5) 2 (4.5%)  
Healthy (18.5 – 24.9) 25 (56.8%)  
Overweight (25 – 29.9) 6 (13.6%)  
Obese (> 30) 11 (25%)  
Single item literacy screener   
Never 26 (59.1%)  






Sometimes 5 (11.4%)  
Often 5 (11.4%)  
Always 0 (0%)  
 
Table 3: Integration of QUAL and QUANT data organized within the SMM 
framework 
Themes QUAL - Participant contextualization QUANT Variables 









 “Um, I would say the worst my symptoms are, 
the more, the more that I worry.” 
 
“If I’m in a lot of pain a lot of times or I have 
shortness of breath and then it can cause 
anxiety and worry, you know, it all kind of 
goes together.” 
 
“And the moment I become depressed and start 
thinking about my condition too much, I find 
that I start experiencing (physical) symptoms.”  
MLHFQ - making 
you worry? (N=43) 
4.07 (1.3) | 5 
 
MLHFQ by- making 
you feel depressed? 
(N=32) 
2.34 (2.1) | 1 
 
PHQ-8 - down, 
depressed, or 
hopeless? (N=27) 

















“The shortness of breath and fatigue and 
tiredness, that all happens at once.”  
 
“I would definitely say the fatigue and 
shortness of breath. I would say they happen 
together.”  
 
“The breathing and the (chest) pain will 
happen together.”  
 
“Pain in the chest may come with fatigue and 
also loss of appetite, but the swollen legs 
maybe comes alone”  
 
“I can also have swollen feet by itself, because 
swollen feet, I would definitely say, that that’s 
around 24/7.”  
Shortness of breath 
AND fatigue- 97% 
(38/39) 
 




Shortness of breath, 
fatigue, dizziness, 
AND chest pain - 
30% (13/44) 
 
SSQ-HF Leg or ankle 
swelling (N=39) 
-How often? 
2.69 (.61) | 3 
-How severe? 
2.03 (.87) | 2 
-How distressful? 
1.95 (1.3) | 1 
Shortness of 
breath and chest 
“At times with the dizziness, with shortness of 
breath, fear can kick in because you never 








fear, worry, and 
fears of death 
 
know when the day is going to be your day. 
And by that, I mean, that you say goodbye to 
this Earth or that you may check in to the 
hospital.” 
 
“Well, when my heart hurts it’s that (that 
scares me). People get scared of dying when 
that happens. Or you can’t breathe good, you 
get scared of stuff like that. I mean, I want to 
live to see my grandkids, you know what I’m 
saying?”  
 
“You get a little scared when you can’t catch a 
breath or when you do get the chest pain, it 
puts little scares in you.” 
-How often? 
2.50 (.67) | 2.5 
-How severe? 
1.95 (.49) | 2 
How distressful? 
1.91 (1.1) | 1.5 
 
SSQ-HF Shortness of 
breath (N=39) 
-How often? 
2.87 (.89) | 3 
-How severe? 
2.36 (.81) | 2 
How distressful?  
2.44 (1.2) | 3 
Feeling like a 
burden to others  
 
“I would definitely say that that feels scary to 
have to lean on somebody. I would also say if I 
don't, I don't, I don't want to be a burden on 
anybody.”   
 
“Sometimes that it also makes... it can make 
me feel like a burden because you're supposed 
MLHFQ by- making 
you feel you are a 
burden to your family 
or friends? (N=37) 






to take care of your children not your children 
take care of you.”  





“Even with my walker, I'm not going to get 
there. I mean, I can tell myself. And then, to 
myself, I'm saying, I'm going to go. And I 
wouldn't get to the driveway. So, I've got to go 
back to the house.” 
 
“What normally would take me an hour to 
clean, takes me well into four or five hours 
because I had to stop because I just get so out 
of breath.” 
 
“It makes me feel uncapable of doing just 
regular, normal things.” 
MLHFQ by- making 
your working around 
the house or yard 
difficult? (N=44)  
3.20 (1.5) | 3.5 
 
MLHFQ by- making 
your going places 
away from home 
difficult? (N=43) 
3.25 (1.5) | 3.5 
Feelings of 
missing out  
 
“That I'm not experiencing the world at its 
fullest, you know? And when I do go out and I 
get out there, I'm like a kid in a candy store. I 
want to see everything, but I just can't.”   
 
“Um, I feel left out because everybody else, 
you know, I can't expect them to stop their 
MLHFQ by- making 
you eat less of the 
foods you like? 
(N=38) 







lives and not go just because I can't, I feel left 
out, but at the same time we do watch movies 
here at the house.”  
 
“I guess you can also say sometimes I feel 
deprived as well, deprived in the sense that I 
can't have all those seasonings and butters 
anymore. So, I feel really deprived about that.” 
MLHFQ by- making 
your relating to or 
doing things with 
your friends or family 
difficult? (N=44)  
3.18 (1.4) | 3 
 
 
Response   
Reducing 
activity level as 
a response to 
symptoms  
 
“If, if your, if your body's not feeling right, 
you know, or you're overexerting yourself, 
check in, and say hey, you got to slow down.” 
 
“So, first you rest and see if it will go away on 
its own, and then you decide what to do.” 
 
“I personally try to keep my activities low.” 
MLHFQ by- making 
you sit or lie down to 
rest during the day? 
(N=43) 








“Yeah, when I sit down, and my chest is 
hurting. I sit down, and that's when I'm 
masking it. They say, well, ‘Mom, why are 








“You have to act normal. So, you have to 
pretend that you're okay. I think it's really 
tiring, really exhausting.” 




working due to 
symptoms  
“Yeah, it does affect me because I'm a 
hairdresser. My work includes a lot of moving, 
standing. So, when I have swollen feet I cannot 
go to work.”  
 
“And I've worked most of my life, but I haven't 
worked in the last three years because of my 
heart.” 
MLHFQ by- making 
your working to earn 
a living difficult? 
(N=37) 
3.48 (2.0) | 5 
 
Support “I feel at ease talking about what I feel with 
my husband and pastor, I really do. […] There 
ain't nothing I can't go to my husband and talk 
about.” 
 
“But I pray. I'm religious. I pray to God. I 
know He is going to get me through anything. 
Any trial I go through, I believe He will help 
me. Even though I'm scared, God don't want 








*N=any score other than 0, MLHFQ Did your HF prevent you from living as you wanted 
during the past month (4 weeks) by (0-5) PHQ-8 Over the last 2 weeks, how often have 
you been bothered by any of the following problems (0-3),  
 
Table 4: Questionnaire Total Scores 
Questionnaire Mean (SD) Median (Minimum-Maximum) 
MLHFQ 64.14 (9.42) 63.0 (21 to 95) 
SSQ-HF 39.20 (16.03) 41.5 (0 to 68) 
PHQ-8 8.98 (6.24) 7.5 (0 to 24) 
 
*MLHFQ=Minnesota Living with Heart Failure Questionnaire, SSQ-HF=Symptom 


















Overview of Manuscripts' Contributions 
        The dissertation compendium consists of 3 manuscripts: (1) an integrative review of 
heart failure (HF) symptom cluster literature to identify themes within the Symptom 
Management Model (SMM) and highlight gaps that researchers should pursue in the 
future; (2) a feasibility study of a convergent mixed methods parallel study protocol for 
studying the HF symptom experience and how symptoms cluster in Black women with 
Heart Failure preserved Ejection Fraction (HFpEF); and (3) a qualitative descriptive 
analysis of individual interviews with Black women with HFpEF about their background 
and symptom experience, and integration of qualitative themes with quantitative 
symptom data (1). Together, these manuscripts illuminate the symptom experience of 
Black women with HFpEF, a population that has been understudied in current HF 
symptom cluster research (2-19). These manuscripts serve as the first step to inform the 
design and future implementation of a large-scale mixed methods HF symptom cluster 
study to form statistically meaningful symptom clusters and integrate qualitative findings 
to gain new perspectives on this population's symptom experience. 
           The comprehensive integrative review of HF symptom cluster literature 
synthesized themes from 18 manuscripts that were eligible for analysis (19). Themes 
were organized within the SMM (1). The integrative review showed that HF symptom 
clusters exist and can be used in clinical practice for symptom monitoring and risk 
assessment. However, current literature minimally examined sex differences in HF 






studies were White (2-19). Additionally, none of the included manuscripts utilized 
qualitative methods to allow participants to describe their symptom experiences. 
           The second manuscript reported the results of the feasibility study and preliminary 
symptom cluster analysis. This study was conducted to determine an innovative symptom 
cluster study design's feasibility and acceptability in an underrepresented population. This 
study's results support the study protocol's feasibility and acceptability, as all benchmarks 
were met. We conducted a hierarchical cluster analysis with the feasibility study sample 
(N=44) to test processes and form preliminary clusters. Three clusters of individuals were 
identified, consisting of a highly symptomatic cluster, mildly symptomatic cluster, and a 
psychologically symptomatic cluster. We compared the preliminary clusters on 
demographics and questionnaire responses. However, hypothesis testing was not the 
focus of this study due to the feasibility design and small sample. Further exploration 
should be conducted in the future with a large sample of participants. 
           The final manuscript consisted of qualitative and mixed methods integration 
results. Qualitative themes about the symptom experience of Black women with HFpEF 
emerged about physical and emotional symptoms co-occurring and interacting, chest pain 
and shortness of breath causing fear and anxiety, women feeling like a burden to their 
families, and physical limitations impacting daily life, activities with friends and family, 
and the ability to work. Quantitative symptom data were integrated with these themes to 
show how results converged or diverged. Symptom scale results coincided with interview 
findings. For instance, participants reported high impact scores for feeling like a burden 
to others, an inability to work, and missing out on activities with friends and families due 






For instance, interview participants said shortness of breath and chest pain made them 
feel fear, anxiety, and fear of death, yet survey respondents rated shortness of breath and 
chest pain symptom distress similar to that of ankle and leg swelling. Ankle and leg 
swelling often occurred alone and was not noted to be particularly distressful in 
interviews and was never tied to fears of death. This discordance in results may be due to 
what the symptom represents. Some participants described their breathing and chest pain 
as things that could "take you out" or thought of them as dealing directly with the heart. 
In comparison, they felt the swelling often occurred, and even though it may be 
bothersome and distressful, they did not feel they would die from it. 
 
Limitations 
        There were several notable limitations of this dissertation study. First, the integrative 
review only searched three databases, and all manuscripts that underwent full-text review 
were from one database. Utilizing more databases and alternative search terms could 
result in a larger sample of manuscripts. Second, study participants self-reported a 
diagnosis of HFpEF. We asked participants if their doctor had given them a diagnosis of 
HFpEF or diastolic HF (with an ejection fraction greater than or equal to 50%). They 
either responded yes, no or unsure. If participants were unsure, they were encouraged to 
call the PI to discuss their diagnosis. One participant did call to discuss her eligibility and 
was deemed eligible for the study. This option was helpful for those who were unsure, 
but a confirmed diagnosis from a medical chart would be preferable. Third, we did not 
know which quantitative data belonged to each interview participant due to an attempt to 






mixed methods integration occurred with quantitative data as a whole rather than 
individual responses. Connecting individual symptom scores to qualitative interview data 
could have provided us with additional insights.  
 
Importance of Theory, Model, or Framework  
The SMM was central to this dissertation. The SMM was used as a framework for 
an integrative review of HF symptom cluster literature due to its multifaceted nature that 
encompasses various components that influence the symptom experience as a whole (1). 
The model was then used to design and plan multiple aspects of the dissertation study, 
including guiding the research question, informing proposal development, and 
influencing symptom questionnaire selection. The SMM was also used as a framework 
for the semi-structured interview guide, qualitative content analysis, triangulation, and 
merging of qualitative and quantitative results. Utilizing the SMM as a framework from 
start to finish allowed for the cohesion of findings and concepts across all dissertation 
studies, ultimately adding strength and rigor to findings. 
The dissertation study also further describes how aspects of person and symptom 
experience, which are components of the SMM, interact to illuminate the symptom 
experience as a whole. Future research could incorporate more components of the model 
to further explore interactions. The SMM combined with domains of the MLHFQ 
provided added information on physical symptoms and emotional symptoms, a 








           This dissertation's results support the feasibility and acceptability of a mixed 
methods study protocol for studying symptom clusters in Black women with HFpEF. 
Recruiting a larger sample to form meaningful clusters should be pursued in future 
research to describe this population's symptom experience further. The studies also 
highlight the importance of emotional/psychological symptoms in HF. Current HF 
treatment guidelines acknowledge emotional/psychological symptoms in HF, but 
guidelines do not exist to treat or manage these symptoms (20). Other HF symptom 
cluster studies have shown that emotional and psychological symptoms happen together 
when they cluster together or happen simultaneously (2-19). However, without the 
qualitative interviews, we could not explain how these symptoms interact with one 
another. Many interview participants discussed how they believed their physical 
symptoms caused their emotional symptoms or vice versa. This finding highlights the 
value of qualitative methods in symptom cluster research. 
           Interviews also showed how a woman's background or lifestyle impacts their 
symptom experience. Minnesota Living with Heart Failure Questionnaire (MLHFQ) 
scores were high for feeling like a burden to others, and these results were confirmed in 
qualitative interviews where almost all participants discussed feeling like a burden when 
they were unable to carry out their normal tasks or needed assistance at work or home 
(21). The distress women felt when not being able to care for their children, partner, or 
family members or work, like they used to before diagnosis, was evident and may explain 
why women have higher rates of depression (23, 24). Exploring whether men also feel 










This dissertation provides the background knowledge and proof of concept data 
necessary for conducting a large-scale mixed methods HF symptom cluster study with a 
population of Black women with HFpEF. Study materials have been developed and 
tested. Feasibility benchmarks were all met, and participants gave the study high ratings 
for acceptability. Facebook ad campaigns have also been developed and could be reused 
for a larger study. To recruit a large enough sample to form statistically significant 
symptom clusters, additional funding is needed to compensate study participants, run 
Facebook ad campaigns, and support study staff.  
When conducting a larger scale study, it would be ideal to pair quantitative and 
qualitative data together for each participant rather than only merging quantitative data as 
a whole with qualitative data. This dissertation aimed to answer the research question of 
what is the symptom experience and how do symptoms clusters for Black women with 
HFpEF? Future research could also compare the symptom experience and symptom 
clusters of Black females with HFpEF to persons of different race/ethnicities, males, and 
to patients with another type of HF with a reduced ejection fraction. We could also 
explore how age affects symptom perception and clustering, since younger age has been 
noted to correspond with more symptom distress and the most symptomatic cluster also 







Contribution to Health, Nursing and Clinical Care 
  This dissertation study provides key insights into nursing, research, and clinical 
care. First, this dissertation illuminates the symptom experience of Black women with 
HFpEF. While conducting qualitative interviews, many participants discussed their 
enthusiasm for being included in the research study, helping others by sharing their 
stories, and wanting their voices to be heard. This enthusiasm for participation shows that 
underrepresented populations in research may not actually be hard to reach or unwilling 
to participate, but that recruitment tactics have to be more targeted to achieve diversity 
and inclusion. When first using Facebook for recruitment, almost all screening 
questionnaires were completed by White respondents. It took targeted efforts to reach our 
population of interest, in which we developed Facebook ads geared specifically to our 
population of interest. When we were only using post within Facebook groups, almost all 
respondents were White. This feasibility study serves as a steppingstone to recruiting a 
large population for a full-scale study and provides key information for recruiting Black 
women in future HF studies.  
This dissertation study also highlights the clinical implications of 
emotional/psychological symptoms. This was a theme in the integrative review, as HF 
symptom cluster studies found emotional/psychological symptoms tied to worse 
outcomes and increased cardiac risks. This theme continued in the mixed methods study, 
as participants discussed interactions between their physical and psychological 
symptoms, and symptom scales had moderately to strongly correlated. It is imperative 
that emotional/psychological are recognized, treated, and included in HF treatment 
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Appendix B: Recruitment Materials 
Facebook ad / posts with possible images / text combos 
Are you a Black woman with heart failure? Are you 35-74 years old? We want to hear 
about your experience with symptoms.  
 
Answer questionnaires about your symptoms and how heart failure symptoms affect your 
life in 20-30 minutes. Additionally, you may participate in an optional interview about 
your health and symptoms if you are interested.  
 
Receive a $25 Amazon eGift Card as a thank you for your participation.  
 
We need to hear your voice and experiences to help drive heart failure research within the 
Black female community.  
 
Participants will receive an Amazon eGift Card ($25) by email or text after completing 
questionnaire and another Amazon eGift Card ($25) if they complete an interview. 
 
Click here to answer screening questions and see if you qualify for the study.  
 
 
IRB Number: « PRO00101261» 
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Appendix C: Permissions 
 
Permission for Minnesota Living with Heart Failure Questionnaire 
 
MLHFQ - Instructional or Student Use License 
 
 
The Minnesota Living With Heart Failure® Questionnaire - Educational Use License is the correct 
license type to choose when the LICENSEE is a student or teacher at an academic institution 
and will use the Questionnaire exclusively for student project(s) or teaching purposes. 
 
Please read the terms and conditions of this license agreement ("Agreement") 
carefully. 
By clicking "SUBMIT" on the "Accept/acknowledge terms" page during the 
Checkout process, 
you are agreeing to the following terms and conditions on behalf of the Licensee 
identified below, and you represent and warrant that you are authorized to do so. 
 





License Fee is $0 USD, payable upon checkout. 
 
 
Licensee: Alexandra Ruppe 
Company - Medical University of South Carolina 
Contact Email - moseleal@musc.edu 
Contact Phone - 8034176635 
 
 
TERMS AND CONDITIONS - The following terms and conditions govern this 
Agreement by and between the Regents of the University of Minnesota, a 
constitutional corporation under the laws of the State of Minnesota, ("University") and 
the Licensee. 
 
Definitions - For purposes of this agreement, the following terms have the following 
meanings. 
 
"Accompanying Documentation" means the following: 
 
MLHFQ FDA MDDT Qualification Package (288 KB PDF) 
 
"Approved Copies" means duplicates of the Work that shall include the statement 
below: 
 
©1986 Regents of the University of Minnesota, All rights reserved. Do not copy or 
reproduce without permission. LIVING WITH HEART FAILURE® is a registered 
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trademark of the Regents of the University of Minnesota. 
 
"Effective Date" means the date when the Licensee clicks the button indicating 
agreement with all the terms and conditions of the license and has successfully 
completed payment in the checkout process. The Effective Date is Mar 26, 2020. 
 
"Licensed Mark" means US Trademark Registration No. 2,378,845 for the mark 
"LIVING WITH HEART FAILURE", registered to the Regents of the University of 
Minnesota. 
 
"Purpose" Means the use of the Licensed Technology pursuant to the Terms & 
Conditions of this Agreement, for use by the Licensee, who must be a student or 
teacher at an academic institution, exclusively for student project(s) or didactic 
purposes and for no other purpose. 
 
"Licensed Technology" means collectively the Work, the Licensed Mark, 
Approved Copies and the Accompanying Documentation. 
 
"Term" The Term of this Agreement shall commence on the Effective Date and 
shall expire, without any further action by the University, on the tenth (10th) 
anniversary of the Effective Date. 
 
"Work" means the Living with Heart Failure ® Questionnaire and the Instructions 
for Data Collection and Scoring. This Work is in the English language; and is 
identified as University Case #: 94019. 
 
Grant of License - Subject to the terms and conditions of the Agreement, 
University hereby grants to Licensee and Licensee accepts a limited, non-exclusive, 
non-transferrable, non-sub-licensable, revocable, world-wide license to reproduce 
the Work and use Approved Copies for the Purpose set forth in this Agreement. 
 
 
Rights of the U.S. Government and Third Parties - No provision of this Agreement 
limits, conditions or otherwise affects the United States of America's or any other third 
party's rights and interests in the Licensed Technology. 
 
University Intellectual Property Rights -Title to and ownership of the Licensed 
Technology shall at all times remain with the University and Licensee shall not 
have any title or ownership interest therein. All rights not expressly granted to 
Licensee under the Agreement are reserved by University. 
 
 
Use of the University's Names and Trademarks - No provision of the Agreement 
grants the Licensee any right or license to use the name, logo, or any marks owned by 
or associated with the University or the names, or identities of any member of the 
faculty, staff, or student body of the University except as may be otherwise provided 
in this Agreement and Licensee shall not use such names or marks without the prior 
  
 149 
written approval of the University's Office of University Relations. 
 
Payment Terms - Licensee shall pay, upon checkout, the License Fee and any 
applicable taxes, duties, fees, excises or other charges. All amounts payable hereunder 
by Licensee are non-refundable and non-creditable. All amounts payable hereunder by 
Licensee shall be payable in United States funds. 
 
Protection of Proprietary Rights - Licensee shall take all steps reasonable to 
protect UNIVERSITY's ownership rights in the Licensed Technology. 
LICENSEE shall not: 
• make copies of the Licensed Technology except as may be allowed for the 
Purpose of the Agreement; remove the UNIVERSITY copyright notice and/or 
other proprietary notices; 
• alter or otherwise modify the Licensed Technology; 
• create derivative works based in whole or in part on the Licensed Technology; 
• reproduce, resell or otherwise distribute Licensed Technology. 
 
Audit - Licensor may audit Licensee's usage and records directly relating to the 
Licensed Technology to ensure that Licensee is using the Licensed Technology in 
compliance with the Agreement. Such audit shall be upon fifteen (15) working days 
advance written notice of such audit, which shall be conducted during normal 
business hours. 
Termination - If the Licensee breaches or fails to perform one or more of its 
obligations under the Agreement, the University may deliver a written notice of default 
to the Licensee. Without further action by a party, the Agreement shall terminate if the 
default has not been cured in full within thirty (30) days. The University may terminate 
the Agreement immediately by delivering to the Licensee a written notice of 
termination if the Licensee or its agents or representatives commences or maintains an 
action in any court of competent jurisdiction or a proceeding before any governmental 
agency asserting or alleging, in any respect, the validity or enforceability of any of the 
Licensed Technology. 
 
The Licensee shall notify the University, in writing, at least thirty (30) days prior to the 
commencement of any such action or the instigation of any such proceeding. Upon 
termination or expiration, all rights granted to Licensee under this Agreement, with 
respect to the Licensed Technology, terminate; and upon request Licensee shall return 
(or destroy and certify destruction) of any copies of the Licensed Technology, however 
Licensee shall be permitted to keep copies of the Licensed Technology to ensure 
compliance with this Agreement and for its own internal data management purposes. 
 
 
Indemnification - The Licensee shall release, defend (upon the request of the 
University), indemnify, and hold harmless the University and its regents, employees, 
agents and representatives from any loss, claim, damage, or liability, of whatever 
kind or nature (including, but not limited to, reasonable attorneys’ and investigative 
expenses), that arises from or in any way relates to (i) the use of the Licensed 
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Technology (including but not limited to any product that contains or is 
manufactured with the use of the Licensed Technology) or (ii) Licensee’s breach of 
any obligation or representation under the Agreement. 
 
 
Permitted Trademark Usage - Licensee's use of a Licensed Mark in any manner 
shall inure to the benefit of the University. The Licensee agrees that it will not: (i) 
challenge, cause, or assist any other person to contest the validity of a Licensed Mark 
or the University's sole and exclusive rights in each Licensed Mark; 
(ii) use a Licensed Mark or any components thereof, or any words or designs 
confusingly similar thereto, in any way other than in connection with the Licensed 
Technology; (iii) attempt to register or register, assist in registering, or cause to be 
registered a Licensed Mark or any components thereof or any words or designs 
confusingly similar thereto, as or within any trademark, corporate name, trade name, or 
domain name; or (iv) commit any act that might prejudice or adversely affect the 
validity of a Licensed Mark or the University's rights in each Licensed Mark. The 
Licensee shall use the Licensed Marks in full compliance with all applicable federal, 
state, territorial, and provincial laws, including all applicable federal export laws and 
regulations. 
 
Trademark Standards - Licensee recognizes the importance to the University of 
maintaining high, uniformly applied standards of quality in the Licensed Technology 
identified by a Licensed Mark, and covenants that Licensed Technology covered by 
this Agreement shall be of high standard and quality. The Licensee agrees to follow 
any and all written specifications of the University relating to the nature and quality of 
Licensed Technology and the use of the Licensed Marks. From time to time during the 
term of the Agreement, as requested by the University in writing, the Licensee shall 
submit sample(s) of requested 
 
Licensed Technology to the University for its inspection and approval. Such 
specimen(s) or sample(s) may be used by University in the filing, prosecution or 
maintenance of a Licensed Mark. Licensee further agrees to cooperate, from time to 
time as necessary, with the University in the filing, prosecution and maintenance of 
the Licensed Marks. 
 
Translations - Licensee may translate the questionnaire solely for its own internal, 
non-commercial use. University is not responsible for and assumes no liability for 
the accuracy of the translation. 
 
Disclaimer - THE LICENSED TECHNOLOGY IS PROVIDED "AS IS." 
UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS 
RELATING TO THE LICENSED TECHNOLOGY, EXPRESS OR IMPLIED, 
STATUTORY OR OTHERWISE, AND EXPRESSLY EXCLUDES THE 
WARRANTY OF NON-INFRINGEMENT OF THIRD-PARTY RIGHTS, 
FITNESS FOR A PARTICULAR PURPOSE OR MERCHANTABILITY. 
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UNIVERSITY DOES NOT WARRANT THAT THE LICENSED TECHNOLOGY 
WILL SATISFY LICENSEE'S REQUIREMENTS. 
 
LIMITATION OF LIABILITY - UNIVERSITY IS NOT LIABLE FOR ANY 
INDIRECT, INCIDENTAL, SPECIAL, OR CONSEQUENTIAL DAMAGES, OR 
DAMAGES FOR LOSS OF PROFITS INCURRED BY THE LICENSEE OR ANY 
THIRD PARTY, WHETHER IN AN ACTION IN CONTRACT OR TORT 
(INCLUDING NEGLIGENCE), OR ANY OTHER LEGAL THEORY, EVEN IF THE 
UNIVERSITY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH 
DAMAGES. IN NO EVENT WILL THE UNIVERSITY'S AGGREGATE 
LIABILITY UNDER THIS AGREEMENT EXCEED THE LICENSE FEE PAID TO 
THE UNIVERSITY UNDER THE AGREEMENT. THIS LIMITATION APPLIES 
REGARDLESS OF WHETHER OTHER PROVISIONS OF THIS LICENSE HAVE 
BEEN BREACHED OR HAVE PROVEN INEFFECTIVE. THE EXISTENCE OF 
MORE THAN ONE CLAIM WILL NOT ENLARGE OR EXTEND THESE LIMITS. 
LICENSEE ACKNOWLEDGES AND AGREES THAT THE FOREGOING 
LIABILITY LIMITATIONS ARE ESSENTIAL ELEMENTS OF THIS LICENSE 
AND THAT IN THE ABSENCE OF SUCH LIMITATIONS, THE MATERIAL AND 
ECONOMIC TERMS OF THIS LICENSE WOULD BE SUBSTANTIALLY 
DIFFERENT. 
 
Export and Regulatory Restrictions - Copyright - The Licensee shall comply with 
all then-current applicable export laws and any regulations (e.g. federal, state, local, 
or provincial) regarding the use of the Licensed Technology in the relevant territory. 
 
Right to Injunctive Relief - Licensee acknowledges and agrees that monetary 
damages are not sufficient to compensate University in the event of Licensee's material 
breach or violation of this Agreement, and that University may be irreparably harmed 
by such breach or violation, and that University will have the right to seek other 
remedies available to it in law and equity to remedy such breach or violation, including 
injunctive and equitable relief. If Licensee fails to perform an obligation or otherwise 
breaches one or more of the terms of this Agreement, Licensee shall pay the 
University's costs and expenses (including actual attorneys' and investigative fees) to 
enforce the terms of this Agreement. 
 
 
Governing Law and Forum - The internal laws of the state of Minnesota shall 
govern the validity, construction and enforceability of this Agreement, without 
giving effect to the conflict of laws principles thereof. Any suit, claim, or other 
action to enforce the terms of this agreement, or any suit, claim or action arising out 
of or related to this agreement, may be brought only in the state courts of Hennepin 
County, Minnesota. The Licensee hereby submits to the jurisdiction of that court 
and waives any objections it may 
have to that court asserting jurisdiction over the Licensee or its assets and property. 
This Agreement is not to be governed by the United Nations Convention on Contracts 
for the International Sale of Goods, or by the Uniform Computer Information 
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Transactions Act (UCITA) as may be enacted by the State of Minnesota. 
 
 
Entire Agreement - This Agreement constitutes the entire understanding of the 
parties with respect to the subject matter hereof, and supersedes all prior agreements 
and understandings of the parties on such subject matter. This Agreement may be 
amended, only in writing, and duly executed by all the parties. 
 
 
Assignments - The Licensee may not assign or delegate any right or duty under this 
Agreement, unless the University has consented, in writing, to such assignment or 
delegation. An assignment or delegation made in violation of this section shall be void 
and shall not bind the other party. 
 
 
Compliance With Laws - Licensee represents and warrants that its use of the 
Licensed Technology will comply with all applicable laws and regulations. 
 
Survival - The following provisions (to the extent they appear in this Agreement) 
survive termination of the Agreement: "Definitions, University Intellectual Property 
Rights, Protection of Proprietary Rights, Payment Terms, Termination, Disclaimer, 
Limitation of Liability, Indemnification, Export Control, Right to Injunctive Relief and 
Attorney's Fees, Governing Law, and any other provision, which by its nature is 
intended to survive. 
 
 
Relationship of the Parties - In entering into, and performing their duties under the 
Agreement, the parties are acting as independent contractors and independent 
employers. No provision of the Agreement creates or is to be construed as creating a 
partnership, joint venture, or agency relationship between the parties. No party has the 
authority to act for or bind the other party in any respect. 
 
Severability - If a court of competent jurisdiction adjudges a provision of the 
Agreement to be unenforceable, invalid, or void, such determination is not to be 
construed as impairing the enforceability of any of the remaining provisions hereof 
and such provisions will remain in full force and effect. 
 
Notice - In order to be effective, all notices, requests, and other communications that a 
party is required or elects to deliver must be in writing and must be delivered 
personally, or by facsimile or electronic mail (provided such delivery is confirmed), or 
by a recognized overnight courier service or by United States mail, first-class, certified 
or registered, postage prepaid, return receipt requested, to the other party at its address 
set forth below or to such other address as such party may designate by notice given 
under this section: 
 




Office for Technology Commercialization, 









Minneapolis, MN  55455 
OTCAgree@umn.edu 
 
If notice alleges breach of the Agreement, a copy must be sent to: 
 
Office of the General Counsel, 
University of Minnesota Attention: 
Director of Transactional Law 
Services. 




If to Licensee: As set forth above in the "Licensee" section. 
 
Accept Terms - Clicking "SUBMIT" on the "Accept/acknowledge terms" page during 
the Checkout process indicates that you agree with the terms and conditions of this 




Permission for Symptom Status Questionnaire - Heart Failure  
 
From: Seongkum Heo  
Sent: Friday, June 19, 2020 3:35 PM 
To: Ruppe, Alexandra [moseleal@musc.edu] 
Subject: Re: SSQ-HF use for dissertation 
 
Hi Alexandra,  
Ok. Great.  I attached the instrument.  
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I hope that everything goes very well for you and your project.  
Seongkum Heo, PhD, RN, AHAF, FHFSA 
From: Ruppe, Alexandra [moseleal@musc.edu] 
Sent: Friday, June 19, 2020 2:07 PM 
To: Seongkum Heo [heo_s@mercer.edu] 
Subject: Re: SSQ-HF use for dissertation 
  
Exactly! That would be great, Dr. Heo. Thanks so much. I will keep you posted on 
progress and I can send you manuscripts for approval before submitting any for 
publication.  
  
From: Seongkum Heo [heo_s@mercer.edu] 
Sent: Friday, June 19, 2020 1:32:05 PM 
To: Ruppe, Alexandra [moseleal@musc.edu] 
Subject: Re: SSQ-HF use for dissertation 
Hi Alexandra,  
Thank you for your interest.  
Yes, I think that it will be good to test in African Americans.  
In addition, the items in the MLHFQ does not assess symptoms, but the limitations (or 
effects) on daily activities, which are different from symptom themselves.  
If you want to use SSQ-HF, I will send you the instrument.  
  Best wishes, Seongkum Heo, PhD, RN, AHAF, FHFSA 
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Appendix D: Instruments Utilized in Dissertation Study  
 
Section 1: REDCap Survey – Instructions and Screening Questionnaire 
 
Welcome and Instructions: 
Thank you for your interest in our study. We are excited to have you! 
The purpose of this study is to explore symptoms for Black women with heart 
failure. Black women have not been included in the majority of heart failure research. It 
is important that Black women have a voice and the ability to share their symptom 
experience. The goal of this research is to study clusters of heart failure symptoms in 
Black women to eventually improve symptom education, monitoring, and treatments. 
First, we ask that you complete a short screening questionnaire to see if you are 
eligible to participate in the study. The screening will take less than 5 minutes. If you are 
eligible and you would still like to participate, you will be asked to answer questions 
about your health status, background, and heart failure symptoms. The survey will take 
about 20-30 minutes to complete. This research study is completely voluntary. Even after 
you have started the survey, you have the right to refuse to answer any question or stop at 
any time. Completion of this survey means you consent to participate in the research 
study. This research study comes with a small risk of loss of confidentiality (meaning 
someone finding out about your health condition or responses). We have minimized this 
risk as much as possible by not tying your name or information to any of your responses 
and keeping all study data on password-protected, encrypted, and secure platforms. 
You will receive a $25 Amazon e-gift card as a token of appreciation for your 
participation in the study. After    completing the survey, please fill out the contact 
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information survey so we know where to send your gift card. You      will be asked if you 
are interested in being contacted for an interview about your symptom experience. These   
interviews will only be between you and me over the phone or video conference and will 
take approximately 30    minutes to 1 hour. Interviews will be audio-recorded and 
transcribed to written word. Audio recordings will be deleted   as soon as transcription is 
complete to protect your identity. If you are asked to participate in an interview, you will 
receive an additional $25 Amazon e-gift card after it is completed. 
Thank you for allowing me the opportunity to share my research study with you. 
If you have any questions/comments or you would like to answer survey questions over 
the phone, please call, text, or email me. I would love to hear from you! 
 
Sincerely, 
Alex Ruppe, BSN, BSPH, RN Cardiac Nurse 












--- PLEASE ANSWER THE FOLLOWING QUESTIONS TO SEE IF YOU ARE 
ELIGIBLE TO JOIN THE STUDY --- 
 




2. Did your doctor tell you the type of heart failure you have is called diastolic 
heart failure (also known as heart failure with preserved ejection fraction)? 
 
Yes, my ejection fraction is 50% or greater 
No, I have a reduced ejection fraction (<50%) 
Unsure  
(If you are unsure about whether you have diastolic heart failure or 
heart failure preserved ejection fraction, please contact the primary 
investigator to determine if you are eligible to participate in this study. 
Alex Ruppe, BSN, BSPH, RN (803) 417-6635 
moseleal@musc.edu) 
 









































10. Have you been diagnosed with any end-stage disease? (e.g., cancer, renal failure, 














I agree that I have answered the questions above truthfully and to the best of my 
knowledge. 
 
X I AGREE 
 
 
Thank you for participating in this survey! If you were not eligible for this study and the 
survey ended, we appreciate you taking the time to answer our questions. 
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If you did qualify to participate in the study, you will see the Heart Failure Survey in 
your queue below. Please click on "Begin Survey" at the bottom of the page and complete 
the entire survey to receive your $25 gift card. We are grateful for your time, answers, and 
feedback and we look forward to furthering research. 
If you have any questions, please reach out. 
Sincerely, 
Alex Ruppe, BSN, BSPH, RN 
Cardiac Nurse 




If you are having symptoms of depression or sad thoughts and would like to speak with 
someone or get connected to a treatment center, the Substance Abuse and Mental Health 
Services Administration (SAMHSA) Treatment Referral Hotline is free, and someone is 
available to help 24/7. You can call the hotline at 1-800-662-HELP (4357). 
If you are currently experiencing severe heart failure symptoms, please contact your 
doctors about your symptoms. If you do not have a doctor or need help contacting yours, you 







Section 2: REDCap Survey – Single Item Literacy Screener, Demographics 
Questionnaire, Feasibility and Acceptability Questions, Contact Information 
ABOUT YOU 
 
Single Item Literacy Screener (free for public use)  
How often do you need to have someone help you when you read instructions, 








How old are you? (Please select your age from the drop-down) 
 
What is your marital status? 
 
Single 





Prefer not to respond 
 
 
How long have you been diagnosed with heart failure? 
 
New diagnosis (< 3 months) 
3 months - 12 months 
1 year - 2 years 
3 years - 4 years 
5 years - 8 years 
9+ years 
Unsure 
Prefer not to respond 
 





How many people live in your household (including yourself)? (please use the drop 
down to select the number of individuals) 
 
What is the HIGHEST level of education you have COMPLETED? 
 
No high school degree 





Prefer not to respond 
 





Public (from Healthcare Marketplace) 
Private (from employer) 
Other 
Unknown 
Prefer not to respond 
 
How tall are you? (please use the drop down to select your height) 
 
How much do you weigh (pounds)? (please use the drop down to select your weight) 
 
Have you been diagnosed with any of the following? (Please check all that apply) 
 
Hypertension (high blood pressure) 
High cholesterol 
Diabetes 
Atrial fibrillation (abnormal heart rhythm) 
Coronary Artery Disease (CAD) 
Asthma 
Chronic Obstructive Pulmonary Disease (COPD) 
Obstructive Sleep Apnea (OSA) 
None of the above 
Unsure 
 
What is your race and ethnicity? Select all that apply. 
 
Black or African American 
White 




Hispanic or Latino 
 
How did you hear about this study? 
 
I received an email or phone call. 
I saw an ad on Facebook. 
I saw a post within a Facebook group. 
Someone told me about this study. 
Other 
 
How did you complete the survey questions? 
 
I completed the survey questions online and on my own. 
I completed the survey questions online with help from someone. 




The way I was contacted about and/or found out about this study seemed like a good 
match. 
  
Completely disagree  
Disagree  




I was easily able to access survey questions and follow survey instructions. 
 
Completely disagree  
Disagree  




The survey questions seemed fitting to me and my condition. 
 
Completely disagree  
Disagree  








Completely disagree  
Disagree  




The amount of time it took me to complete survey questions was acceptable. 
 
Completely disagree  
Disagree  




I was easily able to complete all the parts of this study. 
 
Completely disagree  
Disagree  




The gift card amount ($25) was an acceptable amount of reimbursement. 
 
Completely disagree  
Disagree  




The purpose of this study was explained to me in a way that I could understand. 
 
Completely disagree  
Disagree  




I welcomed the opportunity to share my symptom experience. 
 
Completely disagree  
Disagree  






I would participate in a study such as this one again. 
 
Completely disagree  
Disagree  




I would recommend participating in a study such as this one to someone I know. 
 
Completely disagree  
Disagree  




I agree that I have answered the questions above truthfully and to the best of my 
knowledge. 
 
X  I AGREE 
 
Thank you for completing the survey! 
Please provide your contact information after submitting your survey so we can 
send you your $25 Amazon gift card. 
Contact Information  | 
Thank you for completing the survey portion of the study! Please provide your 
contact information below so we can send you your $25 Amazon gift card. 
 
Also, please let us know if you are interested in being contacted about participating 
in an interview about your symptoms. Participants chosen to participate in 
interviews will receive an additional $25 Amazon gift card once the interview is 
completed. Interviews will be done over the phone or through Doxy.me at a time 
most convenient to you. Please reach out if you have any questions. 
 
What is your name? 
 
What is your phone number? 
 
What is your email address? 
 







Are you interested in being contacted for an interview (for an additional $25 















































Section 3: Minnesota Living with Heart Failure Questionnaire  
 
MINNESOTA LIVING WITH HEART FAILUREâ QUESTIONNAIRE 
 
The following questions ask how much your heart failure (heart condition) 
affected your life during the past month (4 weeks).  After each question, circle the 
0, 1, 2, 3, 4 or 5 to show how much your life was affected.  If a question does not 
apply to you, circle the 0 after that question. 
 
Did your heart failure prevent  
you from living as you wanted during                        Very                            Very 
the past month (4 weeks) by -                          No      Little                 Much  
       
1.  causing swelling in your ankles or legs?           0            1        2        3        4        5 
2.  making you sit or lie down to rest during    
     the day?                    0            1        2        3        4        5 
3.  making your walking about or climbing      
     stairs difficult?                   0            1        2        3        4        5 
4.  making your working around the house    
     or yard difficult?                   0            1        2        3        4        5 
5.  making your going places away from           
     home difficult?                   0            1        2        3        4        5 
6.  making your sleeping well at night 
     difficult?                    0            1        2        3        4        5 
7.  making your relating to or doing things 
     with your friends or family difficult?                0            1        2        3        4        5 
8.  making your working to earn a living 
     difficult?                    0            1        2        3        4        5                                                               
9.  making your recreational pastimes, sports 
     or hobbies difficult?                  0            1        2        3        4        5 
10.  making your sexual activities difficult?    0            1        2        3        4        5 
11.  making you eat less of the foods you  
        like?                    0            1        2        3        4        5 
12.  making you short of breath?                 0            1        2        3        4        5 
13.  making you tired, fatigued, or low on 
       energy?                    0            1        2        3        4        5 
14.  making you stay in a hospital?     0            1        2        3        4        5 
15.  costing you money for medical care?    0            1        2        3        4        5 
16.  giving you side effects from treatments?    0            1        2        3        4        5 
  
17.  making you feel you are a burden to your  
       family or friends?          0            1        2        3        4        5 
18.  making you feel a loss of self-control 
        in your life?                   0            1        2        3        4        5  
19.  making you worry?                  0            1        2        3        4        5 
20.  making it difficult for you to concentrate 
        or remember things?                  0            1        2        3        4        5  
  
 167 




©1986 Regents of the University of Minnesota, All rights reserved.  Do not copy or 
reproduce without permission. LIVING WITH HEART FAILURE® is a registered 
trademark of the Regents of the University of Minnesota. 
 
Instructions for Data Collection and Scoring 
. 
1. Patients should respond to the questionnaire prior to other assessments and 
interactions that may bias their responses. You might tell the patient that you 
would like to get his or her opinion before doing your medical assessment. 
 
2. Ample, uninterrupted time should be provided for the patient to complete the 
questionnaire. We recommend that the patient answer the questions without 
being influenced by others such as their spouse or family members. Studies 
show that patient proxies often have different perspectives. 
 
3. We recommend that you use the first question to give the respondent more 
detailed instructions as follows. 
 
a. Read the introductory paragraph at the top of the questionnaire. 
 
b. Read the first question with the respondent – “Did your heart failure prevent 
you living as you wanted during the last month (4 weeks) by causing swelling in 
your ankles or legs?” Then tell the respondent - 
 
   If you did not have any ankle or leg swelling during the past month 
(4 weeks) you should circle the zero (0) after this question. 
   If you did have swelling that was caused by a sprained ankle or some 
other cause that you are sure was not related to heart failure, you 
should circle the zero (0) after this question. 
   If you had swelling that might be related to your heart condition, then 
rate how much the swelling prevented you from doing things you 
wanted to do or feeling the way you would like to feel. In other 
words, how much did the swelling affect your life? Circle either the 0, 
1, 2, 3, 4 or 5 to indicate how much the swelling affected your life 
during the past month – zero (0) means not at all, one (1) means very 
little and five (5) very much. 
 
4. Ask the patient read and respond to all 21 questions. The entire questionnaire 
may be read directly to the patient if one is careful not to influence responses by 
verbal or physical cues. 
 
5. Check to make sure the patient has responded to each question. If a question 
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does not apply to the patient they should circle the zero (0). Make sure there is 
only one answer clearly marked for each question.  
 
 
Instructions for Data Collection and Scoring (cont’d) 
 
 
1. Score the questionnaire by summating the responses to all 21 questions. In 
addition, a physical dimension score (items 2, 3, 4, 5, 6, 7, 12, 13 on the version 
sent with these instructions) and emotional dimension score (items 17, 18, 19, 20, 
21) have been identified by factor analysis and may be scored by simple 
summation to 
further characterize the effect of heart failure on a patient’s life. 
2. Partially complete questionnaires do occur despite best efforts to minimize 
missing data. However, missing data can greatly bias the data and complicate 
analysis. To reiterate, you need to make sure the respondents understand to mark 
zero for any items that do not apply to them, rather than leave a blank. 
Whenever possible review the questionnaire before the respondent leaves to 
make sure there are no unanswered questions or questions with more than one 
answer. 
 
3. Several methods to impute missing data are discussed in the literature.1, 2 
Multiple imputation using completed questions and perhaps other study 
variables to predict missing responses should be considered.3 If a missing 
response is not imputed, the item will be eliminated from that person’s score 
(the sum of responses). Since intermittently missing data can greatly affect 
within-person changes in scores, you might want to use the same subset of 
questions to represent a person at all times by omitting questions that have 
missing data at any point in time. We do not have any recommendations about 



















Section 4: Symptom Status Questionnaire – Heart Failure 
 
 Symptom Status Questionnaire-Heart Failure 
Instructions: Please read each of the statements carefully, and then 
circle the number that best describes your condition or how much you 
were bothered by these symptoms  
during past 4 weeks. 
 
1. Did you have shortness of breath during day time?   
    0. No (If your answer is no—please go to question 2) 
    1. Yes (If your answer is yes—please fill out 1a, 1b, 1c) 
                 1a. How often? 
 1) Less than once 
per week 
2) 1-2 times per 
week 





                 1b. How severe? 
 1) Slight 2) Moderate  3) Severe 4) Very severe 
                 1c. How much did it distress or bother you? 
                    0) Not 
at all 




2. Did you have shortness of breath when you lay down?   
    0. No (If your answer is no—please go to question 3) 
    1. Yes (If your answer is yes—please fill out 2a, 2b, 2c) 
                  2a. How often? 
 1) Less than once 
per week 
2) 1-2 times per 
week 





                  2b. How severe? 




                  2c. How much did it distress or bother you? 
                  0) Not at 
all 
1) A little bit 2) Somewhat 3) Quite a bit 4) 
Very 
much 
3. Did you have fatigue or lack of energy? 
    0. No (If your answer is no—please go to question 4) 
    1. Yes (If your answer is yes—please fill out 3a, 3b, 3c) 
                  3a. How often? 
 1) Less than once 
per week 





                  3b. How severe? 
 1) Slight 2) Moderate  3) Severe 4) Very severe 
                  3c. How much did it distress or bother you? 




4. Did you have chest pain? 
    0. No (If your answer is no—please go to question 5) 
    1. Yes (If your answer is yes—please fill out 4a, 4b, 4c) 
                  4a. How often? 
 1) Less than once 
per week 





                  4b. How severe? 
 1) Slight 2) Moderate 3) Severe 4) Very severe 








5. Did you have leg or ankle swelling?   
    0. No (If your answer is no—please go to question 6) 
    1. Yes (If your answer is yes—please fill out 5a, 5b, 5c) 
                  5a. How often? 
 1) Less than once 
per week 





                  5b. How severe? 
 1) Slight 2) Moderate  3) Severe 4) Very severe 
                  5c. How much did it distress or bother you? 
                    0) Not at 
all 
1) A little bit 2) Somewhat 3) Quite a bit 4) 
Very 
much 
6. Did you have difficulty sleeping at night? 
    0. No (If your answer is no—please go to question 7) 
    1. Yes (If your answer is yes—please fill out 6a, 6b, 6c) 
                  6a. How often? 
 1) Less than once 
per week 
2) 1-2 times per 
week 





                  6b. How severe? 
 1) Slight 2) Moderate  3) Severe 4) Very severe 
                  6c. How much did it distress or bother you? 
                    0) Not at 
all 
1) A little 
bit 
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Scoring method and interpretation 
1. Sum all scores of a, b, and c for each symptom. For example, dizziness score = 
7a+7b+7c.  
2. If any person did not experience the symptom give 0 for all the items of the symptom.  
3. Thus, possible score range for each symptom will be 0 to 12. These 7 combined scores 
will be used to get Cronbach’s alpha.  
4. To get total symptom score, sum all the 7 combined scores. Thus, the total possible 
score range is 0 to 84 (12*7).  
5. Higher scores indicate more severe heart failure symptoms. 
 
 
7. Did you have dizziness or loss of balance? 
    0. No (If your answer is no—just check No and stop here) 
    1. Yes (If your answer is yes—please fill out 7a, 7b, 7c) 
                 7a. How often? 
 1) Less than once 
per week 
2) 1-2 times per 
week 





                 7b. How severe? 
 1) Slight 2) Moderate 3) Severe 4) Very severe 
                 7c. How much did it distress or bother you? 
                    0) Not at 
all 
1) A little 
bit 















If two consecutive numbers are circled, score the higher (more distress) number. If 
the numbers are not consecutive, do not score the item. Score is the sum of the 8 
items. If more than 1 item missing, set the value of the scale to missing. A score of 




















8 0-24 6.63 5.52 .86 NA 
 
 
Source of Psychometric Data 
U.S. National Chronic Disease Self-Management Study. Study described in Ory 
MG, Ahn S, Jiang L, et al. National study of chronic disease self-management: six 
month outcome findings. Journal of Aging and Health. 2013 [in press]. 
 
Comments 
This is an adaptation of the PHQ-9 scale. Since this scale is self-administered in our 
studies, question #9, "How often during the past 2 weeks were you bothered by 
thoughts that you would be better off dead, or of hurting yourself in some way?", 




Kroenke K, Strine TW, Spritzer RL, Williams JB, Berry JT, Mokdad AH. The 
PHQ-8 as a measure of current depression in the general population. J Affect 
Disord. 2009; 114(1-3):163-73. 
 
Razykov I, Ziegelstein RC, Whooley MA, Thombs BD. The PHQ-9 versus the 
PHQ-8--is item 9 useful for assessing suicide risk in coronary artery disease 
patients? Data from the Heart and Soul Study. J Psychosom Res. 2012; 73(3):163-
168. 
 
This scale is free to use 
without permission 
 
Self-Management Resource Center 




Section 6: Semi-structured Interview Guide 
 
Symptom Experience Interview guide 
 
Person 
To get started, could you tell me a little about yourself so I can get to know you? (probes: 
living situation, kids, marital status, job, education, etc.)  
 
Great! Thank you for sharing. Now, let’s talk about your heart condition and symptoms. I 
am very interested in how you experience and deal with your symptoms. You have heart 
failure and having this disease may make you experience physical or emotional 
discomforts. So, I would like to talk about your symptoms with you if you are 
comfortable with that.  
 
Perception 
1. I would like you to think back to the last 4 weeks. What symptoms did you 
experience related to your heart condition? (Probes: If you are having trouble 
thinking of symptoms, I can give you examples: SOB during daytime or lying 
down, fatigue or lack of energy (need to rest, difficulty with ADLS), chest pain, 
leg or ankle swelling, difficulty sleeping, dizziness or loss of balance, little 
interest/pleasure in doing things, feeling down/depressed/hopeless, feeling 





a. Do any of those symptoms happen together or at the same time? Do any of 
them happen by themselves?  
2. How did those symptoms make you feel? (probe: describe physically and 
emotionally) 
3. When you experience symptoms of heart failure, what does that mean to you? 
 
Evaluation 
4. Can you explain to me how severe your symptoms are? 
5. How often do they occur? (probe: every day, every week, once a month?)  
6. How much do they impact your daily life?  
7. What do you think causes your symptoms?  
8. Do you think your symptoms can be managed or treated?  
 
Response 
9. Let’s talk about how you respond to your symptoms. What do you usually do 
when you are experiencing symptoms? (probes: What do you do when you have 
symptoms that are getting worse? Do you respond to each symptom differently or 
adjust your daily life? Do you change your behaviors, so you do not experience 
them as frequently or severely? How do you know when to call the doctor? Do 
you seek help when your symptoms get worse?) 
10. Do you have a support system? (probe: does someone take care of you and make 
sure you are OK or are you taking care of everyone in your house? Do you share 




when you are having a hard time with symptoms? Does talking about your 
symptoms make you feel better?) 
11. My last question for you is- Has there ever been a time when you hid your 
symptoms from someone else or downplayed how bad they were? I will let you 
think about it for a minute. It could be a family member, friend, in a social setting, 
your nurses or doctors, etc. (probe: quiet time to reflect) If yes, could you tell me 
about it? What was going through your mind and what things made you feel like 
you needed to hide your symptoms?  
12. Is there anything else you want to talk about?  
 
Thank you for your answers. Before we finish, I would like to get some feedback about 
your experience participating in this study and being interviewed. You can be forthright 





1. What was your overall impression of the study? 
 
2. Did you have any problems accessing links or answering survey questions online?  
 





4. What did you think about the length of time it took you to participate in the study?   
 
5. Did the interview questions seem like they were a good fit? 
 
6. What did you like most about the study? 
 
7. What did you like least about the study?  
 
8. Do you have any recommendations on how we could change the study to make it 
more appealing to you?  
 
9. Anything else you want to add?  
 
Thank you for participating! I really appreciate you. For your gift card, would you like it 











Appendix E: Qualitative Codes and Code Descriptions 
 
Name Description 
COVID-19 The impact of COVID-19 on their family life, health, interaction 
with healthcare team, feelings of isolation during quarantine, fears 
around contracting virus with a chronic condition 
Emotional 
symptoms 
Emotional symptoms or feelings in general of how emotional 
symptoms interact with other symptoms 
Fear Expressing feelings of fear or being scared 
Feeling like a 
burden, others 
feeling sorry for 
them 
Feeling like a burden, not wanting to be a burden to others, or 




Expressing weakness relating to what they feel emotionally rather 
than physical weakness or fatigue 
Frustration Frustration with limitations or how someone treated them / what 
they said to them 
Hopelessness Expressing feelings of not having hope, like they are desperate to 
get better, but it is not working, or that there isn’t anything to do to 







Feeling down, sad, or depressed 
Trouble focusing Expresses feelings of it being hard to focus or symptoms making it 
hard to focus  
Trouble sleeping Expresses having trouble sleeping, which may be related to other 
symptoms experienced as well 
Worry Experiencing feelings of worry or anxiety 
Financial stress Insurance, hospitalizations, medications, not being able to work 
Person / 
Demographic 
Person variables ± demographic (Marital status, children, age, and 




Experiencing physical symptoms and how those symptoms interact 
with one another or emotional symptoms  
Chest pain Pain or discomfort in the chest 
Cough Experiencing coughing, whether participant relates it to HF or 
something else 
Dizziness Experiencing dizziness, loss of balance, or feeling lightheaded 
Fatigue Experiencing fatigue, tiredness, increased need to rest, feeling 







Need to urinate frequently 
Lower extremity 
edema 
Swelling or water retention in the legs, ankles, or feet 
Shortness of 
breath 
Feeling short of breath, including dyspnea on exertion, nighttime 
dyspnea, orthopnea 
GI symptoms Symptoms related to GI and appetite  
Quality of life Health related quality of life 
Effect on family 
activities 
Symptoms affecting family activities, being able to do things with 
their family 
Impact on daily 
life and physical 
functioning  
Having trouble carrying out daily activities due to altered physical 
functioning from symptoms  
Support Support from family, friends, church, etc. or lack there of 
Spirituality Expressing spirituality or religious beliefs and use of prayer 
Symptom 
experience 
The symptom experience includes an individual's perception of a 




People evaluate their symptoms by making judgements about the 





lives (Dodd, 2001).  
Severity 
evaluation 
People evaluate how severe a symptom is. This also includes 
evaluation of the threat posed by a symptom, such as whether or 
not it is dangerous or has a disabling effect (Dodd, 2001) 
Cause evaluation People evaluate where the symptom is coming from or what is 
causing the symptom  
Symptom 
perception 
Perception of symptoms refers to whether an individual notices a 
change from the way he or she usually feels or behaves. 
Symptom 
response 
Responses to symptoms include physiological, psychological, 
sociocultural 
and behavioral components (Dodd, 2001). 
Changing diet Changing what they eat, seasonings and salt intake, fluid and water 
intake 





Hiding or not fully telling others how they are feeling or what is 
occurring with their disease process. This can include downplaying 
how bad symptoms, or the disease is from others  
Reducing 
activity level 
Changing activity level based on what symptoms they are 









Reaching out to their doctor when noticing a change in symptoms 
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Dissertation Proposal: A Mixed Methods Approach to Symptom Clusters in 
Black Women with Heart Failure Preserved Ejection Fraction: A Feasibility 
Study 
 
SPECIFIC AIMS                                                                                                                                            
 Patients with heart failure (HF) have a complex and multi-factorial symptom 
experience that makes symptom self-monitoring and self-management difficult (1-4). 
Four out of five patients with HF are hospitalized each year with exacerbations that could 
be avoided with early detection (1). Heart failure symptoms can be clustered together into 
symptom clusters to potentially assess risk of exacerbation and allow symptoms to be 
identified early, monitored, and managed as a cluster (2, 5-21). However, there are 
several notable gaps in existing HF symptom cluster studies. In a review of the literature, 
no studies using qualitative or mixed methods (MM) were identified (5-21). While it is 
known that females with HF have a greater symptom burden, few HF symptom cluster 
studies have addressed sex differences (2-21). Females experience worse quality of life 
(QoL) and functional impairment, and have higher rates of edema, depression, exercise 
intolerance, and dyspnea on exertion compared to males (3, 4). Females with HF are 
diagnosed or referred to cardiologists later than males and disproportionately receive 
fewer recommended therapies or less self-management education (22-24). There is a 
critical need to identify sex specific symptom clusters for females with HF. Additionally, 
HF symptom cluster research lacks racial/ethnic diversity, with the majority of U.S. 
studies contain at least 70% White participants, despite Black Americans having a 50% 




disparities in patients with HF preserved ejection fraction (HFpEF), a type of HF caused 
by diastolic dysfunction in which relaxation of the left ventricle is impaired from 
increased stiffness (25, 26). Black Americans with HFpEF tend to be younger, report 
worse QoL, and have a greater risk of hospitalization than White patients (26).   
 The long-term goal of this research is to examine the symptom experience of 
Black women with HFpEF and how symptoms cluster in this population. Achievement of 
this goal could lead to improved education for HF symptom self-management and self-
monitoring. The purpose of this MM study is to 1) assess the feasibility and acceptability 
of this proposed study protocol and procedures for ascertaining symptom clusters in 
Black women with HFpEF and 2) preliminarily analyze and integrate quantitative and 
qualitative results (27). This purpose stems from the following research question: What 
is the feasibility and acceptability of study processes, resources, and human and data 
management of a convergent MM study of symptom clusters in Black women with 
HFpEF? (27, 28). The rationale for this study is that determining feasibility and 
acceptability for recruitment and implementation in a population that is underrepresented 
in current HF symptom cluster research is a necessary first step to achieving the long-
term research goal. If deemed feasible and acceptable, the proposed study will illuminate 
the experiences of those who are underrecognized, undertreated and have a greater 
symptom burden, and an MM approach allows for a more comprehensive examination of 
the HF symptom experience (3, 4). Black female participants with HFpEF will be 
recruited from Facebook across the U.S. Participants (n=50) will be administered the 
Minnesota Living with HF Questionnaire (MLHFQ), a 21-item health related QoL 




about the presence, frequency, severity, and distress of 7 physical HF symptoms in the 
last 4 weeks, and the Personal Health Questionnaire Depression Scale (PHQ-8), which 
asks about the frequency of 8 depressive symptoms over the last 2 weeks (2, 11, 29, 30). 
Individual, semi-structured interviews guided by qualitative description will be conducted 
with at least 15 participants to examine the symptom experience of Black women with 
HFpEF (31-34). The interview guide follows the Symptom Management Model (SMM)’s 
symptom experience dimension and person domain, while also integrating domains of the 
MLHFQ (35, 36). After results are analyzed, common concepts will be compared through 
simultaneous integration to create a comparative joint display to represent findings (28, 
37). This application addresses the following specific aims: 
AIM 1: Determine feasibility and acceptability of conducting a convergent mixed 
methods symptom cluster study with a population of Black females with HFpEF (27).  
AIM 2: Explore preliminary HF symptom clusters of physical and 
psychological/emotional symptoms by cluster analysis of data collected from MLHFQ, 
SSQ-HF, and PHQ-8 respondents(n=50) (29, 30, 36).  
AIM 3: Explore the SMM’s symptom experience dimension and person domain 
using 15 individual, semi-structured interviews guided by qualitative description (32, 35).  
AIM 4: Integrate qualitative themes and quantitative symptom data to examine 
confirmation, expansion, and discordance of results (28).  
IMPACT: The National Institute of Nursing Research (NINR) highlighted symptom 
cluster research as a critical component to advancing symptom science (11). The 
proposed study will provide valuable insights for recruiting a high-risk and understudied 




The proposed study would also improve research efforts for the health of women by 
considering sex and gender influences, a specific goal of the 2019-2023 Trans-NIH 
Strategic Plan for Women's Health Research (38). 
A. SIGNIFICANCE 
Heart failure (HF) is a severe cardiovascular disease in which up to 30% of patients die 
within 1 year after diagnosis (3, 23). HF is the most common cause of hospitalization in 
the U.S. for those over the age of 65 and almost 1/4th of patients with HF will be 
readmitted within 6 months after discharge (39). Inpatient hospitalizations for HF cost 
over $30 billion a year, accounting for over 60% of total HF related costs in the U.S. 
(40).  
A1. Burden of HF symptoms in females: The lifetime risk for developing HF is 1 in 5 
for both males and females, yet on average, less than 25% of females are included in HF 
clinical trials, and females often do not receive the same recommended therapies as men 
(23). HF is especially burdensome for females, who report poorer health, more 
depression, worse quality of life and symptom severity, and more frequent and longer 
hospitalization than males (1, 17, 23, 41, 42). HF with preserved ejection fraction 
(HFpEF) is more prevalent in females, by a factor of 2 in some studies (23). This type of 
HF is poorly understood, and more research is needed to characterize the symptom 
experience (23, 26). 
A2. Greater risk and worse outcomes for Black patients with HF: Black Americans 
are 1.5 times more likely to develop HF compared to White Americans and at a 2.5 times 
greater risk of dying from HF compared to White Americans (43). Black females have 




females (75.3 and 47.0 per 100,000, respectively) (3). Black Americans also often have 
difficulty recognizing and interpreting symptoms (43). This can lead to delays in seeking 
treatment and ultimately result in avoidable hospitalizations from HF exacerbations (43). 
This cascade of events is why understanding the symptom experience and how symptoms 
cluster for Black females with HFpEF is necessary. 
A3. Symptom clusters in HF: A symptom cluster is two or more symptoms that occur 
simultaneously in a disease (2, 34). Knowledge about how symptoms cluster can help 
patients to more easily recognize impending exacerbations, be used for developing more 
targeted and effective interventions, and assist in determining risk for adverse health 
outcomes (2, 5-21). A small body of literature exists for HF symptom clusters that 
validates these potential uses (2, 5-21). However, research that has been conducted in this 
area minimally examines sex differences, does not include qualitative methodologies, and 
lacks racial and ethnic diversity (2, 5-21). Since few Black females have been included in 
HF symptom cluster research, it is first necessary to determine if it is feasible to recruit 
this population, what barriers and facilitators to adequate recruitment exist, and 
participants’ willingness to participate in research studies (27). Qualitative methods are 
needed to explore the intersection of gender, sex, and race and impact on the symptom 
experience, as quantitative instruments alone have limited ability in encompassing such 
factors. Studying the symptom experience and symptom clusters in relation to gender, 
sex, race, and type of HF is warranted considering the increased burden of HF symptoms, 
greater risk, and worst outcomes in females, Black Americans, and patients with HFpEF 




A4. The intersection of sex/gender, race/ethnicity, and health: Sex/gender and 
race/ethnicity have a complex interaction that influences health and should be considered 
when studying symptoms (44). Many factors contribute to the health disparities and 
worse outcomes that are evident for multiple conditions, such as societal and cultural 
stressors. This study aims to examine how the intersection of such factors can impact 
symptom clusters and the symptom experience of Black women with HFpEF using mixed 
methods (MM). Sex and gender differences in symptom perception and impact are also 
prevalent in other chronic diseases. Females with Chronic Obstructive Pulmonary 
Disorder report higher levels of anxiety and depression, worse quality of life, worse 
perceived control of symptoms, and greater functional impairment (45-48). Women are 
noted to have increased pain sensitivity and risk, and women with Chronic Venous 
Disease were found to have worse neuropathic pain (burning, throbbing, and night 
cramps) compared to males (49). Woman gender in asthma is associated with more 
severe symptom intensity, frequency, and limitations from symptoms, and women with 
asthma report poorer quality of life (50). This evidence supports the need for sex/gender 
specific exploration of symptom clusters and the  
symptom experience.  
B. INNOVATION AND CONCEPTUAL FRAMEWORK   
B1. Innovation: Current HF practice paradigms diagnose and treat males and females 
using the same guidelines, despite growing evidence of differences in symptom 
expression, burden and quality of life by sex (1-4, 23). This study is innovative in that 
it seeks to shift this paradigm by placing an emphasis on sex and race that was 




exploring the symptom experience and symptom clusters for Black females with HFpEF 
using MM. The convergent MM design is a novel approach to HF symptom cluster 
research that, to our knowledge, has not been conducted before. Utilizing MM allows for 
a more comprehensive exploration of the HF symptom experience and symptom clusters 
for Black women. Symptom clusters are created based on data from questionnaires, 
which have a limited ability in assessing personal factors and symptom perceptions, 
evaluations, and responses. Individual, semi-structured interviews guided by qualitative 
description allow for a straight description of the symptom experience as described by 
participants (31-34). Examining study feasibility is needed for understanding the nuances 
of recruitment and data collection within a population of Black females with HFpEF and 
validation of the SSQ-HF in this population (27). A review of HF symptom cluster 
literature revealed that of the eight studies conducted in the U.S., five had >70% white 
participants, and the SSQ-HF has not been well validated in a Black population (7-9, 11-
14, 20, 29). Findings from this study could potentially improve inclusion of the 
population in future research, thus increasing generalizability of HF symptom cluster 
research long-term.  
B2. Conceptual Framework: The Symptom Management Model (SMM), based on the 
Symptom Management Theory (SMT), highlights the multi-faceted nature and complex 
interactions of symptom components (35). Symptom experience, components of 
symptom management strategies, outcomes and symptom status, person, environment, 
and health and illness are the six components that comprise the SMM (35). For the 
present study, symptom experience and person influence the semi-structured interview 




overall research question, and were chosen because they allow for exploration of 
demographic, psychological, and sociological factors that can influence the symptom 
experience of a Black woman with HFpEF (35). These components will also guide 
content analysis of interview data and the triangulation of questionnaire and interview 
results (35). The three domains of the MLHFQ (physical symptoms, emotional 
symptoms, and QoL) also influenced interview guide questions, which sets the stage for 
merging of quantitative and qualitative results (28, 36). 
C. APPROACH 
C1. Design Overview: d 
C2. Preliminary studies: In an integrative review of HF symptom cluster science, the PI 
noted the following prominent findings (21). Current research has validated the existence 
of HF physical symptom clusters and emotional/psychological symptom clusters and has 
shown that physical symptoms can cluster with emotional/psychological symptoms (2, 5-
7, 9, 10, 20, 13-16, 19). One study found identical symptom clusters for males and 
females; however, females reported significantly higher distress from symptoms (12). 
Those who were younger reported more psychological and emotional distress, with no 
relation to actual severity, and higher education levels were associated with lower 
symptom severity (5, 8, 9, 11, 19). Symptom clusters can also be used to assess risk of 
mortality, disease-specific health status, cardiac event-free survival, cardiac event risk, 
and predicted hospitalization (6-8, 10, 12, 18, 19). The literature also supports the 
importance of recognizing emotional/psychological symptoms in patients with HF, as 
they can be the most distressing of HF symptoms and result in the highest risk for adverse 




C3. Setting: The study population will be recruited through Facebook using ads and 
posts within Facebook groups.  
C4. Inclusion/exclusion criteria: Inclusion criteria include being a Black female with a 
self-reported diagnosis of HFpEF (ejection fraction greater than or equal to 50%). 
Participants must be in the age range of 35 to 74 years old. This age range was 
determined after a consultation with the dissertation committee HF expert to be 
representative of most females with HF, while excluding ages that are more likely to 
result in outliers. Exclusion criteria include having a diagnosis of a severe or end-stage 
disease, stroke or myocardial infarction in the last 6 months, hospitalization in the last 4 
weeks, or if the patient is currently experiencing a HF exacerbation that requires 
hospitalization. 
C5. Recruitment and retention: After receiving IRB approval, participants will be 
recruited using Facebook posts and ads. Facebook respondents will self-report a 
diagnosis of HFpEF from a healthcare provider and state their ejection fraction to 
determine eligibility. Electronic flyers will be distributed via email or Facebook, and will 
contain study purposes, contact info, a link to the REDCap® screening questionnaire, and 
will offer an amazon electronic gift card. Participants will also be called to complete 
screening via phone if interested. If eligible, the PI will provide a link to the REDCap® 
survey. All survey respondents will be asked about interview participation interest and 
contact preferences. The PI will reach out to all participants interested in scheduling an 
interview and will coordinate a time that works best for the subject for informed consent 
and interviews via phone. Participants will also have the option to meet virtually through 




D. AIM 1: FEASIBILITY Determine feasibility and acceptability of conducting a 
convergent mixed methods symptom cluster study with a population of Black 
females with HFpEF (27).  
D1. Sample size: This study will utilize purposive sampling to ensure the inclusion of 
only Black women with HFpEF (52). To determine the sample size for the feasibility 
study, Leon, Davis, and Kraemer propose a pragmatic approach based on recruitment and 
needs for establishing feasibility (53). We estimate it will take approximately 2 hours to 
recruit each potential participant, including calling or emailing the participant, leaving a 
voicemail, follow-up calls, screening, etc. Further assuming that the PI will be able to 
spend approximately 25 hours per week (~100 hours a month) actively recruiting, this 
would result in approximately 50 potential participants a month. If 20% of participants 
agree to participate, that would result in 10 enrolled participants a month. Since the study 
is being conducted over 5 months, this would result in a sample size of 50 participants. 
Therefore, feasibility data will be collected for at least 50 participants.  
D2. Variables: Consent rate, recruitment rate, interview interest rate, survey completion 
rate, feasibility/acceptability scores, data collection time for interviews, recruitment 
burden, transcription time, software reliability, adverse patient events, 
inclusion/exclusion criteria, semi-structured interview questions adequate for answering 
research question, triangulation of quant and qual results 
D3. Procedures: Participants fitting the inclusion criteria will be recruited as previously 
described. To further determine eligibility, the screening form within REDCap® will be 
accessed and completed by the participant via a link or by the PI in the case of a 




is eligible for study participation, for feasibility purposes of assessing inclusion/exclusion 
criteria. Participants will be asked to provide consent to be contacted for questionnaire 
and interview portions and to signify their contact preferences. If the patient is deemed 
eligible for study participation after screening, the PI will provide a link for REDCap® 
questionnaires or determine a time that works best for the participant to complete aspects 
of the study via phone. Demographic information will be collected using the REDCap® 
demographic questionnaire and participants will complete the questionnaires. If the 
participant is completing study aspects over the phone with the PI, notes will be 
transcribed to capture the approximate time for completion and any verbalized or 
observed problems with instrument items or instructions. Following questionnaire 
completion, participants will be asked if they are interested in participating in an 
interview. The PI will select participants based on the sampling frame and conduct semi-
structured interviews using the interview guide. After the questionnaires are administered 
and/or the interview is completed, the AIM and FIM questionnaires will be administered 
to assess participant acceptability and feasibility (51). Feasibility and acceptability 
measures will be recorded in Excel throughout the entire process. These measures include 
whether approached subjects agree to participate, number of participants recruited each 
week and month, completion rate of MLHFQ, amount of time it takes to complete each 
aspect and the study and total time for all components, functionality and acceptability of 
data collection platforms.  
D4. Data management: All questionnaires will be developed using MUSC’s REDCap® 
application and will be stored on REDCap®’s secure, password-protected server. To 




unless every questionnaire item has an answer. An item can only be skipped if a 
participant explicitly refuses to answer. In this case, the PI will record a 9 on the 
questionnaire in REDCap®. Data will remain in REDCap® until analysis, during which 
it will be exported to SPSS. No patient identifiers will be exported to SPSS and only 
dissertation committee members will have access to participant data. Exporting of data 
will be tested before study employment to ensure consistent data formatting. Data on 
feasibility and acceptability variables will be stored in a secure, password-protected BOX 
folder on MUSC’s server.  
Data analysis. The feasibility of study processes, resources, and human and data 
management will be analyzed as the primary aim of this study (27). The consent rate will 
be determined by calculating the percentage of eligible participants who consent by 
completing the next survey, with a goal consent rate of >90%. The recruitment rate will 
be determined by calculating the percentage of participants successfully recruited out of 
the recruitment goal. Recruitment of >85% of the 50 participants goal is the benchmark. 
The interview interest rate will be determined by calculating the percentage of 
participants who indicate interest in being interviewed, with a goal interview interest rate 
of >30%. Surveys will be examined for missing data and the percentage of surveys with 
missing data will be calculated. The survey completion rate goal is >85% fully completed 
surveys. The feasibility and acceptability question results will be analyzed by calculating 
a mean score. A mean score of 3 or greater on a scale of 0-5 will support participant 
acceptability and feasibility. Time to complete interviews will analyzed by calculating the 
mean and range of interview length. The goal interview length time will be less than 1 




week, with a goal of <20 hours spent per week recruiting. Time spent editing transcripts 
for accuracy will be tracked and averaged, with a goal of <2 hours per interview. 
Software reliability and adverse patient events will be tracked, with the goal of no major 
events.  
E. AIM 2: QUANTITATIVE Explore preliminary HF symptom clusters of physical 
and psychological/emotional symptoms by completing cluster analysis of data 
collected from MLHFQ, SSQ-HF, and PHQ-8 respondents (n=50) (29, 30, 36). 
E1. Sample Size Consideration: Sampling method and size for the quantitative portion 
of the study are the same as previously described for the feasibility aim. A sample size of 
50 Black females with HFpEF will allow for preliminary clustering of symptoms within 
this feasibility study.  
E2. Variables: MLHFQ physical symptoms (edema, fatigue/increased need to rest, 
fatigue/low energy, shortness of breath, sleep difficulties), emotional/psychological 
symptoms (worrying, feeling depressed, cognitive problems), QoL score, SSQ-HF 
symptoms (presence, frequency, severity and distress of shortness of breath, orthopnea, 
fatigue, chest pain, lower extremity swelling, difficulty sleeping, dizziness or loss of 
balance), PHQ-8 responses, age, self-reported ejection fraction, length of time diagnosed 
with HF, marital status, number of children, household number, highest level of 
education, height, weight, body mass index, presence of co-morbidities (hypertension 
(HTN), high cholesterol (HLD), diabetes mellitus (DM), atrial fibrillation (AFIB), 
coronary artery disease (CAD), asthma, COPD, obstructive sleep apnea (OSA) 
E3. Procedures: Demographic and clinical features on each participant will be collected 




questionnaire, which include the variables listed above. Comorbidity diseases were 
chosen due to commonality in patients with HF and their potential impact on HF 
symptoms (2, 5-21). The questionnaires will be administered to participants before 
qualitative interviews to minimize bias (36). The MLHFQ is a quality-of-life 
questionnaire designed for patient with HF in 1984 by Rector and Cohn (36). The 
questionnaire includes 21 questions related to the impact of physical symptoms, 
emotional/ psychological symptoms, and HF related activities on daily life (36). To 
complete the questionnaire, the participants rate how much an item affected their life in 
the past month (4 weeks) using a Likert scale of 0-5 with 0 indicating none, 1 very little, 
and 5 very much (36). The total score ranges from 0 to 105, with a higher scoring 
indicating worse quality of life and more impact from symptoms and components of HF. 
The MLHFQ has excellent internal consistency with a Cronbach’s α usually ranging from 
0.89-0.96 and has shown success in forming symptom clusters in multiple other HF 
symptom cluster studies (2, 5-7, 9, 17, 18, 20, 36). The questionnaire is short, easy to 
administer, and has been validated for its psychometric properties (2, 5-7, 9, 17, 18, 20, 
36). The domains of the MLHFQ align with study aims and are also implemented in 
qualitative interviews for data collection consistency. The SSQ-HF is a HF symptom 
scale established in 2015 that measures the presence, frequency, severity, and distress of 
7 physical symptoms mostly commonly reported in HF in the last 4 weeks (29). If a 
symptom is present, the respondent then rates frequency, severity, and distress using a 
Likert scale of 1-4, with 1 being less and 4 being most (29). The Cronbach’s α for the 
SSQ-HF is 0.80 and matches the time frame of the MLHFQ (29, 36). The PHQ-8 asks 




every day, over the past 2 weeks (30). This depressive symptom scale is widely used and 
has a Cronbach’s α of 0.83 (30). The participants will read instructions and complete the 
questionnaires via the REDCap® link, or the PI will read questionnaire items to the 
participant and record answers in REDCap®.  
E4. Data management: Data management practices for the quantitative aim are the same 
as previously described for the feasibility aim. 
Demographic and clinical data analysis. Demographic and clinical variables will be 
analyzed within SPSS for frequencies and valid percentages and means and standard 
deviations for descriptive statistics. Results will be displayed in a demographics table.  
Cluster analysis. A hierarchical cluster analysis will be used to explore preliminary 
symptom clusters of physical and emotional/psychological symptoms included in the 
MLHFQ, SSQ-HF, and PHQ-8 (29, 30, 36, 54, 55). The hierarchical cluster method was 
chosen because it can be used to cluster variables (symptoms) rather than just cases 
(study participants) (54, 55). It also allows the researcher to select the best number of 
clusters after running the analysis rather than having to define the number of clusters at 
the start, such as in K-means clustering (54, 55). Hierarchical clustering creates compact 
and homogenous clusters and differences in clusters are maximized (2, 9, 54, 55). The 3 
main steps to hierarchical clustering are to calculate distances between variables, link 
clusters, and then determine the right number of clusters based on dendrogram results 
(55). For this study, each variable (symptom) will be placed in a separate column and 
participant data (responses to the questionnaire) will be placed across each row within 
SPSS and a hierarchical cluster analysis will be run. The analysis will be conducted by 




symptoms will be selected as the variables for the analysis. In plots, the dendrogram 
option will be selected. A dendrogram is a tree like structure that shows a graphic 
visualization of how clusters are related (55). Branches are based on semi-partial r-
squared scores and smaller branches signify more similar clusters (55). All variables will 
be merged into a single cluster at the start since this is an exploratory analysis and the 
best number of clusters is unknown. Next, Euclidean distance is the selected method for 
calculating distance, and it determines which cases are most similar by calculating the 
square root of the sum of squared distances (55). This method is commonly used for 
interval level data and places an emphasis on larger distances since it is squared. For 
clustering method, the ultimate goal is to use Ward’s method of clustering, as it is best for 
maximizing significant differences between clusters by using the F value (55). However, 
single-linkage clustering is best for identifying outliers. Therefore, a single-linkage 
analysis will be run first to remove outliers and then Ward’s method will be used once 
outliers are removed. The PI will confer with the research team statistician to determine 
best number of cases by visually examining the dendrogram for dissimilarity between 
clusters and drawing a cut-off line (55). The analysis will then be repeated, specifying 
number of cases at the start.  
F. AIM 3: QUALITATIVE Explore the SMM’s symptom experience dimension and 
person domain using 15 individual, semi-structured interviews guided by qualitative 
description (31, 36).  
F1. Sample Size: The goal sample size for interviews is 15. We will assess for data 




F2. Recruitment and retention: A purposive sampling strategy will be used to recruit at 
least 15 Black females with HFpEF for the individual, semi-structured interviews. The PI 
will reach out to all individuals interested in being interviewed to ensure every participant 
who wants to be interviewed has the opportunity. 
F3. Variables: Codes and themes derived from the qualitative analysis will be grouped 
within SMM’s symptom experience dimension and person domain and MLHFQ 
domains. 
F4. Procedures: Individual interviews will be conducted via a free HIPAA compliant 
videoconference platform, or via telephone if unable to complete through 
videoconference. The PI will ask participants open-ended questions in a semi-structured 
interview format about their personal background (e.g., living situation, kids, marital 
status, job, education) and symptom experience. The interview guide was developed by 
combining components of the SMM and domains of the MLHFQ (35, 36). An interview 
guide facilitates consistency in data collection while also allowing for unanticipated 
responses (31). Participants will be asked to describe their symptoms in the last 4 weeks 
to correspond with the MLHFQ symptom recall time frame (36). Probes, both 
questioning and silent, will be used to facilitate thoughtful responses from participants 
(31). Mirroring during interviews will be utilized to ensure the PI is capturing the true 
perspective of each participant (31). Individual interviews allow participants to freely 
share their experience while maintaining confidentiality and allows for higher credibility 
and validity than focus groups (31).  
F5: Data management: Interview audio will be recorded directly on the mobile device 




and HIPAA compliant platform will be used for interview transcription. The PI will 
confirm the accuracy of transcriptions for all interviews and make edits as needed. The 
audio recordings and transcripts will be kept in a password protected, electronic folder in 
MUSC’s BOX per IRB requirements. Audio recordings will be destroyed once 
transcriptions are complete to protect the identity of participants. After transcription, 
NVivo® will also be used to support thematic coding and analysis by the PI in 
consultation with dissertation chair (Dr. Magwood, Professor, MUSC) and committee HF 
expert (Dr. Dunbar, Professor, Emory University).  
Data analysis. Qualitative description will guide qualitative analysis of interview data 
(31-34). The PI will first read through transcripts completely and highlight identified text 
that may represent aspects of the symptom experience phenomenon (34). This first step is 
meant to increase trustworthiness by not allowing broad code structures to result in the PI 
missing important findings that do not fit within the selected frameworks (34). A directed 
approach to content analysis will then be used with SMM components and MLHFQ 
domains as broad code types to guide development of sub-codes (34-36). Interviews will 
be transcribed and analyzed as they are collected using a constant comparative method 
(31). Two to three transcripts will be analyzed at a time and then codes will be revised as 
needed (31). The PI will keep a detailed audit trail throughout data collection and 
analysis to support dependability (31). A detailed audit trail will be valuable in ensuring 
reproducible methods in a future study (31). The PI has personal experiences from caring 
for Black females with HF. Therefore, bracketing of those experiences is required before 




G. AIM 4: INTEGRATION OF RESULTS FROM AIM 2 AND 3 AIM 4: Integrate 
qualitative themes and quantitative symptom data to examine confirmation, 
expansion, and discordance of results (28, 37). 
G1. Procedures: Quantitative data and qualitative data will be collected simultaneously 
and analyzed separately, as previously described (28). Results from will then be merged 
through triangulation with the components of the SMM and MLHFQ (28, 35, 36).   
G2. Data management: Quantitative and qualitative data will continue to be managed as 
previously described. Data integration files will be stored in a secure, password-protected 
BOX folder on MUSC’s server.  
Data analysis. Preliminary symptom clusters and interview themes will undergo 
simultaneous integration (28). This involves first identifying common concepts. Common 
concepts will be identified by triangulating results with SMM components and MLHFQ 
domains (28, 35, 36). Common concepts will then be compared and contrasted to 
determine how results interact (28). Outcomes from the MM analyses will be used to 
interpret and explain the convergence or divergence in the results (28). This analysis will 
provide a richer understanding of the symptom clusters and the symptom experience. 
Findings will be represented using a comparative joint (28, 37). 
H. POTENTIAL PROBLEMS, ALTERNATIVE STRATEGIES, AND 
BENCHMARKS FOR SUCCESS 
H1: Challenges in mixed methods design: MM requires skills and experience with both 
quantitative and qualitative data collection and analysis, which is challenging for any 
researcher, especially a novice. However, the dissertation team behind this proposed 




will be essential to the success of this study. MM studies also require considerable time 
and resources. Timeliness is essential, and the PI will continually analyze qualitative data 
while still conducting other study aspects. Also, integration of results is another skill set 
and will require considerable time, effort, and collaboration with the dissertation 
committee.  
H2: Recruitment challenges: Due to COVID-19, face-to-face interactions are not 
currently possible. Recruiting via electronic flyers and calls can be challenging in 
establishing trust. Recruitment strategies include tailored social media ads using 
Facebook Ad Manager and collaborating with admins of HF support groups on 
Facebook. Participants would complete the survey via a REDCap® link and provide their 
phone number if interested in being contacted for an interview. Snowball sampling could 
be used to allow participants to share the ad with others that may qualify. Facebook ad 
manager would allow for detailed tracking of recruitment efforts to support the feasibility 
aim. The challenge that arises from this recruitment strategy is using self-report of 
HFpEF diagnosis from participants. HFpEF is a complex disease process that providers 
themselves find difficult to diagnosis (57). Asking participants to self-report their 
diagnosis is inferior to a confirmed diagnosis from a medical chart.  
H3: Generalizability: This study aims to assess the feasibility of an MM study. A 
sample size of 50 is adequate for fulfilling feasibility aims; however, the sample size is 
not adequate to form significant symptom clusters. Future research will be needed to 
create generalizable symptom cluster evidence.  
H4: Future research: If this study shows promise of feasibility, future research will 




and plan, a full study could create new evidence for the symptom experience and 
symptom clusters for Black women with HFpEF. Findings could be used to create 
tailored symptom education and self-management strategies for this high-risk population.  






Consent rate % of eligible participants 
consented by completing 
next survey 
>90% consent rate 
Recruitment % of participant recruitment 
goal 
>85% of recruitment 
goal (goal N=50 for 
survey, goal N=15 for 
interview) 
Interview interest rate % of participants interested 
in an interview 
>30% interview interest 




Average scores ranging from 
1-5 
Average score of 4 or 
higher 




Data collection time - 
Interview 
Interview duration average < 60 minutes 
Recruitment burden Time spent with recruitment 
/ week 
< 20 hours 
Management   
Transcription time Time spent with transcription 
/ editing transcripts 
< 2 hours / interview 
Software reliability  Issues with software / data 
management platforms 
No major events 
Adverse patient events  Adverse events during data 
collection 
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PROTECTION OF HUMAN SUBJECTS 
 
The proposed study qualifies for Institutional Review Board (IRB) exempt review 
categories 2 and 4.  Feasibility, questionnaire and interview data will be collected and 
analyzed from participants. Medical University of South Carolina (MUSC)’s IRB will 
serve as the main governing body from which the primary investigator (PI) will seek IRB 
approval.  
Risks to Human Subjects  
There is minimal risk to human subjects for the proposed study. Purposive 
sampling will be used to recruit a minimum of 50 participants from Facebook and word 
of mouth.  
Inclusion criteria: female sex, woman gender, Black race, a confirmed or self-
reported diagnosis of heart failure preserved ejection fraction, English speaking, and 35 
to 74 years old.  
Exclusion criteria: a diagnosis of an end-stage co-morbidity, stroke or myocardial 
infarction in the last 6 months, and currently experiencing an HF exacerbation that 
requires immediate hospitalization. 
After receiving IRB approval, participants will be recruited using Facebook posts 
and ads. Facebook respondents will self-report a diagnosis of HFpEF from a healthcare 
provider and state their ejection fraction to determine eligibility. Electronic flyers will be 
distributed via email or Facebook, and will contain study purposes, contact info, a link to 
the REDCap® screening questionnaire, and will offer an amazon electronic gift card ($25 




also be called to complete screening via phone if interested. If eligible, the PI will 
provide a link to the REDCap® survey. All survey respondents will be asked about 
interview participation interest and contact preferences. The PI will reach out to all 
participants interested in scheduling an interview and will coordinate a time that works 
best for the subject for informed consent and interviews via phone. Participants will also 
have the option to meet virtually through a free and HIPAA compliant platform if they 
have the technological capability. 
First, demographic information will be collected with a questionnaire in 
REDCap®, where it will be stored on the secure and password protected server. Next, the 
PI will administer the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The 
MLHFQ includes 21 questions related to the impact of physical symptoms, 
emotional/psychological symptoms, and HF related activities on daily life. To complete 
the questionnaire, the participants rate how much an item affected their life in the past 4 
weeks using a Likert scale of 0-5 with 0 indicating none, 1 very little, and 5 very much. 
The questionnaire will be administered to a minimum of the 50 participants. Next, the PI 
will administer the Symptom Status Questionnaire-Heart Failure (SSQ-HF). The SSQ-HF 
asks about the presence, frequency, severity, and distress of 7 HF symptoms in the last 4 
weeks using a Likert scale of 1-4 if a symptom is present with 4 being the most frequent, 
severe, or distressful. Next, the PI will administer the Personal Health Questionnaire 
Depression Scale (PHQ-8). The PHQ-8 asks about the frequency of 8 depressive 
symptoms over the last 2 weeks using a Likert scale of 0-3, with 0 being not at all and 3 
being nearly every day. Individual, semi-structured interviews will be conducted with at 




Interviews will also be conducted by telephone or via a HIPAA compliant platform at a 
time most convenient to the participant. The PI will ask participants open-ended 
questions about their sociocultural and demographic background and symptom 
experience. Participants will be asked to describe their symptoms and their response to 
symptoms in the last 4 weeks. After the MLHFQ is administered and the interview is 
complete, participants will be asked questions about feasibility and acceptability of the 
study protocol. It is predicted that all aspects of the study will take less than 2 hours per 
encounter if an interview is conducted and less than 1 hour if an interview is not 
conducted. 
The risk to subjects is breach in confidentiality about their disease, background 
and symptom experiences. There is also a risk that asking about symptoms and how they 
have affected their life in the last month could bring up negative feelings for the 
participant. Referral to mental health services may be completed by the PI if deemed 
necessary. It is also possible that the PI determines the participant may be currently 
having an acute exacerbation of HF in which they need immediate treatment. In this case, 
the participant would be referred to the clinic or emergency services, depending on 
perceived severity, and the PI would follow up to ensure safety of the participant.   
Adequacy of Protection Against Risks  
Every member of the research team will be required to have human subjects 
research training (CITI), patient privacy training (HIPAA), and any other training 
deemed necessary by the IRB. Responses to questionnaires will be recorded within 
REDCap® and will not be tied to any personal identifiers. No patient identifiers will be 




access to REDCap®. Audio from interviews will be recorded on a mobile device and 
uploaded to MUSC’s secure BOX server as soon as possible. An encrypted, secure, and 
HIPAA compliant platform will be used for interview transcription. The audio recordings 
and transcripts will be kept in a password protected, electronic folder in MUSC’s BOX 
per IRB requirements. Audio recordings will be destroyed once transcriptions are 
complete to protect the identity of participants. 
Withdrawal of Subjects 
Participants will be informed that they are allowed to withdrawal from the study 
at any time or refuse any aspect of the study. If the participant wishes to be removed from 
the study, the PI will not require anything in writing from the participants. Any 
information collected on the participant will be destroyed and the total number of 
withdrawn participants will be recorded for feasibility purposes.   
Potential Benefits of the Proposed Research to Human Subjects and Others  
There is no direct benefit to participants. Data from this study will be used to 
potentially support feasibility of a large, mixed methods study that aims to better 
understand the symptom experience and how symptoms clusters for Black women with 
HFpEF. This is a notably high-risk population that could eventually benefit from research 
focused on describing their symptom experience.  
Importance of the Knowledge to be Gained  
The proposed study has the potential impact of better understanding symptom 
clusters and the symptom experience for a high-risk and understudied population. 
Considering the increased burden of HF symptoms, greater risk, and worst outcomes in 




the symptom experience and symptom clusters in relation to gender, sex, race, and type 
of HF. Also, examining the feasibility of the proposed mixed methods study would allow 
others in the field to understand the nuances of recruitment and data collection for a 
Black, urban population of female participants with HFpEF. Data on recruitment efforts 
for an understudied population could potentially improve inclusion of the population in 
future research, thus increasing generalizability of HF symptom cluster research long-
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